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 Summary 
The major topic of this work was the development of novel synthetic routes towards 
enantiomerically pure building blocks for 2-deoxy-L-ribose and non-natural L-nucleosides 
derived thereof, with their therapeutic importance outlined in Chapter 1.  
 
In Chapter 2 the synthesis of enantiomerically pure R-(+)-5-benzyloxymethyl-5H-furan-2-
one (1) is described, which we chose as chiral starting material for the synthesis of 2-
deoxy-L-ribose. 1 was obtained from L-ascorbic acid in 5 steps and 26% overall yield. As 
an alternative 1 can also be obtained from R-(-)-benzylglycidol by either using 
PhSeCH2CO2H (2 steps, 61% overall yield) or PhSCH2CO2H (3 steps, 35% overall yield).  
 
In Chapter 3 the synthesis of 2-deoxy-L-ribose and building blocks derived thereof starting 
from 1 is described. We were able to prepare 2-deoxy-L-ribose following two different 
routes: 
The first route is based on previous experiments described by Fleming et al. related to the 
diastereoselective addition of silyl cuprate reagents to Michael systems, and to the fact that 
the silyl functions in the resulting derivatives can be transformed into the corresponding 
hydroxy groups with retention of configuration. We were able to synthesize 2-deoxy-L-
ribose (4 steps, 28% overall yield from 1) and related building blocks in enantiomerically 
pure form. 
The second route involves a) dihydroxylation of 1, b) selective protection of the 2-OH 
group and c) selective removal of this function. This way 2-deoxy-L-ribose was obtained 
from 1 in 5 steps with an overall yield of 18%.  
In comparing the two routes we feel that the dihydroxylation route has several advantages 
in using a) simpler procedures, b) commercially available reagents and c) being faster. The 
only remaining drawback is the requirement for one additional step and a lower overall 
yield (18%) as compared to the silyl based procedure (28%). This is, in our opinion, more 
than compensated by the rapid and facile procedure. 
 
In Chapter 4 the synthesis of two selected 2-deoxy-L-nucleosides is described. The 
Vorbrüggen procedure was used in the case of L-thymidine and the KI catalyzed procedure 
in the case of 2-deoxy-L-adenosine. In order to avoid equilibration between the pyranoside 
and furanoside forms of the free sugar, the 5-O-benzyl protected derivative 47 was 
employed. In order to demonstrate the usefulness of our building block having the 
backbone of 2-deoxy-L-ribose, we synthesized L-thymidine - a pyrimidine L-nucleoside- 
and 2-deoxy-L-adenosine, a purinic nucleoside. L-thymidine and 2-deoxy-L-adenosine 
were obtained in 48% and 30% overall yield, respectively. The major and unresolved 
remaining problem is the lack of diastereoselectivity in the coupling reactions leading to 
mixtures of α,β-anomers of the final nucleosides. 
 
In Chapter 5 the instability of δ-lactones towards acid catalysis is investigated. The 
enantiomerically pure (≥98% ee) R-(+)-6-methyl-tetrahydro-pyran-2-one (87) was 
prepared via TFA catalyzed cyclization of the corresponding acid. It was observed that this 
δ-lactone converts into an equilibrium mixture with its trimer (90) (monomer/trimer 20:80) 
corresponding to a ∆G ≅ -0.8 kcal mol-1 if traces of TFA are still present in the final 
product. The transformation can be followed by 1H and 13C-NMR. The structure of 90 was 
established by chemical correlation with the monomer and its molecular weight determined 
via its colligative properties. p-TsOH in contrast was shown to be a highly suitable catalyst 
for such cyclizations leading to pure and stable δ-lactones. 
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 2 
1 Overview 
 
One of the most exciting developments in nucleic acid chemistry has been the discovery of 
remarkably efficient routes towards the synthesis of DNA and RNA sequences1. These 
advancements allow for the production of any desired natural sequence as well as 
sequences having virtually any modification in the basic nucleotide structure. Many of 
these oligonucleotide analogs, particularly those having phosphate and sugar 
modifications, are important not only for structural and biological studies but also for the 
development of new therapeutic agents. Of particular importance in this regard are 
oligonucleotide analogs that interact selectively with RNA (the “antisense” strategy)2, 
double-stranded DNA (the “antigene” strategy)3, or peptide sequences (the “sense” 
strategy)4. 
The term nucleoside was originally applied to ribose derivatives of purines that can be 
isolated from an alkaline RNA hydrolysate. Later, this name was given to all purine and 
pyrimidine N-glycosides of D-ribose and 2-deoxy-D-ribose. Today, this term refers to all 
natural or synthetic compounds which consist of a heterocyclic nitrogen-containing base 
(aglycon) and a carbohydrate residue (glycon). The nitrogen atom (N-nucleoside) or carbon 
atom (C-nucleoside) of the heterocycle is linked to the anomeric carbon atom of the sugar 
residue. Ribonucleosides and deoxyribonucleosides are obtained from naturally occurring 
RNA and DNA by enzymatic or chemical hydrolysis. Most nucleosides are stable within a 
wide pH range. However, under strongly acidic or alkaline conditions at elevated 
temperature cleavage of the N-glycosidic bond may occur.  
The natural purine nucleosides are adenosine, deoxyadenosine, guanosine, and 
deoxyguanosine. The natural pyrimidine nucleosides are cytidine, deoxycytidine, 
thymidine, and uridine, all of them carrying the nucleobases in the β-orientation on the 
anomeric center (Figure 1.1). 
A limited number of nucleosides in the α-D configuration (e.g. 5,6-
dimethylbenzylimidazole-α-D-ribofuranoside of vitamin B12) can be isolated from natural 
substances. 
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Figure 1.1: Structures of the natural nucleosides present in DNA and RNA. 
 
L-Nucleosides are the enantiomers of the natural nucleosides which have an inverted 
configuration at all chiral centers. By analogy with the natural D-nucleosides, the aglycon 
moiety is designated to be β-oriented if it is cis to the 4’-hydroxymethyl group of the sugar 
moiety (Figure 1.2). 
 
cis
β-D-nucleoside β-L-nucleoside
O
HO
HO R
B OB
R OH
OH
O
HO
HO R
B
cis
 
 
Figure 1.2: Nomenclature of nucleoside enantiomers. 
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Enzyme catalyzed reactions are normally highly stereoselective and frequently act only on 
one enantiomer. This may be one possible reason why it took so long to pay attention to L-
nucleosides for their use in therapy. It was simply assumed that optically active compounds 
resembling natural nucleosides would be invariably more active than the unnatural L-
enantiomers. Belleau et al.5 first described the synthesis and anti-HIV activity of an 
unusual nucleoside analogue, racemic (±)-2’,3’-dideoxy-3’-thiacytidine (BCH-189). 
Subsequently, it was - rather surprisingly - discovered that the L-isomer of BCH-189 (3TC) 
was more potent and less toxic than its D-isomer6 (Figure 1.3). Since then, a number of L-
nucleoside analogs have been synthesized and were biologically evaluated.  
 
S
O
HO
N
NO NH2
S
ON
OH
N OH2N
(+)-BCH-189                                          (-)-3TC (lamivudine)  
 
Figure 1.3: 3TC, the first L-nucleoside with anti-HIV activity. 
 
However, the most surprising aspect was the fact that in some instances cellular kinases are 
able to phosphorylate L-nucleosides to their triphosphates, and thereby induce various 
biological activities. 
With the exception of optical rotation the physical and most of the chemical properties of 
L-nucleosides are identical with those of the D-counterparts. However, their 
pharmacological properties can differ for each isomer.  
The origin of these differences may be: 
 
• Different modes of nucleoside transport into the cells 
• Anabolic and catabolic enzymes which act on these compounds 
• Different interactions with the target enzymes (viral, cellular) 
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1.1 Anticancer activity of L-nucleosides 
 
Several different therapies are available for the treatment of cancer. Some of the most 
common include surgery, radiation and chemotherapy. However, none of these treatments 
can be considered a true cure, as all of them have shortcomings which make them 
unsuitable for treating certain types of cancer. For example, surgery, which is the oldest 
and most widely used approach at this stage, is quite effective in treating some cancers but 
cannot be used to treat tumors that are attached to vital organs nor tumors that have 
metastasized widely throughout the body. Radiation exploits the sensitivity of dividing 
cells to X-rays, but it is also not effective in treating metastasized tumors, which are the 
most common cause of cancer death7. Both surgery and radiation therapy can be effective 
in treating localized disease, but the frequent occurrence of metastases means that some 
form of systemic therapy is needed to increase the chances of a cure8.  
Chemotherapy is systemic and can therefore be used against metastasized tumors. 
Chemotherapy aims to target the differences between normal and cancer cells and therefore 
to achieve selective toxicity.  However, available chemotherapeutic drugs often display 
severe side effects. This is due to incomplete selectivity since the differences between 
normal and cancer cells are often relatively subtle7. 
There are several classes of chemotherapeutic drugs. They include antimetabolites, such as 
fluorouracil and methotrexate, topoisomerase inhibitors, such as doxorubicin and 
alkylating agents such as cyclophosphamide and chlorambucil. Many of these drugs 
interfere with tumor cell replication, and especially target rapidly dividing cells. All rapidly 
dividing cells require abundant supplies of deoxythymidylate for DNA synthesis. This 
makes them particulary vulnerable to inhibition of dTMP synthesis. Inhibitors of 
thymidylate synthesis and dihydrofolate reductase prevent uncontrolled cell proliferation 
by blocking its production and hence DNA replication.  
It has been shown that cellular membrane transport systems used in the uptake of sugars, 
amino acids, and nucleosides frequently function at higher capacity in transformed cells. 
Moreover the rate of DNA and RNA production as well as protein synthesis increase in 
cells undergoing rapid proliferation. 
Until recently, it was believed that L-isomers of nucleosides could not be effective anti-
cancer and anti-viral drugs as they would not be recognized by the cellular enzymes 
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responsible for their transport and activation9. However, a study by Casillas et al.10 showed 
that L-adenosine was a substrate for a transporter expressed in chromaffin tissue 
(homogeneous neural cell population). Today there is a growing body of evidence that 
enzymes involved in nucleoside metabolism that lack enantioselectivity with respect to D- 
and L-nucleosides are more common than was previously believed11. The L-nucleoside 
analogue, L-(-)-dioxolane cytidine (β-L-(-)-2’,3’-dideoxy-3’-oxacytidine), in addition to 
having potent anti-HBV and anti-HIV activity is also extremely cytotoxic (Figure 1.4). 
 
O
ON
OH
N OH2N
β-L-dioxolane cytidine  
 
Figure 1.4: β-L-dioxolane cytidine, an anticancer agent. 
 
When its anti-cancer potential was evaluated in comparison to arabinoside cytosine -the 
most effective drug clinically available for the treatment of acute leukemia- the L-
nucleoside was found to be effective against both solid and lymphoid tumors. This 
compound was a good substrate for replicative and repair DNA polymerases but resistant 
to inactivation by cytidine deaminase, which increased its effectiveness9. Toxicity 
experiments indicated that very high doses of the drug were well tolerated by mice12. All 
these factors may contribute to a greater efficacy of this compound in treating some types 
of tumors in comparison to currently available antitumor agents13. L-(-)-dioxolane cytidine 
is now at the stage of clinical trials. 
 
 
1.2 Antiviral activity of L-nucleosides 
 
Since the emergence of HIV, a number of nucleoside analogs with anti-HIV and anti-HBV 
activity have been synthesized. This antiviral activity is generally associated with one of 
the enantiomers. Interestingly, some unnatural L-nucleosides are more potent in this 
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respect than their natural D-counterparts. Biochemical studies suggest that among initial 
enzymes involved in the phosphorylation of the nucleosides, cellular deoxycytidine kinase 
(dCK) lacks stereoselectivity and often can phosphorylate both enantiomers.  
The mode of action of L-nucleosides as antiviral agent has been found to be similar to 
those of D-nucleosides; their intracellular phosphorylation to 5’-triphosphates inhibits the 
viral DNA polymerase with the resulting chain terminations of the viral DNA14. However, 
L-nucleosides exhibit different substrate specificities towards catabolizing enzymes, such 
as deoxycytidine deaminase and adenosine deaminase15. This property of L-nucleosides 
may be related to their enhanced potency as anti-HIV and anti-HBV agents. 
 
N
N
N
NHO
NH
NH2
ABV (Glaxo Wellcome)
O N
N
N
NHHO
O
ddI (Bristol-Myers Squibb)
O
HO
N
NO NH2
ddC (Hoffman La Roche)
O
HO
N3
N
N OO
         AZT (Glaxo Wellcome)
O
HO
N
N OO
         d4T (Bristol-Myers Squibb)
S
ON
OH
N OH2N
         3TC (Glaxo Wellcome) 
H
H
 
 
Figure 1.5: Nucleoside analogues approved by the FDA as anti-HIV drugs. 
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To date, only six nucleoside analogues have been approved by the American Food and 
Drug Administration as inhibitors of HIV replication. They are currently used clinically 
either alone or in conjunction with other inhibitors16. Among these six compounds, five 
have D-stereochemistry (AZT, ddI, ddC, d4T, ABV). One is the already described L-
configured 3TC (Figure 1.5). 
Lamivudine (3TC) or (2R,5S)-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine has the 
advantage of being less cytotoxic than the corresponding D-enantiomer. In addition to its 
anti-HIV properties, this very important compound also displays a powerful activity 
against the hepatitis B virus, and is currently administered in therapy against this virus16,17. 
 
 
1.3 Antimalaria activity of L-nucleosides 
 
Malaria, mostly caused by the parasite Plasmodium falciparum, devastates the world’s 
tropical zone. The World Health Organization indicates renewed activity of this endemic 
disease, with 300 to 500 million cases per year, 2.3 billion persons at risk, and 1.5 to 2.7 
million deaths per year18. 
Vaccination is considered to be an approach that will complement other strategies for 
prevention and control of the disease in the future, and in the last 10 years studies have 
been aimed at the development of a malaria vaccine.  
Due to the resistance of the parasite towards known drugs there is an increased need for 
novel antimalarials, particularly of those which have no affect on the host. When the 
malaria parasite invades the red blood cell, it induces a unique transport pathway in their 
membrane19. This transport pathway takes up both natural purine and pyrimidine 
nucleosides and bases. But surprisingly it also takes up non-physiological L-purine 
nucleosides. The concept of selective drug design is based on the fact that the malaria 
parasite must salvage purine nucleosides from the serum as it has no purine de novo 
pathway and thus utilizes preformed purines as nucleosides. Unlike normal erythrocytes, 
the induced nucleoside transport sites are not stereoselective, and low concentration of L-
nucleoside analogues are selectively transported exclusively into infected erythrocytes 
while normal erythrocytes are not affected20. Thus a unique opportunity exists for 
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exploiting these changes in transport phenomena as a strategy for gaining selective access 
to the malaria parasite. 
The design of substrates or inhibitors of the parasite metabolic pathways which a) gain 
selective entry to parasitised cells, and b) target only malarial enzymatic pathways, would 
be a powerful combination in the design of a specific agent against malaria. 
 
 
1.4 Aim of this thesis 
 
Main goal of this thesis was the development of new strategies towards the synthesis of L-
sugars as precursors of their corresponding L-nucleosides. In particular our effort has been 
focused towards novel routes to 2-deoxy-L-nucleosides whose syntheses are among the 
most difficult in nucleoside chemistry because total yields are frequently only moderate 
and the ratio of the β and α anomers are often difficult to control and to reproduce21. 
Our retrosynthetic approach to 2-deoxy-L-nucleosides is summarized in Scheme 1.1. The 
nucleoside structure can be obtained from a coupling reaction between a nucleobase and a 
suitable protected sugar carrying on the C-1 anomeric center an “activated” leaving group 
(i.e. halogens, acyloxy) which allow for SN displacement with nucleophiles. 1-halogenated 
sugars, however, are quite instable and reactions employing these starting materials are not 
always reproducible. On the contrary 1-acyloxy sugars are stable and excellent procedures 
have been developed over the years for their reactions with nucleobases (see chapter 4). 
Taking a general 2-deoxy-L-nucleoside as an example and following Scheme 1.1, we could 
break the C-N bond in position a in order to obtain the 1-acyloxy sugar III and the 
nucleobase. The 2-deoxy-L-ribose moiety III contains a protected hemiacetal function and 
could be synthesized (see cleavage b) from the β-hydroxy-γ-lactone II by selective 
reduction followed by acylation. II represents in our retrosynthetic analysis the most 
crucial intermediate. We felt that II could be derived from the α,β-unsaturated lactone I 
which contains a Michael 1,4-system which could allow for the insertion of  HO- in the 4-
position (cleavage c). The suitably protected hydroxymethyl group in I could play an 
important role in terms of diastereoselectivity. 
II may be thought to be derived also from the dihydroxy derivative IV via selective 
protection (activation) of the 2-hydroxy group followed by its selective removal (cleavage 
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d). IV could also be correlated directly to I if one could exploit the reactivity of its double 
bond and thus allow for a classical cis-dihydroxylation (cleavage e). 
 
β-2-deoxy-L-nucleoside
O O
RO
R'O
O
O O
RO
O O
RO
HO O R''
O O
RO
HO OH
a b
de
O O
RO
HO
c
e
III
III
VIV
+
O
HO
HO
N
Het N
Het
H
 
 
Scheme 1.1: Retrosynthetic analysis of 2-Deoxy-L-nucleosides 
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This work is divided into four main chapters:  
 
• the first part is dedicated to an investigation of the synthesis and reactivity of chiral 
γ-lactones; various novel approaches are reported. 
 
• the second part shows the application of γ-lactones as chiral building blocks for the 
synthesis of carbohydrates; the hydroxy functionalities were introduced by either 
1,4-addition of suitable nucleophiles or syn-dihydroxylation. 
 
• the third part describes the synthesis of 2-deoxy-L-nucleosides; here the major 
unresolved problem remains the problem of obtaining pure anomers. When 
building blocks with the 2-deoxy-L-ribose moieties were used always α,β-mixtures 
of the final L-nucleosides were obtained. 
 
• The fourth part describes an intensive study on synthesis and reactivity of 
enantiomerically pure δ-lactones with some new and surprising observations 
regarding their stability under acidic conditions. 
  
 
Results and Discussion 
                                                                                                             Results and Discussion 
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2 Synthesis of γ-lactones – Central building blocks for 2-
Deoxy-L-ribose 
 
In the previous chapter (retrosynthetic analysis) the utility of γ-lactones for the synthesis of 
L-sugars as precursors of the corresponding nucleosides was shown. Compounds having 
structures such as I (see chapter 1, Scheme 1.1) could represent ideal starting materials in 
order to achieve this goal. In particular we felt that the 5-O-benzyl protected butenolide 1 
(Figure 2.1) could display the suitable characteristics because it carries the acid and base 
stable benzyl group which could be easily removed by standard catalytic hydrogenation. 
Moreover, since the derivatization of the double bond in 1 would create additional chiral 
centers, the bulky benzyl group could direct these transformations diastereoselectively and 
control the attack from the opposite side of the lactone ring. 
 
O
O
O
1  
 
Figure 2.1: R-(+)-5-Benzyloxymethyl-5H-furan-2-one 
 
R-(+)-5-benzyloxymethyl-5H-furan-2-one (1) is not commercially available and its 
precursor R-(+)-5-hydroxymethyl-5H-furan-2-one (16, Scheme 2.2), carrying the free 
hydroxy group is extremely expensive (452 EUR/g, Fluka). The high cost of this 
compound prompted us to look for alternative processes which would allow for an 
economical and large scale preparation of this material.  
 
 
2.1 Synthesis of 1 from L-tartaric acid22 
 
In the literature several approaches towards 1 were described. One strategy allows the 
synthesis of 1 in 7 steps starting from L-tartaric acid with an overall yield of 35% (Scheme 
2.1). 
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Scheme 2.1: a) acetone dimethylacetal, p-TsOH, MeOH; b) LiAlH4; c) NaH, BnBr; d) PPh3, CCl4; e) n-BuLi; 
f) CO2, n-BuLi; g) H2, Pd, BaSO4. 
 
The first step employs the diesterification of the carboxylic acid functions in 2 with 
concomitant acetal formation leading to 3 using acetone dimethylacetal in MeOH in the 
presence of p-TsOH. This is followed by reduction of the ester groups with LiAlH4 
affording the diol 4. Monoprotection of the diol 4 (NaH/BnBr) leads to 5 which is 
converted into the chloride 6 using PPh3 in CCl4. Double deprotonation with n-BuLi leads 
to the alkyne 7 via the intermediate alkene. Carbonylation to 8 and selective reduction with 
concomitant cyclization finally leads to 1. Although this way a high overall yield can be 
achieved, we felt that the large number of steps and the use of moisture sensitive 
                                                                                                             Results and Discussion 
 15 
organometallic reagents would render this method not very convenient for preparations on 
a large scale. 
 
 
2.2 Synthesis of 1 from L-ascorbic acid 
 
Another attractive starting material for the preparation of 1 certainly is (S)-glyceraldehyde 
(12) which can be obtained both from L-ascorbic acid23 and L-mannitol24.  
We decided to use the route starting from L-ascorbic acid (9) because of its low cost and 
the limited number of steps required in this procedure. 
Starting from L-ascorbic acid (9) Hubschwerlen23c described the synthesis of R-(-)-Z-3-
(2,2-Dimethyl-[1,3]-dioxolan-4-yl)-acrylic acid ethyl ester (14) in good overall yield 
(Scheme 2.2).  
14 represents an excellent intermediate for our purpose since the cleavage of the acetal 
function under acidic conditions and subsequent cyclization would directly lead to R-(+)-5-
hydroxymethyl-5H-furan-2-one (16) which could possibly be transformed into the desired 
benzyl protected derivative 1. 
The first step involves the catalytic hydrogenation of an aqueous solution of 9 using Pd/C 
10% over a period of 24h with a H2 pressure of 5 Bar. The completely hydrogenated 
product 10 was isolated in quantitative yield and with high chemical purity. The second 
step involves the regioselective protection of one diol function using isopropenyl 
methylether as reagent. This reaction was carried out in DMF using p-TsOH as catalyst. 
The acetal 11 was isolated in 76% yield. Oxidation of the cis diol function in 11 with 
NaIO4 produced the instable (S)-glyceraldehyde (12) which was reacted without isolation 
with the Wittig reagent (Triphenyl-λ5-phosphanylidene)-acetic acid ethyl ester25 (13) 
leading to a mixture of the desired α,β-unsaturated Z-ester 14 and E-ester 15. This mixture 
was easily separated by column chromatography on silica gel leading to pure 14 in 58% 
yield starting from 11. 
In order to prepare our target compound R-(+)-5-benzyloxymethyl-5H-furan-2-one (1), the 
acetal function was cleaved under acidic conditions26 (aqueous 10% H2SO4) leading to a 
concomitant, spontaneous cyclization under the formation of R-(+)-5-hydroxymethyl-5H-
furan-2-one (16) in 72% yield.  
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Scheme 2.2: a) H2, Pd/C 10%, water, 50 °C, 24h; b) Isopropenylmethylether, p-TsOH, DMF, rt, 24h; c) 
NaIO4, water, rt, 2h; d) Ph3P=CHCO2Et (13), dichloromethane/H2O, rt, over night. e) H2SO4 (10% in water), 
MeOH, rt, 2h; f) Cl3CC(=NH)OBn (17), CF3SO3H, dichloromethane/cyclohexane (2/1), rt, 2h. 
 
While more classical methods for the introduction of the benzyl group (NaH/BnBr, 
Ag2O/BnBr27) failed, 1 was obtained from 16 in 84% yield using 2,2,2-Trichloro-
acetimidic acid benzyl ester28 (17) in the presence of CF3SO3H (Scheme 2.2). 
This way 1 was obtained in  29% overall yield starting from L-ascorbic acid (9). The 
synthesis can be carried out conveniently on a 100g scale using standard equipment. In 
view of the facile procedure further up-scaling into the Kg scale should be possible without 
difficulty. 
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2.3 Synthesis of 1 from R-(-)-2-benzyloxymethyl oxirane using the 
Krapcho method 
 
One of the procedures described in the literature for the synthesis of γ-lactones is the 
Krapcho method29. This strategy consists in the reaction of an epoxide with the ester 
enolate of a malonic ester in order to obtain a γ-hydroxy diester which upon heating 
cyclizes to γ-lactone via concomitant decarboxylation (Scheme 2.3). 
 
O
R
O OR
a
b 
O OR
CO2Et
R CO2Et
OH CO2Et
 
 
Scheme 2.3: Krapcho method. a) M-CH(CO2Et)2; b) NaCl, H2O, DMSO, 150 °C 
 
In our case the epoxide of choice was obviously R-(-)-2-benzyloxymethyl oxirane (18), a 
compound which is commercially available. As outlined in Scheme 2.4 reaction of 18 with 
the lithium salt of malonic acid diethyl ester at –78 °C in THF using BF3-Et2O for the 
activation of the epoxide towards the nucleophilic attack led to 19 in 81% yield. If this 
reaction is carried out in ethanol using sodium ethoxide as base, the yield is reduced to 
only 50%. This can probably be explained by the lack of regioselectivity in the ring 
opening reaction under these conditions. For the cyclization reaction 19 was heated in 
DMSO in the presence of H2O and NaCl at 150 °C for 6h to afford the lactone 21 in only 
36% yield via decarboxylation of the intermediate β-carboxyl ester 20. The conversion of 
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the saturated lactone 21 into 1 was already described30. Deprotonation with LDA at –78 °C 
and quenching with PhSeBr produced 22 as mixture of diastereoisomers in 52% yield after 
chromatographic separation on silica gel. Oxidation to the selenium oxide was 
accomplished with NaIO431 followed by concomitant syn-elimination32 to produce 1 with a 
yield of 85%. If the oxidation is carried out with H2O232e 1 is isolated in only 65% yield 
(Scheme 2.4). 
 
O
BnO
O O
BnO
BnO
CO2Et
OH CO2Et
18  19
1
a
81%
c
52%
O O
BnO
SePh22
d
85%
b 
36%
21
O O
BnO
O O
BnO
CO2Et20
 
Scheme 2.4: a) diethylmalonate, BuLi, BF3-Et2O, THF, -78 °C, 1.30h; b) NaCl, H2O, DMSO, 150 °C, 6h; c) 
HMDS, BuLi, PhSeBr, THF, -78 °C, 5min; d) NaIO4, MeOH/H2O, rt, 1h. 
 
Although in this procedure the number of steps can be reduced to 4, the low overall yield 
of this process (13%) provides no advantage over the preparation of 1 starting from L-
ascorbic acid. Furthermore, requirement for toxic selenium derivatives for the introduction 
of the double bond in the lactone ring renders this method not very attractive from an 
ecological point of view. 
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2.4 Synthesis of 1 from R-(-)-2-benzyloxymethyl oxirane using 
PhSeCH2CO2H or PhSCH2CO2H 
 
In order to improve the above method, alternative approaches towards 1 were explored. 
Thus, as an alternative to the introduction of the double bond following the Krapcho 
method, retrosynthetic analysis of 22 reveals the interesting possibility to obtain 22 starting 
from R-(-)-2-benzyloxymethyl oxirane (18) and phenylselanyl acetic acid (23) by breaking 
the bonds in positions a and b as represented in Scheme 2.5. 
 
22
O O
BnO
SePh
a
b
O
BnO
HO O
SePh
18 23  
 
Scheme 2.5: Retrosynthesis of (3R,S-5R)-Benzyloxymethyl-3-(phenylselanyl)-dihydro-furan-2-one (22) 
 
Thus, deprotonation of the acidic proton α to the carbonyl group (together with the OH 
proton) in 23 would form a di-enolate which could add regioselectively to the epoxide 18 
leading to 22 which, as previously shown, can be transformed into 1 in 85% yield by 
oxidative syn-elimination32. Using commercially available R-(-)-2-benzyloxymethyl 
oxirane (18) (≥98% ee), we were indeed able to obtain 1 this way in two steps with an 
overall yield of 61% (Scheme 2.6). 
Thus, nucleophilic ring opening of 18 with the dilithium salt of PhSeCH2CO2H at –78 °C 
followed by refluxing with AcOH overnight led to (3R,S-5R)-benzyloxymethyl-3-
(phenylselanyl)-dihydro-furan-2-one (22) in 72% yield as mixture of diastereoisomers. 
Oxidation of the phenylselenide function with NaIO4 was accomplished with concomitant 
formal syn-elimination of benzeneselenenic acid (PhSeOH) in 24 leading directly and in 
85% yield to 1. 
In comparison to the routes using L-tartaric acid or L-ascorbic acid as starting materials this 
method is of course much more convenient since it requires only two steps and produces 1 
with an overall yield of 61%.  
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Scheme 2.6: a) 1. LDA, THF, -78 °C – rt, 3h; 2. AcOH, reflux, overnight. b) NaIO4, MeOH/H2O, rt, 1h. 
 
PhSeCH2CO2H is not commercially available but can be prepared33 easily and in a 
preparative scale simply by reacting chloroacetic acid (25) and diphenyldiselenide (26, 
Scheme 2.7). 
 
PhSe
OH
O
23
Cl
OH
O
25 26
Se Se
PhPh a
70%
 
 
Scheme 2.7: a) NaBH4, EtOH, 7h, rt. 
 
The major drawback of this method is the use of toxic selenium compounds which, 
especially for large scale preparations, represents an ecological problem. 
An alternative for the introduction of the required double bond and mechanistically related 
would be the syn-elimination of the corresponding aryl sulfoxides34. Thus, based on the 
retrosynthetic Scheme 2.5, we decided to exchange selenium by sulfur, in reacting 18 with 
phenylsulfanyl acetic acid (27, Scheme 2.8). 
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Scheme 2.8 a) 1. LDA, THF, -78 °C – rt, 3h; 2. AcOH, reflux, overnight. b) NaIO4, MeOH/H2O, rt, over 
night. c) toluene, reflux, 30 min. 
 
Thus, ring opening of 18 with the dilithium salt of PhSCH2CO2H led to (3R,S- 5R)-5-
benzyloxymethyl-3-(phenylsulfanyl)-dihydro-furan-2-one (28) in 70% yield again as 
mixture of diastereoisomers. Oxidation with NaIO4 produced a diastereoisomeric mixture 
of the corresponding sulfoxides 29, which in this case are stable and can be isolated. After 
work up and without further purification this mixture was refluxed in toluene for 30min 
leading to 1 in 50% yield. 
Also 27 is not commercially available but can be prepared35 in one step reaction from 
bromoacetic acid (30) and thiophenol (31) using NaOH as base (Scheme 2.9). 
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Scheme 2.9: a) NaOH, THF/H2O, 30min, rt. 
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While the use of PhSeCH2CO2H thus allows the production of 1 in only two steps with an 
overall yield of 61%, the use of PhSCH2CO2H (three steps, 35% yield) may be of 
advantage from an ecological point of view by avoiding the employment of toxic selenium 
compounds. Both reactions can be scaled up to 5g without any difficulties. 
 
 
2.5 Determination of the optical purity of 1 
 
For the determination of the optical purity of 1 an HPLC method on a chiral support had to 
be developed. As reference for the HPLC separation ent-1 was prepared from 
commercially available S-(-)-5-hydroxymethyl-5H-furan-2-one ent-(16) using the 
procedure described in Scheme 2.2. Due to the presence of a benzyl group as chromophor, 
UV detection could be employed. 
Although a wide variety of different columns were tried, no satisfactory separation of the 
R,S mixture was achieved. Therefore we decided to investigate other protective groups for 
the 5-hydroxymethyl function in 1. 
The characteristics of this protecting group should be a) the simplicity of introduction 
together with b) the requirement of a suitable chromophor for UV detection. This prompted 
us to investigate the use of silyl ethers carrying phenyl groups. 
Unfortunately, the introduction of these silyl groups proved to be not straightforward. 
Using more standard conditions (Et3N, DMAP, t-BuPh2SiCl36) and depending on the 
employed reaction times various degrees of racemization were observed. We attribute this 
to the transient deprotonation of the allylic proton (homologous acid) at C-5 (Scheme 
2.10). If, however, t-BuPh2SiCl and NH4NO337 are used, the desired R-(+)-5-(tert-butyl-
diphenyl-silanyloxymethyl)-5H-furan-2-one (32) was obtained with excellent yield and 
free of racemization. 
Excellent separations were achieved using the column LiChoCART 250-4 (S,S)-Whelk-
5µm and the following conditions: eluent n-hexane/isopropanol (97/3 v/v), flow rate 1 
ml/min, detector UV 254 nm. As shown in Figure 2.2a a base line separation of the 
racemic mixture was achieved under these conditions allowing a reliable determination of 
the enantiomeric purities of 1 derived from the various employed routes. 
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Scheme 2.10 a) t-BuPh2SiCl, NH4NO3, DMF, rt, 24h; b) t-BuPh2SiCl, Et3N, DMAP, dichloromethane, 0 °C – 
rt, 4h. 
 
 
 
 
Figure 2.2: HPLC analysis. Column LiChoCART 250-4 (S,S)-Whelk-5µm eluent n-hexane/isopropanol (97/3 
v/v), flow rate 1 ml/min, detector UV 254 nm. a) racemic mixture of 32; b) R-(32) from L-ascorbic acid, ee 
≥98%; c) R-(32) from Krapcho method and from PhSeCH2CO2H, ee ≥97%; d) R-(32) from PhSCH2CO2H, ee 
≥95%. 
a) b) c)
R S 
R R
S S 
R
S 
d)
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Starting from L-ascorbic acid the resulting 16 was converted directly into 32. In contrast, 
starting from R-(-)-2-benzyloxymethyl oxirane (18), the benzyl group had to be first 
removed (H2, Pd/C) and the resulting 16 then transformed into 32 using the sequence 
described in Scheme 2.11. 
 
90%
1                                                                            
O O
BnO
 
O O
t-BuPh2SiOa
32  
 
Scheme 2.11: a) 1. Pd/C 10%, AcOEt, rt, 1h; 2. t-BuPh2SiCl, NH4NO3, DMF, rt, 24h. 
 
 
2.6 Synthesis of γ-lactones – Summary 
 
In conclusion, four different methods have been developed towards the synthesis of R-(+)-
5-benzyloxymethyl-5H-furan-2-one (1) with all routes having various advantages and also 
drawbacks (Scheme 2.12).  
The first route uses L-ascorbic acid as starting material and produces the product with the 
highest enantiomeric purity (≥98% ee). This should always be taken into consideration 
when - as in our case - the synthesis of biologically active molecules is planned. On the 
other hand this route requires the largest number of steps with an overall yield from L-
ascorbic acid of 29%. The Krapcho method starting from R-(-)-2-benzyloxymethyl oxirane 
(18) results in a poor overall yield of only 13% and furthermore utilizes toxic selenium 
derivatives. The enantiomeric purity is also very high (≥97% ee). A much better alternative 
– although also using selenium compounds as intermediates – is the route using R-(-)-2-
benzyloxymethyl oxirane (18) and PhSeCH2CO2H. Only two steps are required and an 
overall yield of 61% is achieved. Again the enantiomeric purity is very high. The last 
procedure using PhSCH2CO2H eliminates all problems regarding toxic compounds. In this 
case we have to accept a lower overall yield (35%) and the lowest enantiomeric purity 
(≥95% ee) observed among all studied procedures. 
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Scheme 2.12: 4 routes to R-(+)-5-benzyloxymethyl-5H-furan-2-one (1) 
 
In summary, the enantiomeric excess achieved in the syntheses of R-(+)-5-
benzyloxymethyl-5H-furan-2-one (1) via these all four different routes are as follows: 
 
• from L-ascorbic acid:        ≥98% ee  
• from R-(-)-2-benzyloxymethyl oxirane using the Krapcho method: ≥97% ee 
• from R-(-)-2-benzyloxymethyl oxirane using PhSeCH2CO2H:  ≥97% ee 
• from R-(-)-2-benzyloxymethyl oxirane using PhSCH2CO2H:  ≥95% ee 
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3 2-Deoxy-L-ribose and building blocks derived thereof 
 
3.1. Introduction – State of the art 
 
This chapter describes new methodologies for the synthesis of carbohydrates of the L-
series and derivatives thereof. Next to constituting building blocks for L-nucleosides with 
both natural and non-natural nucleobases and thus attractive candidates for numerous 
therapeutic applications in treating cancer, viral diseases and malaria (chapter 1) these L-
riboses are the building blocks for enantio-DNA which could code for D-proteins and an 
enantiomeric living world. 
Several synthetic approaches to 2-deoxy-L-ribose have been published in recent years, 
most of them starting with molecules of the “chiral pool” such as L-arabinose or L-ascorbic 
acid38. Alternatively, the required absolute configuration was introduced by 
asymmetrization of an achiral starting material e.g. by employing the Sharpless 
epoxidation39. 
The most attractive methods, largely developed by Michael Jung et al. are described 
below. 
 
 
3.1.1 2-Deoxy-L-ribose starting from L-arabinose40: 
 
Perbenzoylation of L-arabinose (33) followed by treatment with HBr/AcOH affords the 
isomeric furanose 34 and the pyranose 35 which are separable via column 
chromatography. Reductive radical rearrangement of the bromopyranose 35 under the 
Giese41 conditions leads to the deoxygenated intermediate 36 in 60% yield which can be 
hydrolyzed leading to 2-deoxy-L-ribose (37 + 38) in high yield (Scheme 3.1). 
As an alternative42 and shown in Scheme 3.2, L-arabinose (33) was first transformed into 
its methyl glycoside and then esterified with 4-methylbenzoic acid chloride (TolCl). 
Reaction with HBr/AcOH led to the bromo-derivative 39 in 67% overall yield. Also in this 
case, using the Giese41 1,2-acyloxy shift rearrangement the desired 2-deoxygenated 
intermediate 40 was produced in 50% yield. 40 can then be easily hydrolyzed to 2-deoxy-
L-ribose.  
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Scheme 3.1: a) 1. BzCl, pyridine; 2. HBr, AcOH; b) Bu3SnH, AIBN; c) hydrolysis. 
 
The major importance of this intermediate resides in the fact that it has been employed in 
some cases for the diastereoselective formation of single anomers of 2-deoxy-L-
nucleosides42 (see chapter 4). 
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Scheme 3.2: a) 1. MeOH, HCl. 2. TolCl, pyridine. 3. HBr/AcOH; b) Bu3SnH, AIBN; c) hydrolysis. 
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One limitation of these procedures resides in the fact that under the Giese41 conditions 
(Bu3SnH/AIBN) is not always possible to completely control the 1,2-acyloxy shift. This 
causes the production of variable amounts of “direct reduction” products of 39 to 41 with 
sometimes severe losses of chemical yield. 
 
 
3.1.2 2-Deoxy-L-ribose via Sharpless Epoxidation39 
 
Sharpless epoxidation of the dienol 42 produces the epoxide 43 in 62% yield and with 
100% enantiomeric excess. Ring opening of the activated [Ti(iOPr)4] epoxide with BnOH 
leads to 44 in 60% yield. 44 can then be transformed into the acetal 45 in 75% yield. 
Wacker oxidation of the terminal olefin produced the aldehyde 46 in 38% yield. The 
benzyl protected 2-deoxy-L-ribose 47 was finally obtained via acid catalyzed cyclization of 
46 in 58% yield (Scheme 3.3). 
 
OH OH
O
OBn
HO OH
OBn
OO
OBnOHC
OOO OH
BnO
HO
42 43 44
454647
a
62%
b
c
de
60%
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38%58%
 
Scheme 3.3: a) D-(-)DIPT, Ti(iOPr)4, tBuOOH, CH2Cl2; b) BnOH, Ti(iOPr)4; c) acetone, CuSO4, TsOH; d) 
PdCl2 (0.2eq), CuCl, O2, DMF/H2O 7:1; e) 1N HCl. 
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3.2 Retrosynthetic analysis 
 
As outlined in Scheme 1.1 of chapter 1 and largely discussed in chapter 2, our 
retrosynthetic approach towards the synthesis of 2-deoxy-L-ribose and of the 
corresponding 2-deoxy-L-nuceosides employs as starting material the butenolide 1. L-
thymidine as an example, can thus be formed by coupling the nucleobase thymine and 
peracetylated 47. 47 could be obtained by selective reduction of the β-hydroxy-γ-lactone 
48 which in turn could be obtained by diastereoselective, formal 1,4-addition of OH - to the 
Michael system in 1 (Scheme 3.4). 
 
β-L-thymidine
O OH
BnO
HO
O O
BnO
O O
BnO
HO
47
481
O
HO
HO
N
N OO
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Scheme 3.4: Retrosynthesis of β-L-thymidine: correlation with 1 
 
 
3.3 The reactivity of nucleophilic oxygen species in 1,4-additions to 1 
 
In a Michael system such as in 1 (Figure 3.1), there are two electrophilic positions present: 
the C=O group (hard 2-position) and the C=C group (soft 4-position). In accordance with 
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the “hard-soft-acid-base” (HSAB) rationale43, most oxygen nucleophiles (hard) would 
react preferentially with the carbonyl group although some selected examples for Michael 
additions of alcohols are reported in the literature44. 
 
1
2
34
soft nucleophiles 
hard nucleophiles
O O
BnO
1  
 
Figure 3.1: sites of reactivity of 1. 
 
 
3.3.1 1,4-Addition of benzyl alcoholates - Attempts 
 
Our first attempts along these lines employed benzyl alcoholates, because once introduced, 
the benzyl group could be easily removed by catalytic hydrogenation leading to the β-
hydroxy-γ-lactone 48. Unfortunately, the formation of 3-benzyloxy derivative 49 was not 
observed. The basic conditions employed (NaH, BnOH) probably favored the opening of 
the lactone ring and thus 1,2-addition (Scheme 3.5). 
 
O O
BnO
1
O O
BnO
O
Ph 49
O O
BnO
HO
48
a
 
Scheme 3.5: a) BnOH, NaH, DMF 
 
 
3.3.2 1,4-Addition of acetates - Attempts 
 
As another nucleophilic oxygen species we considered the acetate anion. Following its 
successful introduction, the hydrolysis of the thus generated 50 would lead to β-hydroxy-γ-
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lactone 48 (Scheme 3.6). Although polar aprotic solvents (HMPT/DMSO) and a large 
counter ion (Cs+) were employed– conditions that enhance nucleophilicity – the formation 
of the 3-acetoxy derivative 50 was not observed. In this case, however, a different product 
was isolated, which was identified as having the dimeric structure 51. Evidently, the 
basicity of the reaction system favored deprotonation of the acidic transient allylic proton 
in 1 to form the corresponding enolate which could then react in a 1,4-addition with itself 
leading to 51. The literature evidence supported such reactions45 and the chemical analyses 
clearly confirmed the structure of 51. 
 
O O
BnO
1
O O
BnO
O
O
50
a
O O
O
BnO
O OBn
51
1
27%
O O
BnO
a
48
 
 
Scheme 3.6: a) CsOAc, DMSO, HMPT, rt, 1h. 
 
These results clearly indicate the difficulties encountered in the direct introduction of the 
“hard” oxygen atom via a Michael addition to systems such as 1. The lability of the lactone 
ring under basic conditions favors the formation of open chain products (1,2-addition) and 
the acidic allylic proton in the 5-position generates carbanions which can further react with 
Michael systems as described above (Scheme 3.6). 
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3.4 Epoxidation of the double bond in 1 - Attempts 
 
3.4.1 Epoxidation using peroxycarboxylic acids 
 
Diastereoselective epoxidation of 1 (Scheme 3.7) would lead to a highly attractive 
intermediate 52 which could possibly be regioselectively opened to the β-hydroxy-γ-
lactone 48, whose importance was already described in the retrosynthetic Scheme 3.4 
(paragraph 3.2). 
 
O O
BnO
O
O O
BnO
1
O O
BnO
HO
4852
[O] H
 
 
Scheme 3.7: Diastereoselective epoxidation of 1. 
 
General reagents for the direct conversion of alkenes to epoxides are peroxycarboxylic 
acids. m-Chloroperoxybenzoic acid (m-CPBA), peroxyacetic acid (CH3CO3H), 
peroxybenzoic acid (PhCO3H) and peroxytrifluoroacetic acid (CF3CO3H) are particularly 
convenient reagents due either a) to their simplicity of application (m-CPBA and 
CH3CO3H are commercially available) or b) for their strong oxidizing properties such as 
CF3CO3H (Scheme 3.8). 
 
O
R
R'
R
R'
+     RCO2H
R R
R' R'
+     RCO3H
 
 
Scheme 3.8: Epoxidation of simple olefins 
 
These epoxidations usually work well when the alkene is substituted with electron-
donating groups. However, if electron-attracting substituents such as carbonyl groups are 
directly attached to the double bond, no epoxidation is usually observed. Here only the 
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strongly oxidizing agent CF3CO3H found limited applications46. No epoxidations of 1 were 
observed with any of the above reagents (Scheme 3.9). 
 
O O
BnO
O
O O
BnO
1 52
CF3CO3H
 
 
Scheme 3.9: Attempts to epoxidize 1 using CF3CO3H 
 
 
3.4.2 Epoxidation using H2O2 
 
Another general method for the direct conversion of alkenes to epoxides employs the use 
of H2O2. The mechanism is completely different as observed in the case of 
peroxycarboxylic acids. Here, the reactive species is the deprotonated form of the 
peroxides and thus reactions have to be carried out under basic conditions (Scheme 3.10). 
 
R' R
O
+ HOO
R' R
OO
HO
O
R'
O
R + HO
 
 
Scheme 3.10: Mechanism of olefin epoxidation by H2O2 
 
1 was thus reacted under standard conditions using 30% aqueous H2O2 in MeOH and 4N 
NaOH as base. Unfortunately, again 52 could not be obtained following this procedure 
(Scheme 3.11). Tishler et al.47 reported an extensive study on the epoxidation of 
butenolides. This paper confirms the difficulty to epoxidize butenolides such as 1 under 
standard conditions (the paper reports butenolides to be unreactive under all the published 
epoxidation methods). 
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Scheme 3.11: Attempts to epoxidize 1 using H2O2 
 
Also the use of dioxiranes48 (e.g. dimethyl dioxiranes), which are reported to be capable to 
epoxidize double bonds conjugated with carbonyl groups were unsuccessful when applied 
to 1. 
 
 
3.5 Using the dimethyl-phenyl-silyl group as nucleophile 
 
The β-hydroxy-γ-lactone 48 can potentially be synthesized from 1 using known Fleming 
chemistry49 via Michael addition of the dimethyl-phenylsilyl group which, once 
introduced, can easily be transformed to an OH group50. The actual reagent for this 1,4-
addition is the organocuprate with the formula (PhMe2Si)2Cu(CN)Li2 which can be 
prepared directly from dimethyl-phenylsilyl chloride and lithium metal. This cuprate 
reagent has the disadvantage of being unstable and therefore must be prepared in situ 
immediately prior to use. Following this route cuprate addition of (PhMe2Si)2Cu(CN)Li2 
(53) to 1 indeed afforded the desired, corresponding silyl derivative 54 in 90% yield. As to 
judge from the 13C-NMR, only the desired diastereoisomer was produced (Scheme 3.12). 
 
O O
BnO
1
O O
BnO
Si
Ph
a
54
90%
 
 
Scheme 3.12: a) (PhMe2Si)2Cu(CN)Li2 (53), THF, -45 °C, 1h. 
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Normally the reagent is used in double excess to the substrate. This, of course, can cause 
some economical problems in large scale syntheses. 
 
 
3.6 Conversion of the dimethyl-phenylsilyl group into-OH group 
 
Fleming at al. also reported that a variety of reagents can transform the dimethyl-
phenylsilyl function into an OH group50. As shown in Scheme 3.13, protodesilylation of 
the phenyl group can be accomplished in the simplest way by using HCl or HBF4. If these 
two reagents are employed, the halogenosilyl intermediate 55 must first be isolated and 
then further reacted with peracids to afford the desired β-hydroxy-γ-lactone 48. This is 
obtained with retention of configuration following the mechanism outlined in Scheme 
3.13. 
 
a + Ph-E b
O O
BnO
Si
Ph
O O
BnO
Si
X
O O
BnO
Si
O
RCO2
O O
BnO
O
Si
RCO2
O O
BnO
HO
48
54 55
 
Scheme 3.13: Mechanism of peracid oxidation of the dimethyl-phenyl silyl group; a) E+X- = [Hg(OAc)2, Br2, 
HCl, HBF4]; b) peracids. 
 
However, also other reagents were described allowing the accomplishment of both steps a 
and b (Scheme 3.13) in the sense of a “one pot procedure”, thus avoiding the isolation of 
the intermediate 55. 
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3.6.1 Desilylation using Hg(OAc)2/AcO2H50b 
 
For this transformation an excess of AcO2H and Hg(OAc)2 was added to 54 and the 
resulting mixture stirred for 3h at rt. After work up the desired 48 was isolated in 44% 
yield with complete retention of configuration (Scheme 3.14). 
 
a
O O
BnO
Si
Ph
O O
BnO
HO
4854
44%
 
 
Scheme 3.14: a) Hg(OAc)2, AcO2H, AcOH, rt, 3h. 
 
 
3.6.2 Desilylation using Hg(CF3CO2)2/AcO2H50c 
 
It was reported in the literature that the more active Hg(CF3CO2)2 in some cases led to 
higher yields for this transformation. However, in our hands and using  similar conditions 
as described for the Hg(OAc)2 procedure (paragraph 3.6.1), 48 was produced with lower 
yield (38%, Scheme 3.15). 
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O O
BnO
Si
Ph
O O
BnO
HO
4854
38%
 
 
Scheme 3.15: a) Hg(CF3CO2)2, AcO2H, AcOH/CF3CO2H, 0 °C - rt, 3.5h. 
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3.6.3 Desilylation using Br2/AcO2H50b 
 
Finally, conversion of the silyl derivative 54 into the corresponding β-hydroxy-γ-lactone 
48 was achieved in 65% yield by using Br2/AcO2H at rt for 5h. In addition to producing the 
highest yield, this method has also the advantage of avoiding mercury containing reagents 
(Scheme 3.16). 
 
a
O O
BnO
Si
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O O
BnO
HO
4854
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Scheme 3.16: a) Br2 (1M in AcOH), AcO2H, 0 °C -  rt, 5h. 
 
Furthermore this method can be carried out without using elemental bromine which can be 
produced in situ by oxidation of KBr to Br2. The yields are comparable with those obtained 
if Br2 is used directly.  
 
 
3.7 Reduction of lactone 48 to lactol 47 
 
For the reduction of the lactone 48 to the lactol 47 two different method were tested. 
 
3.7.1 Using DIBAL 
 
Diisobutylaluminum hydride (DIBAL) is reported to reduce selectively esters and lactones 
to aldehydes and hemiacetals respectively51. Using three equivalents of DIBAL for the 
reduction of 48 at –78 °C for 4h led to 47 in only 10% yield together with unreacted 
starting material. All attempts to increase the yield by extending the reaction times or 
increasing the temperature (e.g. –50 °C for 7h) did not lead to any improvement (Scheme 
3.17). 
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Scheme 3.17: a) DIBAL, THF, -78 °C, 4h. 
 
 
3.7.2 Using Disiamylborane 
 
It is reported in the literature52 that disiamylborane can selectively reduce lactones to 
lactols. Disiamylborane is not commercially available, but can be easily prepared in situ 
from BH3 (1M solution in THF) and 2-methyl-2-butene (Scheme 3.18) 
 
+   BH3 B
H
disiamylborane
a
 
 
Scheme 3.18: In situ preparation of disiamylborane a) THF, 0 °C, 20min 
 
Thus, the β-hydroxy-γ-lactone 48 was reacted with an excess of disiamylborane in THF for 
24h at rt and the corresponding lactol 47 was obtained in 60% yield as anomeric mixture 
(α/β ≅ 70/30 in CDCl3, Scheme 3.19). 
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Scheme 3.19: a) disiamylborane, THF, rt, 24h. 
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47 represents the desired building block for the synthesis of 2-deoxy-L-nucleosides. 
Starting from R-(+)-5-benzyloxymethyl-5H-furan-2-one (1) we were able to produce 47 
this way in 35% overall yield. The applications of 47 for the syntheses of nucleosides are 
described in chapter 4. 
 
 
3.8 Synthesis of 2-Deoxy-L-ribose: removal of the benzyl protecting 
group 
 
The removal of the benzyl group in 47 would led directly to 2-deoxy-L-ribose. It was 
known from the literature53 that we would obtain a mixture of the pyranoside and 
furanoside forms this way. Therefore, for synthesis of nucleosides, the benzyl protected 
building block 47 would have to be employed. However, in order to show the effectiveness 
of our route and in order to allow a comparison of the final sugar with natural 2-deoxy-D-
ribose, we carried out the deprotection by using transfer hydrogenation54 (HCOOH, Pd/C 
10%) in MeOH at rt for 1h.  
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2-deoxy-L-ribose 3837
 
Scheme 3.20: a) (PhMe2Si)2Cu(CN)Li2 (53), THF, -45 °C, 1h; b) Br2, AcOOH, AcOH, rt, 5h; c) 
disiamylborane, THF, rt, 24h; d) HCOOH, 10% Pd/C, MeOH, rt, 1h. 
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As shown in Scheme 3.20 (which also summarizes the complete, optimized route from 1), 
this way 2-deoxy-L-ribose was obtained in 80% yield as a mixture of the α,β-pyranose 37 
and the α,β-furanose 38 in a ratio of 72:28. The anomeric ratios for 37 and 38 were nearly 
1:1 in both cases (1H-NMR analysis). 
In summary, the above described route allowed the synthesis of 2-deoxy-L-ribose with an 
overall yield of 28% starting from R-(+)-5-benzyloxymethyl-5H-furan-2-one (1). 
 
 
3.9 Enolate trapping with electrophiles: 2-hydroxylation of 54 
 
Another synthetic possibility offered by the silyl derivative 54 involves the insertion of a 
substituent into the 2-position. In paragraphs 3.7 and 3.8 we have described the utility of 
the cuprate reagent (PhMe2Si)2Cu(CN)Li2 (53) as “masked” OH group. When this cuprate 
reagent reacts with α,β-unsaturated carbonyl systems such as in 1, the enolate 56 is first 
formed which, upon quenching with water, yields the desired β-silyl derivative 54 (Scheme 
3.21). If, however, 56 could be trapped with an electrophile, the 2-substituted derivatives 
with the general structure of 57 could be formed. As a further advantage, the bulky 
dimethyl-phenylsilyl group could direct this addition diastereoselectively from the opposite 
face. 
 
O O
BnO
1
O O 
BnO
Si
Ph 56
silyl reagent M E O O BnO
Si
Ph
E
57
O O 
BnO
Si
Ph 54
H2O
 
 
Scheme 3.21: Enolate trapping with electrophiles 
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Clearly, in planning the synthesis of nucleosides an introduction of an hydroxy group into 
the 2-position was of major interest (chapter 4). We were therefore looking for an 
“electrophilic OH-reagent”. In the literature essentially two reagents are described for this 
propose: 
 
• 3-phenyl-2-(phenylsulfonyl)-oxaziridine (Davis’ reagent, 58)55 and 
• Oxodiperoxy molybdenum-(pyridine)-hexamethyl-phosphoric triamide (MoOPH, 
Mimoun’ reagent, 5956, Figure 3.2). 
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Figure 3.2: The Davis’ and Mimoun’ reagents 
 
Both are instable and therefore not commercially available. However, once prepared they 
can be stored in a freezer for several months. 
58 was prepared by oxidation of N-benzylidene-benzensulfonamide (60) in a biphasic 
system consisting of toluene/H2O and using potassium monopersulfate triple salt Oxone® 
(2KHSO5.KHSO4.K2SO4) as oxidant. 58 was isolated in 79% yield (Scheme 3.22). 
The preparation of 59 was accomplished by oxidation of MoO3 with 30% H2O2 followed 
by precipitation of the resulting yellow solid by addition of pyridine and HMPT in 
anhydrous THF (Scheme 3.22). 
Our first attempts to introduce the OH group by trapping the enolate 56 (Scheme 3.21) in 
the presence of either 58 or 59 completely failed. It seemed that the complex salt mixture 
present following the cuprate addition to 1 interferes with these reagents. Therefore, 
subsequently we decided to first isolate the β-silyl derivative 54 prior to these reactions. 
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Scheme 3.22: a) Oxone®, K2CO3, toluene, H2O, rt, 30min; b) 1. 30% H2O2, 40 °C, 3.5h, HMPT. 2. pyridine. 
 
Using the Davis’ reagent 58 in THF at –78 °C, and employing different bases for the 
deprotonation (KMDS, LDA), no product was isolated. In contrast, however, and under 
similar conditions, the Mimoun’ reagent 59 indeed led to (3S,4R,5S)-(-)-5-
benzyloxymethyl-4-(dimethyl-phenyl-silanyl)-3-hydroxy-dihydro-furan-2-one (61) in 52% 
yield as a single diastereoisomer (13C-NMR). The use of 2 equivalents of base (KMDS) at 
–60 °C for 1h proved to be the optimal reaction conditions (Scheme 3.23). 61 could be an 
attractive starting material for L-arabinose. 
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Scheme 3.23: a) Davis’ reagent 58, THF, LDA or KMDS; b) Mimoun’ reagent 59, KMDS, THF, -60 °C, 1h. 
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3.10 Inversion of the 2-OH group in 61 - Attempts 
 
The successful synthesis of diastereomerically pure 61 opened a variety of additional 
synthetic possibilities. Thus, in the synthesis of nucleosides the 2-OH group could direct 
the diastereoselective insertion of a nucleobase from the opposite face leading to α-
configurated anomers of L-nucleosides. We also considered the possibility to invert the 
configuration of the 2-OH group in order to prepare the corresponding building blocks for 
both the synthesis of α and β-L-nucleosides. 
 
 
3.10.1 The Mitsunobu reaction57 
 
The Mitsunobu reaction is one of the most widely used methods for the inversion of 
hydroxy groups (Scheme 3.24). 
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Scheme 3.24: Mechanism of the Mitsunobu reaction 
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However, according to the literature problems are encountered when the hydroxy function 
to be inverted is sterically hindered such as in the case of secondary OH groups in γ-
lactones58. As standard reagent for the Mitsunobu reaction carboxylic acids are employed 
which serve as nucleophile and thus lead to the inverted alcohol in form of its carboxylic 
ester. For the inversion of the 2-OH group in 61 we decided to employ chloroacetic acid 
mainly for two reasons: a) chloroacetic acid is a small nucleophile and therefore could 
avoid sterical problems and b) the chloroacetate of the desired 62 can be selectively 
hydrolyzed in the presence of the lactone moiety by using thiourea/NaHCO359. 
Unfortunately, however, no reaction was observed when these Mitsunobu conditions were 
applied to 61 (Scheme 3.25). 
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Scheme 3.25: a) Ph3P, DEAD, ClCH2COOH, toluene, rt – reflux. 
 
 
3.10.2 The KNO2/triflate method 
 
In an article published by Moriarty  at al.58 the superiority of KNO2 for the inversion of 
hindered alcohols was reported. For this, the OH group must first be activated by 
transformation into its triflate ester which could then be displaced following a SN2 
mechanism into the corresponding, inverted alcohol. Thus, 61 was reacted in 
dichloromethane at 0 °C with triflic anhydride (Tf2O) using pyridine as base. Under this 
conditions, however, the triflate ester 63 was not obtained. In contrast, Peterson 
elimination60 occurred leading to 1 with the double bond in the 2,3 positions  (Scheme 
3.26). 
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Scheme 3.26: a) Tf2O, pyridine, CH2Cl2, 0 °C, 3h. 
 
Since this elimination is catalyzed both by bases and acids and independent of the order of 
addition of the reagents, 1 is always formed. A recent publication by Lambert et al.61 
confirms the high instability of such trans β-hydroxysilanes even when activated in form 
of the less reactive mesylate esters. 
 
 
3.10.3 The DCC/CuCl method62 
 
In the literature it was reported that the system dicyclohexylcarbodiimide (DCC)/CuCl can 
activate alcohols so that they can be  displaced with carboxylic acids. This reaction, in 
comparison to the Mitsunobu reaction57, employs the “smaller” activating agent DCC in 
contrast to the bulky DEAD/triphenylphosphonium complex formed during the Mitsunobu 
reaction (compare Scheme 3.24). Clearly the intermediate 64 is first formed. However, 
when 64 was reacted with chloroacetic acid, the butenolide 1 was again the only product 
(Scheme 3.27). 
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Scheme 3.27: a) DCC, CuCl, dioxane, 3 days, 50°C; b) ClCH2CO2H. 
 
 
3.11 Dihydroxylation of the double bond of 1 
 
As already described in the retrosynthetic Scheme 1.1 (chapter 1), the insertion of two 
hydroxy groups in the crucial 2 and 3 positions of 1 could open another route towards the 
synthesis of 2-deoxy-L-ribose via regioselective deoxygenation of the 2-OH group in the 
thus produced V (Scheme 3.28). 
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Scheme 3.28: Retrosynthesis of β-hydroxy-lactone II via dihydroxylation of the double bond in 1 
 
Mukaiyama at al.63 described the dihydroxylation of butenolides using KMnO4 in 
dichloromethane in the presence of crown ethers. Following this procedure (KMnO4, 
dicyclohexano-18-crown-6, CH2Cl2, -42 °C, 2h), 1 was thus reacted and indeed the 
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dihydroxylated product 65 was obtained in 50% yield as a single isomer (NMR analyses) 
together with unreacted starting material (60% recovered yield, Scheme 3.29). 
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Scheme 3.29: a) KMnO4, dicyclohexano-18-crown-6, dichloromethane, -42 °C, 2h 
 
If the same reaction is carried out employing the one phase system acetone/H2O64, a yield 
of only 27% is obtained.  
 
 
3.12 Regioselective 2-deoxygenation of 65 
 
Once 65 was obtained this way, the next step of course was the regioselective removal of 
the 2-OH group in this material. Several methods to this effect are described in the 
literature. 
 
 
3.12.1 2-Deoxygenation using SmI2 
 
Hanessian at al.65 reported the deoxygenation of cyclic acetals such as 66 (easily 
obtainable from cis diols) via the one-electron-transfer reagent samarium iodide (SmI2) 
leading to α-deoxy-lactones 67. A number of such examples were described, leading to the 
corresponding products in very good yields and in very short reaction times (Scheme 3.30). 
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Scheme 3.30: a) SmI2, ethylene glycol, THF, rt, 3h. 
 
Samarium iodide, however, is weakly radioactive (α-rays, spec. activity 1.2 Bq/ml) and is 
not commercially available in Germany by standard suppliers. 
 
 
3.12.2 Deoxygenation of the corresponding 2-triflate esters 
 
Fleet et al.66 reported several examples for the deoxygenation of a triflate function in the 
α-position of a lactone moiety using lithium iodide.  
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Scheme 3.31: a) LiI-3H2O, THF, AcOH, reflux, 12h. 
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As shown in Scheme 3.31, the mechanism of this reaction involves the nucleophilic attack 
of the iodide anion to the activated electrophilic 2-carbon atom of the lactone 68. By this 
the corresponding 2-iodo-derivative 69 is obtained as a mixture of diastereoisomers (SN1 
type reaction also involved). Further reaction of the 2-iodo-derivative 69 with a second 
iodide forms the corresponding enolate 70 which upon aqueous work-up forms the desired 
2-deoxy-lactone 71. 
The reported yields are very high. However, based on the described examples it seemed 
necessary to protect all OH groups, requiring for our substrate 65 several additional steps 
for the required protections and deprotections.  
However another good method for the deoxygenation of triflates in the α-position of the 
lactone moiety is described in the literature67. Hydrogenolysis using 10% Pd/C in the 
presence of a base in order to neutralize the produced TfOH leads to the deoxygenated 
products in high yields (Scheme 3.32). 
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Scheme 3.32: Deoxygenation of the 2-OH group in 65 
 
For our target products the 2-O-Tf derivative 72 clearly is the substrate of choice. For this, 
however, a regioselective protection of 65 is required. Examples for this are already 
reported in the literature67,68. However, when 65 was reacted in THF/pyridine at –20 °C 
using 1 equivalent of triflic anhydride (Tf2O), a complex mixture of products was obtained 
which renders this method not advantageous for our propose (Scheme 3.33) 
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Scheme 3.33: a) Tf2O, THF/pyridine, –20 °C. 
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3.12.3 Deoxygenation of tosylate esters 
 
Paulsen and Stoye69 reported the deoxygenation of tosylates in the α-position of lactones 
using hydrazine. A detailed mechanistic study of this deoxygenation reaction is reported. 
Stoichiometric amounts of hydrazine and anhydrous conditions are required in order to 
favor the formation of the desired 2-deoxy-lactones (Scheme 3.34). 
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Scheme 3.34: a) 1eq NH2NH2, dry solvent 
 
Nucleophilic addition of  hydrazine to the carbonyl group of the lactone 73 forms the 
hydrazide 74, which spontaneously eliminates diimide. This, in turn disproportionates to 
hydrazine and nitrogen. The resulting ketene 75 is highly instable and if the reaction is 
carried out without an excess of hydrazine and in complete absence of water, the 
cyclization to the 2-deoxy-lactone 76 occurs.  
In a modification70 of this procedure and with an excess of hydrazine hydrate the hydrazide 
77 can be formed resulting from the reaction of hydrazine with the ketene 75. 77 is stable 
and can be isolated if needed. It can also be oxidized in situ with Br2/H2O to the 
corresponding lactone 76 (Scheme 3.35). 
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Scheme 3.35: a) excess of 80% aqueous NH2NH2; b) Br2, H2O. 
 
 
 
3.12.4 Synthesis of 2-Deoxy-L-ribose via deoxygenation of tosylate esters 
 
With this background we tested the reactivity of TsCl towards 65 in order to 
regioselectively protect its 2-OH group. This reaction proved to be highly sensitive to the 
employed temperature and the solvent used. Thus, first attempts carried out in acetone at 0 
°C yielded the tosylate 78 in only 50% yield. Furthermore. the reaction was not completely 
regioselective. Finally and after several attempts, regioselective protection of the 2-OH 
group was accomplished successfully with p-TsCl in dichloromethane at –20 °C for 18h 
leading to the regioisomer 78 in 82% yield. This was then further reacted with an 80% 
aqueous solution of hydrazine and bromine in THF at 0 °C leading to the desired β-
hydroxy γ-lactone 48 in 75% yield (Scheme 3.36). 
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Scheme 3.36: a) p-TsCl, Et3N, dichloromethane, -20 °C, 18h; b) aq. NH2NH2, Br2, THF, 0 °C-rt, 30min. 
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As already described in paragraphs 3.7 and 3.8 (compare also scheme 3.20) 48 can be 
transformed in 2-deoxy-L-ribose in two steps with an overall yield of 48%. 
In comparison to the previously reported method for the synthesis of 2-deoxy-L-ribose 
(using the dimethyl-phenyl silyl group, paragraph 3.5) we feel that this route has several 
advantages in using a) simpler procedures, b) commercially available reagents and c) being 
faster. The only remaining drawback is the requirement for one additional step to transform 
R-(+)-5-benzyloxymethyl-5H-furan-2-one (1) into 2-deoxy-L-ribose and this with a lower 
overall yield (18%) as compared to the silyl based procedure (28%). This, however in our 
opinion, is more than compensated by the above rapid and facile procedure. 
 
 
3.13 2-Deoxy-L-ribose and building blocks derived thereof - Summary 
 
In conclusion, we have devised two novel and efficient routes to the above target 
molecules starting from our central building block 1 and based on two different concepts 
for the regioselective hydroxylation of the 3 (3’)-position: 
 
a) Diastereoselective 1,4-addition of a silyl cuprate followed by the introduction of 
the 3-OH group under retention of configuration (Scheme 3.37) 
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Scheme 3.37: a) (PhMe2Si)2Cu(CN)Li2 (53), THF, -45 °C, 1h; b) Br2, AcOOH, AcOH, rt, 5h; c) 
disiamylborane, THF, rt, 24h; e) HCOOH, 10% Pd/C, MeOH, rt, 1h. 
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b) Diastereoselective dihydroxylation of 1 followed by regioselective removal of the 
2-OH group (Scheme 3.38). 
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Scheme 3.38: a) KMnO4, dicyclohexano-18-crown-6, dichloromethane, -42 °C, 2h; b) p-TsCl, Et3N, 
dichloromethane, -20 °C, 18h; c) aq. NH2NH2, Br2, THF, 0 °C-rt, 30min. 
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4 2-Deoxy-L-nucleosides – Formation of N-glycosidic bonds 
 
 
In the past most syntheses of nucleosides were designed to prove the structures of various 
ribo- and deoxyribonucleosides. Now such syntheses are aimed mainly at producing 
nucleoside analogues of therapeutic value. In spite of many advances in this area, it 
remains more economical to produce the major natural nucleosides by degrading nucleic 
acids rather than by total synthesis71.  
Several general methods for the synthesis of nucleosides have been developed over the 
years mainly focused at the stereoselective formation of N-glycosidic bonds. 
 
 
4.1 Formation of N-glycosidic bonds: Coupling reactions using heavy 
metal salts 
 
Fischer and Helferich72 introduced the use of heavy metal salts [initially silver (I)] of a 
purine base to catalyze the nucleophilic displacement of a halogen substituent at C-1 of a 
protected sugar. In a later modification73 mercury (II) salts were used in order to improve 
the yields of the resulting products. These syntheses lead to products with the desired 
regioselectivity, i.e. bonding to N-9 of the purine base and in most cases also the β-
stereoselectivity at C-1 of the sugar moiety is achieved (Scheme 4.1). 
Major disadvantages of the above described methods are a) the low solubility of the 
mercury derivatives and b) the instability of the 1-halogenated sugar. The methods can be 
somewhat improved if the 1-halogenated sugar is generated in situ by the use of TiCl4 or 
SnCl4. 
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Scheme 4.1: Synthesis of adenosine using heavy metal salts of nucleobases. 
 
 
4.2 Nucleoside synthesis: the quaternization procedure  
 
Hilbert and Johnson74 noticed that pyrimidines are sufficiently nucleophilic in order to 
react directly with halogenated sugars without the need for a catalyst. The initial product is 
a quaternary salt which, at higher temperature, eliminates alkyl halide leading to a 
condensation product which can be further modified to produce natural nucleosides 
(Scheme 4.2) The major disadvantage of this method is the formation of mixtures of α and 
β anomers, although the use of HgBr2 increases the proportion of the desired β-anomers.  
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Scheme 4.2: Nucleoside synthesis via the quaternization method 
 
 
4.3 Nucleoside synthesis via transglycosylation 
 
Sometimes it is possible to convert natural nucleosides into nucleosides having a modified 
sugar moiety. This way, the antiviral AZT has been synthesized using thymidine as starting 
material75. For this the natural thymidine was reacted under the Mitsunobu conditions to 
afford a cyclic intermediate which upon treatment with lithium azide and hydrolysis of the 
5’-O-carboxylic ester afforded AZT in 73% overall yield (Scheme 4.3). 
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Scheme 4.3: Synthesis of AZT75 
 
When such transformations are not possible (i.e. in 2’-deoxyadenosine) the sugar moiety 
can be transferred from one nucleobase to another by a process known as 
transglycosidation. 
This method is particularly effective in transferring sugars from pyrimidines (π-deficient 
heterocycles) to purines (π-rich heterocycles). Disadvantages are associated with the 
typical problems of all SN1 mechanisms: formation of diastereoisomeric mixtures of α and 
β anomers and the lack of regioselectivity (formation of N-7 and N-9 regioisomers). 
This method allowed the synthesis of α-anomers of purine nucleosides which sometimes 
can be separated by chromatography from the corresponding β-anomers (Scheme 4.4). The 
use of the Friedel Crafts catalyst TMS-triflate allows for the formation of the carbocation 
at C-1 which reacts with the more basic silylated adenine to form a mixture of α and β 
acetyl protected anomers. Subsequently, aminolysis of the ester groups produces the 
mixture of α and β adenosine. 
 
                                                                                                             Results and Discussion 
 58 
O
AcO
AcO
N
NO NHBz
O N
N
N
NHO
HO
NH2
O N
N
N
NHO
HO
NH2
β
α
a
 
Scheme 4.4: a) 1. TMS-benzoyladenine, TMS-triflate; 2. NH3, MeOH. 
 
 
4.4 Nucleoside synthesis via the Vorbrüggen method 
 
Today one of the most widely used methods for the synthesis of nucleosides is the 
Vorbrüggen method using silylated bases76. Silylated bases have the major advantage to be 
easily prepared and to react smoothly with stable sugars in a homogeneous solution. 
The reactions are carried out using a peracylated sugar, the corresponding silylated base 
and a Friedel-Crafts catalyst [SnCl4, AgClO4, (CH3) 3SiOSO2C4F9, (CH3)3SiOSO2CF3] 
(Scheme 4.5).  
Vorbrüggen et al.76b studied the differences in reactivity of different Friedel-Crafts 
catalysts and discovered the superiority of TMS-triflate for these transformations.  
The mechanism involves 2 stages76a: 
 
• The reaction of the peracylated sugar with the Friedel-Crafts catalyst leading to an 
electrophilic sugar cation. 
• The formation of a σ-complex between the Friedel-Crafts catalyst and the silylated 
bases which generates the N-nucleophile that will attack the carbocation from the 
opposite β-side following the Baker’s 1,2-trans rule. 
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Scheme 4.5: Mechanism of nucleoside formation via the Vorbrüggen method. 
 
After basic work up - typically aqueous NaHCO3 and dichloromethane - the nucleosides 
are normally obtained in good yield.  
 
 
4.5 Control of anomeric stereochemistry 
 
One major goal still unresolved in nucleoside chemistry is the complete control of 
stereochemistry at the C-1 anomeric center of the sugar moiety.  
In the case of riboses carrying a 2’-OH group the nucleosides are formed by attack from 
the opposite face with good to excellent stereoselectivity. In contrast, for 2’-deoxy-
nucleosides no efficient method is available for a comparable stereocontrol. The missing 
2’-OH group does not allow the formation of the cyclic intermediate (compare Scheme 
4.5) and therefore normally leads to a mixture of α and β isomers. Their separation by 
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chromatography is mostly tedious77 and the success depends largely on the particular 
molecular structure. 
 
 
4.6 Synthesis of α,β-L-thymidine 
 
One of the major goals of this thesis was the synthesis of L-thymidine by using the newly 
developed procedures for the synthesis of the 2-deoxy-L-ribose derivatives. L-thymidine 
displays various biological activities78, could be the starting material for the synthesis of 
important drugs (e.g. enantio-AZT)75 and, moreover, via transglycosidations purinic bases 
can be easily exchanged with the pyrimidinic base thymine. 
The starting material of choice for the synthesis of 2-deoxy-L-nucleosides was the 5-benzyl 
protected 2-deoxy-L-ribose 47. 
Among several available methods, we decided to opt for the Vorbrüggen procedure for the 
reasons outlined in the previous paragraphs. For the coupling reaction we needed to 
prepare first the peracylated form of 47 which could be then reacted with silylated 
nucleobases under Friedel-Crafts catalysis (Scheme 4.6). 
Thus, 47 was first esterified to form the diacetyl derivative 79 using Ac2O/pyridine in 
THF. 79 was isolated as 1:1 mixture of α and β anomers in 95% yield. Subsequently, the 
coupling reaction with silylated thymine was achieved in acetonitrile using as catalyst 
TMS-triflate. The diprotected L-nucleoside 80 was obtained in 73% yield as anomeric 
mixture (α/β ≅ 1/2, 1H-NMR). The removal of the protecting groups was carried out in the 
following sequence: first the acetate function was hydrolized via aminolysis using n-
butylamine to afford the 5’-benzyl protected L-thymidine 81 in 90% yield. Second, 
catalytic hydrogenation (10% Pd/C) in MeOH produced the desired 2-deoxy-L-thymidine 
82 in 76% yield again as anomeric mixture (α/β ≅ 1/2, 1H-NMR). Here, the major and yet 
unresolved problem is the chromatographic separation of the α and β anomers. Several 
HPLC columns have been tested for this propose but none gave encouraging results.  
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Scheme 4.6: a) Ac2O, pyridine, THF, rt, 18h; b) TMS-thymine, TMS-triflate, acetonitrile, -30 °C – 0 °C, 
30min; c) n-BuNH2, MeOH, rt, 3h; d) H2, 10% Pd/C, MeOH, rt, 1h.  
 
As shown in Figure 4.1. partial separation could be observed using the following 
conditions: column LiChroCART 250-4, LiChroSpher 100, RP-8 (5µm), UV 262, eluent: 
methanol - phosphate buffer pH 4.4 – water (0.1:5:94.9), flow rate 1ml/min. 
Using natural β-D-thymidine as reference we were able to establish that the most abundant 
product in the mixture was the desired β-anomer. This observation has also been confirmed 
by the 1H and 13C-NMR spectra of our product 82 and natural β-D-thymidine (Figure 4.2). 
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Figure 4.1: HPLC analysis. column LiChroCART 250-4, LiChroSPHER 100, RP-8 (5µm), UV 262, eluent: 
methanol - phosphate buffer pH 4.4 – water (0.1:5:94.9.), flow rate 1ml/min; a) natural β-D-thymidine b) 
α,β-L-thymidine 
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Figure 4.2: 1H and 13C NMR’s (400 MHz, D2O) of a) natural β-D-thymidine b) α,β-L-thymidine 
a) b)
β -L-thymidine
α -L-thymidine
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4.7 Synthesis of α,β-2-deoxy-L-adenosine 
 
The use of our building block 79 was also tested for the synthesis of 2-deoxy-L-adenosine. 
Here, the nucleobase adenine cannot be directly silylated as in the case of thymine because 
it contains an exocyclic amino group which must be first protected (e.g. as N-benzoyl 
derivative). However, it is reported in the literature79 that nucleobases with exocyclic 
amino groups can be directly reacted in toluene/CH3CN in the presence of KI and dibenzo-
18-crown-6 (Scheme 4.7) This way the diacetyl derivative 79 was transformed into the 
anomeric mixture (α/β ≅ 2/1, 1H-NMR) 83 in 56% yield. 83 was then deprotected with n-
butylamine in MeOH to yield the 84 in 88% yield. Finally, removal of the benzyl group 
using Pd(OH)2/C in EtOH/cyclohexene (2/1) produced the desired anomeric mixture of 
α,β-2-deoxy-L-adenosine 85 in 65% yield (Scheme 4.7). 
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Scheme 4.7: a) TMS-adenine, KI, dibenzo-18-crown-6, toluene/CH3CN (1/1), reflux, 4h; b) n-BuNH2, 
MeOH, rt, 1h; c) Pd(OH)2/C, EtOH, cyclohexene, reflux, 2h. 
 
Separations of the α and β anomers of 85 by HPLC are particularly tedious. Although 
different columns were employed, no encouraging results were obtained in our hands. 
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However, the α,β-ratio of 85 could be measured via 1H-NMR using as reference natural β-
2-deoxy-D-adenosine. As readily interpretable from the Figure 4.3, the resulting anomeric 
ratio hare was α/β ≅ 2/1. Thus, unlike in the case of thymidine, here the α configured-
anomer is produced preferentially. 
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Figure 4.3: 1H and 13C NMR’s (400 MHz, CD3OD) of a) natural β-2-deoxy-D-adenosine b) α,β-2-deoxy-L-
adenosine. 
 
 
 
4.8 Synthesis of α,β-nucleosides - Summary 
 
In summary, using our enantiomerically pure building block 47 two 2-deoxy-L-nucleosides 
were synthesized. For the synthesis of α,β-L-thymidine (82) the classical Vorbrüggen 
procedure was employed for the coupling reaction followed by standard removal of the 
protecting groups. 82 was obtained in 3 steps (50% overall yield) starting from 79 as 
anomeric mixture (α/β ≅ 1/2, Scheme 4.8). 
a)
b)
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Scheme 4.8: a) TMS-thymine, TMS-triflate, acetonitrile, -30 °C – 0 °C, 30min; b) n-BuNH2, MeOH, rt, 3h; 
c) H2, 10% Pd/C, MeOH, rt, 1h.  
 
 
In a second example the synthesis of α,β-2-deoxy-L-adenine (85) was carried out in 3 steps 
(32% overall yield). In this case the coupling reaction between the silylated adenosine and 
the peracetylated sugar 79 was accomplished in the presence of KI and dibenzo-18-crown-
6. After removal of protecting groups, 2-deoxy-L-adenine (85) was obtained as mixture of 
the α and β anomers (α/β ≅ 1/2, Scheme 4.9). 
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Scheme 4.9: a) TMS-adenine, KI, dibenzo-18-crown-6, toluene/CH3CN (1/1), reflux, 4h; b) n-BuNH2, 
MeOH, rt, 1h; c) Pd(OH)2/C, EtOH, cyclohexene, reflux, 2h. 
 
 
4.9 Conclusions and outlook 
 
The control of stereochemistry in the Vorbrüggen coupling reaction of protected 2-deoxy-
sugars with nucleobases remains an unresolved problem. In all of our examples mixtures of 
α,β-isomers were obtained.  
In the literature we found however, a single example of a sugar derivative leading to only 
one diastereoisomer of 2-deoxy-L-nucleosides, the chloro derivatives 8642 and ent-8680 
(Scheme 4.10). 
A number of disadvantages are however associated with reactions using these building 
blocks. High diastereoselectivity is only obtained when the sodium salt of “activated” 
purine bases carrying chloro substituents on the aromatic ring are employed81 (Scheme 
4.10). 
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Scheme 4.10: Synthesis of β-nucleosides from 86. 
 
Moreover the reaction is not always regiospecific regarding the base. 86 is also rather 
unstable, it can isomerize82 to the β-derivative, especially in polar solvents and in the 
presence of Lewis acids. Furthermore there is a tendency of 86 to eliminate HCl and p-
toluic acid83. Regardless of this situation, it has been possible in a number of cases to 
obtain pure β-anomers by recrystallization of the impure reaction mixtures84 and 86 is up 
to now the only building block which in some cases leads to single β-anomers of 2-deoxy-
nucleosides.  
An alternative possibility for the synthesis of single β-anomers of 2-deoxy-nucleosides is 
the deoxygenation of the 2’-OH group in the already formed nucleoside (Scheme 4.11). 
This way it is possible to exploit first the “directing effect” of the 2’-OH moiety with the 
result that a single β-anomer can be obtained.  
Among the most frequently used methods for such deoxygenations are: 
 
 
• photochemical removal of the 2’-O-(3-trifluoromethylbenzoyl) group85 
• Barton radical fragmentation of 2’-thionocarbonates86 
• reduction of 2’-tosylates with Li(HBEt3)87 
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Scheme 4.11: Retrosynthesis of 2-deoxy-L-nucleosides via regioselective 2-deoxygenation. 
 
Clearly, in these cases the selective removal of the OH group is of major importance. This 
requires additional steps for the introduction and removal of suitable protection groups. 
Furthermore in some cases only highly diluted solutions are prone to deoxygenation 
rendering the scale up of these transformations problematic85. 
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5 δ-lactones 
 
Chiral 6-substituted δ-lactones have been identified as insect pheromones88. Due to their 
frequently low sensory threshold concentrations they represent key aroma constituents in 
various fruits and plants. 
Interestingly enough – although natural products – these molecules are isolated from 
natural sources frequently not in enantiomerically pure form but as mixture of 
enantiomers88c in which the R-configurated compounds are usually dominating. Since the 
physiological activities – odor or taste – are possibly dependent on the absolute 
configuration of these molecules, as a consequence the flavour notes of fruits can vary 
according to the region of growth, condition of storage and degree of ripeness. In spite of 
the importance of these molecules as aroma constituents there seems to exist no systematic 
study in which the relationship between organoleptic properties and their absolute 
configurations has been studied in detail, e.g. by a systematic determination of sensory 
threshold concentrations. Moreover there seem to be uncertainties regarding absolute 
configurations in a number of cases. The reason for this situation probably resides in the 
fact that enantiomerically pure δ-lactones of both absolute configurations are not easily 
accessible in multigram quantities.  
 
 
5.1 Synthesis of δ-lactones 
 
In view of a systematic study of organoleptic properties and detailed determinations of 
sensory threshold concentrations, the synthesis of both enantiomeric series of these 
molecules was accomplished in our laboratory89 (Scheme 5.1). 
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Scheme 5.1: Synthesis of enantiomerically pure R and S-δ-lactones. 
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5.2 Acid catalyzed trimerization of δ-lactones 
 
Surprisingly and quite unexpectedly we found, however, that when e.g. R-(+)-6-methyl-
tetrahydro-pyran-2-one (87) was prepared, it proved to be instable upon storage in neat 
form even at low temperatures (Scheme 5.2). This became evident when crystalline 87 
slowly turned into a liquid, the change in physical appearance being accompanied by a 
change of optical rotation from [ ]20Dα = +36 (c 0.7, CHCl3) to [ ]20Dα = -7 (c 1.0, CHCl3) for 
what turned out to be an equilibrium mixture of 87 and a newly formed compound for 
which we assigned the trimeric structure 90. 
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Scheme 5.2: a) tert-butyl propiolate, n-BuLi, BF3-Et2O, THF, -78 °C, 2.5h; b) H2, 5% Pd/C, AcOEt, -20 °C, 
6h; c) TFA, CH2Cl2, rt, 24h. 
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Nucleophilic ring opening of (R)-2-methyloxirane by the anion of tert-butyl propiolate led 
to R-(-)-5-hydroxy-hex-2-ynoic acid tert-butyl ester 88 which was hydrogenated (5% Pd/C, 
AcOEt, -20 °C; 6h, 99%) quantitatively to the saturated derivative 89 which was in turn, 
cyclized to 87 in presence of catalytic amounts of trifluoroacetic acid. 87 was isolated by 
column chromatography on silica gel [Et2O/n-hexane (2/1)], followed by short path 
distillation (Kugelrohr, 70 °C, 10-3 mBar) as white solid (m.p. 31 °C). Although 
monitoring of the reaction by T.l.c. and GC confirmed quantitative conversion the yield 
was only 50%, probably due to the solubility of 87 in the aqueous solution used for work 
up. 
The thus prepared 87 showed a chemical purity of ≥99% (GC analysis) which was further 
confirmed by the clean and readily interpretable 1H and 13C-NMR spectra (Figure 5.1a). 87 
was optically pure with an optical rotation of [ ]20Dα = +36 (c 0.7, CHCl3 stab. with 1% 
EtOH). 
However, upon storage in neat form at rt, 87 slowly equilibrates with its trimer 90. This 
trimerization surprisingly turned out to be a very clean transformation, no other oligomers 
or polymers are observed. It can be conveniently monitored via the corresponding 1H and 
13C-NMR spectra which were taken in regular (7 days) intervals. Thus pure 87 (Figure 
5.1a) having a characteristic multiplet at δ= 4.39 ppm in the 1H-NMR spectrum (and a 
signal at δ= 171.67 ppm for the carbonyl carbon in the 13C-NMR) was slowly transformed 
into (6R,12R,18R)- (-)-6,12,18-trimethyl-1,7,3-trioxa-cyclooctadecane-2,8,14-trione 90, 
having a corresponding multiplet at δ= 4.90 ppm (3 carbonyl carbons at 172.84 ppm in the 
13C-NMR) (Figure 5.1b). After ca. 35 days an equilibrium mixture of 87 and 90 is obtained 
with a ratio (determined by integration of the 1H-NMR signals) of ca. 20:80 (Figure 5.1C). 
The existence of a true thermodynamic equilibrium was supported by the fact that the same 
mixture is obtained starting from either pure 87 or 90 (Scheme 5.3). 
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Figure 5.1: 1H and 13C-NMR spectra (CDCl3, 400 MHz). (A) freshly synthesized 87; (B) product stored at 20 
°C for 21 days; (C) product stored at 20 °C for 35 days. 
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Scheme 5.3: Acid catalyzed equilibration of 87 and 90 
 
Pure 90 was obtained by removal of 87 from the equilibrium mixture by short path 
distillation (Kugelrohr, 100 °C, 10-3mBar). Next to a correct elemental analysis and the 
obvious similarity of the 1H and 13C-NMR spectra of 87 and 90 which allowed a facile 
interpretation4, 90 was chemically correlated with 87. Hydrolysis of 90 with 2N NaOH in 
H2O/THF led to the corresponding sodium salt of R-(-)-5-hydroxy-hexanoic acid 91. After 
acidification with aqueous conc. HCl and removal of all solvents, the resulting 91 was 
recyclized to 87 without loss of optical purity (Scheme 5.4). 
 
90 87
  91
OH
CO2H
a,b c
quant. 35%
 
 
Scheme 5.4: a) 2N NaOH, THF/H2O, 0 °C – rt, 30min; b) conc. HCl, 0 °C; c) TFA, CH2Cl2, rt, 24h. 
 
Next to proving the molecular constitution of 90 this sequence also allows a regeneration 
of 87 from the impure mixture. 
However, in spite of all these informations the correct structure of 90 remained unclear, 
with other oligomeric structures such as the corresponding dimer or tetramer being obvious 
options. All of them being symmetric (n-fold axes Cn) they would all display 6 carbon 
atoms in the 13C-NMR. Also the determination of the molecular weight by various MS 
techniques (EI, CI, electrospray)90 proved to be unsuccessful. The thermal instability of 90 
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led to signals resulting of monomer, dimer and oligomers with unit differences of m/z = 
114. 
Thus the molecular weight of 90 had to be determined the “old fashioned way” exploiting 
the colligative properties of this material. Using the freezing point depression in 1,4-
dioxane we were able to calculate a molecular weight for 90 of 367.16 (theor. 342.43) 
(Figure 5.2). 
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Figure 5.2: Determination of molecular weight of 90 by its freezing point depression in 1,4-dioxane. 
 
In this formula Kf represents the cryoscopic constant (-4.63 for 1,4-dioxane) and ∆Tf = Tf 
solution - Tf solvent  is the difference of the freezing points between pure 1,4-dioxane and the 
under described solution of 90 in the same solvent (see chapter 6.6.6). We found for 90 a 
M.W. of 367.16 (theor. 342.43), the error thus was 7.2%.  
From the equilibrium constant at 20 °C it can be calculated that the trimeric structure 90 is 
thermodynamically more stable than 87 by a ∆G°≅ -0.8 kcal mol-1, a difference which is 
clearly sufficient to partially transform 87 into 90 (Equation 5.1). 
 
supercool ing
effect
freezing poin t
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∆G° = - RT ln k = -2.303 RT log k
At 20 °C, k     80/20    4 
∆G°    -1.34 log 4     - 0.8 kcal mol-1.
~= ~=
~= ~=  
 
Equation 5.1: calculation of ∆G° for an equilibrium constant ≅ 4 
 
It is interesting to speculate why only the trimer, having an 18 membered ring is formed in 
this transformation so cleanly without any trace of the corresponding dimer, tetramer or 
other oligomers and polymers. 
The relative stabilities of lactones having 3 to 23 ring members had been determined 
earlier, revealing clearly the higher stability of the 18-membered ring system91 over the 6 
and the 12-membered rings (i.e. monomer and dimer). This is in good agreement with our 
observations and the calculated ∆G°≅ -0.8 kcal mol-1. 
With enantiomerically pure δ-lactones being important flavour compounds and thus 
attractive synthetic targets we were curious to elucidate the reasons for the surprising 
trimerization of such a δ-lactone. Clearly, the instability of 87 could only be the result of 
an acid catalyzed process initiated by the presence of traces of TFA introduced during the 
cyclization of 89 (Scheme 5.1). Since δ-lactones are instable towards base, the removal of 
TFA during work up by extraction with aqueous Na2CO3 solution causes considerably 
reduced product yields. We therefore initially opted for column chromatography and short 
path distillation in the hope that the last traces of TFA would be completely removed this 
way. Evidently this was not the case. If the organic phase during work up is indeed washed 
with Na2CO3, the resulting 87 (isolated in greatly reduced yield of only 35%) is perfectly 
stable upon storage. The addition of a trace of TFA immediately initiates again the above 
described trimerization. 
Clearly TFA is not the method of choice for the cyclization reaction leading to 87. 
Since 87 is both base labile and soluble in an aqueous environment we now optimized the 
cyclization procedure by using p-TsOH in toluene (Scheme 5.5). No aqueous work up is 
required in this case. Considerably improved yields of 70% were obtained and the resulting 
product is perfectly stable during storage at room temperature. 
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Scheme 5.5: a) p-TsOH, toluene, reflux, 1.30h. 
 
 
5.3 δ-lactones - Summary 
 
The enantiomerically pure (≥98% ee) R-(+)-6-methyl-tetrahydro-pyran-2-one 87 in the 
presence of traces of trifluoroacetic acid (TFA) converts into an equilibrium mixture with 
its trimer 90 [87:90 = 20:80] corresponding to a ∆G ≅ -0.8 kcal mol-1 (Scheme 5.6). The 
transformation can be followed by 1H and 13C-NMR. The structure of 90 was established 
by chemical correlation with 87 and its molecular weight determined via its colligative 
properties. 
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Scheme 5.6: Acid catalyzed equilibration of 87 and 90 
 
Although base catalyzed oligomerization of δ-lactones has already been reported in the 
literature92, this to the best of our knowledge seems to be the first example for an acid 
(TFA) catalyzed oligomerization of δ-lactones. 
 
                                                                                                             Results and Discussion 
 78 
6. Summary 
 
The major topic of this work was the development of novel synthetic routes to 
enantiomerically pure building blocks for 2-deoxy-L-ribose and non-natural L-nucleosides 
derived thereof.  
 
 
6.1 Synthesis of R-(+)-5-Benzyloxymethyl-5H-furan-2-one (1) 
 
We chose as chiral starting material for the synthesis of 2-deoxy-L-ribose enantiomerically 
pure R-(+)-5-benzyloxymethyl-5H-furan-2-one (1) which was obtained from L-ascorbic 
acid in 5 steps and 26% overall yield (Scheme 6.1). As an alternative 1 was obtained 
starting from R-(-)-benzylglycidol by either using PhSeCH2CO2H (2 steps, 61% overall 
yield) or PhSCH2CO2H (3 steps, 35% overall yield, Scheme 6.2).  
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Scheme 6.1: a) H2, Pd/C 10%, water, 50 °C, 24h; b) Isopropenylmethylether, p-TsOH, DMF, rt, 24h; c) 
NaIO4, water, rt, 2h; d) Ph3P=CHCO2Et, dichloromethane/H2O, rt, over night; e) H2SO4 (10% in water), 
MeOH, rt, 2h; f) Cl3CC(=NH)OBn, CF3SO3H, dichloromethane/ cyclohexane (2/1), rt, 2h. 
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Scheme 6.2: a) 1. PhXCH2CO2H (X=Se or S), LDA, THF, -78 °C – rt, 3h; 2. AcOH, reflux, overnight. b) 
NaIO4, MeOH/H2O, rt, 1h from Se, overnight from S. c) toluene, reflux, 30 min. 
 
From 1 we were able to prepare 2-deoxy-L-ribose and building blocks derived thereof 
following two different routes. 
 
 
6.2 2-Deoxy-L-ribose via Michael 1,4-addition of silyl cuprates 
 
Based on previous experiments described by Fleming et al49 related to the 
diastereoselective addition of silyl cuprate reagents to Michael systems, and due to the fact 
that the silyl functions in the resulting derivatives can be transformed into the 
corresponding hydroxy groups with retention of configuration, we were able to synthesize 
2-deoxy-L-ribose (4 steps, 28% overall yield from 1) and related building blocks in 
enantiomerically pure form (Scheme 6.3). 
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Scheme 6.3: a) (PhMe2Si)2Cu(CN)Li2, CuCN, THF, -45 °C, 1h; b) Br2, AcOOH, AcOH, rt, 5h; c) 
disiamylborane, THF, rt, 24h; d) HCOOH, Pd/C 10%, MeOH, rt, 1h. 
 
 
6.3 2-deoxy-L-ribose via Mukaiyama63 dihydroxylation 
 
This route involves a) dihydroxylation of 1, b) selective protection of the 2-OH group and 
c) selective removal of this function (Scheme 6.4). This way 2-deoxy-L-ribose was 
obtained from 1 in 5 steps with an overall yield of 18%.  
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Scheme 6.4: a) KMnO4, dicyclohexano-18-crown-6, dichloromethane, -42 °C, 2h; b) p-TsCl, Et3N, 
dichloromethane, -20 °C, 18h; c) aq. NH2NH2, Br2, THF, 0 °C-rt, 30min. 
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In comparing the two routes we feel that the dihydroxylation route has several advantages 
in using a) simpler procedures, b) commercially available reagents and c) being faster. The 
only remaining drawback is the requirement for one additional step and a lower overall 
yield (18%) as compared to the silyl based procedure (28%). This is, in our opinion, more 
than compensated by the rapid and facile procedure. 
 
6.4 Synthesis of 2-deoxy-L-nucleosides 
 
The two 2-deoxy-L-nucleosides were synthesized using the Vorbrüggen procedure in the 
case of L-thymidine and the KI catalyzed procedure in the case of 2-deoxy-L-adenosine. In 
order to avoid equilibration between the pyranoside and furanoside forms of the free sugar, 
the 5-O-benzyl protected derivative 47 was employed as starting material. In order to 
demonstrate the usefulness of our building block with the backbone 2-deoxy-L-ribose, we 
synthesized L-thymidine - a pyrimidine L-nucleoside- and 2-deoxy-L-adenosine, a purinic 
nucleoside. As summarized in Scheme 6.5, L-thymidine and 2-deoxy-L-adenosine were 
obtained in 48% and 30% overall yield, respectively. 
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Scheme 6.5: a) Ac2O, pyridine, THF, rt, 18h; b) base=T: TMS-thymine, TMS-triflate, acetonitrile, -30 °C – 0 
°C, 30min; base=A: TMS-adenine, KI, dibenzo-18-crown-6, toluene/CH3CN (1/1), reflux, 4h; c) n-BuNH2, 
MeOH, rt, 3h (base=T), 1h (base=A); d) Pd(OH)2/C, EtOH, cyclohexene, reflux, 2h. 
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The major and unresolved problem remains the lack of diastereoselectivity in coupling 
reaction leading to mixtures of α,β-anomers of the final nucleosides. 
 
 
6.5 TFA catalyzed trimerization of R-(+)-6-Methyl-tetrahydro-pyran-2-
one 
 
The enantiomerically pure (≥98% ee) R-(+)-6-methyl-tetrahydro-pyran-2-one was prepared 
via TFA catalyzed cyclization of the corresponding δ-hydroxy carboxylic acid. It was 
observed that this δ-lactone converts into an equilibrium mixture with its trimer form 
(monomer/trimer 20:80) corresponding to a ∆G ≅ -0.8 kcal mol-1 if traces of TFA are still 
present in the final product. The transformation can be followed by 1H and 13C-NMR. The 
structure of the trimer was established by chemical correlation with the monomer and its 
molecular weight determined via its colligative properties (Scheme 6.6). 
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Scheme 6.6: trimerization of R-(+)-6-Methyl-tetrahydro-pyran-2-one catalyzed by TFA 
 
p-TsOH in contrast was shown to be a highly suitable catalyst for such cyclizations leading 
to pure and stable δ-lactones. 
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7 Syntheses and analyses 
 
7.1 Analytical Instruments 
 
1H-NMR    Bruker WM 250 (250.133 MHz) 
     Bruker WM 400 (400.132 MHz) 
 
13C-NMR    Bruker WM 250 (62.896 MHz) 
     Bruker WM 400 (100.625 MHz) 
 
IR     Perkin-Elmer Infrared Spectrophotometer 1420 
 
Polarimeter    Perkin-Elmer 241 (thermostated at +20 °C) 
 
GC     Shimadzu GC 14B, FID 250 °C, Integrator HP 3390A 
 
HPLC     Merck L-6200 Intelligent Pump, L-4000 UV detector 
 
TLC SiO2 60F254 (Merck), detection with UV, 
Vanillin/H2SO4 
 
MS Varian MAT 311 A (EI, 70 eV). 
 
EA Elementar Vario EL 
 
Melting points Büchi 510  
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7.2 General 
 
The chemical reagents used in this dissertation were obtained from standard suppliers 
(Fluka, Sigma-Aldrich, Merck) and, if not differently specified in the description of the 
particular reaction, used without further purifications. Solvents employed in reactions were 
normally distilled and when necessary dried using standard procedures93 and drying agents. 
For standard work up procedures they were directly used as purchased. Solvents used for 
HPLC analyses were of gradient quality and degassed in a sonicator for 20min prior to use. 
Particular attention was given to reactions carried out under anhydrous conditions. In these 
cases all glassware, stoppers, septa, magnetic stirrers and syringes were dried over night in 
a oven thermostated at 80 °C, allowed to cool in a desiccator which was opened only prior 
to use. For the transfer of reagents sterile packaged one-way plastic syringes were 
employed. Hypodermic needles for medical use were used together with long metal 
needles (especially to transfer anhydrous solvents) and the latter dried in an oven as 
described for the glassware. The inert gas used for all reactions was argon 4.8. Merck silica 
gel 60 (70-230 mesh) was used for column chromatography. Vacuum distillations were 
accomplished with standard equipment using either membrane pumps or oil pumps. 
Alternatively, short path distillations (Kugelrohr) were also used. Deuterated solvents for 
NMR analyses were obtained from the Aldrich company and used without any internal 
standard. In the NMR analyses the letters s,d,t,q,m, refer to singlet, doublet, triplet, quartet 
and multiplet respectively with all various combinations possible (e.g. dd is double 
doublet). Reported melting points are uncorrected. 
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7.2.1 List of abbreviations 
 
[ ]20Dα   specific rotation [expressed without units; the actual units, deg mL/(g dm) 
are understood] 
Ac acetyl 
AcO2H peracetic acid 
AIBN 2,2’-azobisisobutyronitrile 
atm  atmosphere(s) 
Bn benzyl 
bp boiling point 
br broad 
calcd calculated 
CI chemical ionization 
cm centimeters 
δ chemical shift in parts per million 
d doublet; day(s) 
DCC N,N-dicyclohexylcarbodiimide 
DEAD diethyal azodicarboxylate 
DIAD diisopropyl azodicarboxylate 
DIBAL diisobutylaluminum hydride 
DMAP 4-(dimethylamino)pyridine 
DME dimethoxyethane 
DMF dimethylformamide 
DMSO dimethyl sulfoxide 
ee enantiomeric excess 
EI electron impact 
FAB fast atomic bombardment 
GC gas chromatography 
h hour(s) 
HMDS hexamethyldisilazane 
HMPT hexamethyphosporic triamide 
Hz Hertz 
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J coupling constant 
LDA lithium diisopropylamide 
KHMDS potassium hexamethyldisilazane 
µ micro 
m multiplet, meter(s), milli 
MHz megahertz 
min minute(s) 
mol mole(s) 
mp melting point 
Ms methanesulfonyl (mesyl) 
MS mass spectrometry 
m/z mass to charge ratio 
Ph phenyl 
ppm parts per million 
q quartet 
Rf retention factor 
rt room temperature 
s singlet, second(s) 
t triplet 
Tf trifluoromethanesulfonyl (triflyl) 
Tf2O trifluoromethanesulfonic acid anhydride (triflic anhydride) 
TFA trifluoroacetic acid 
Tlc thin layer chromatography 
Ts tosyl (p-toluenesulfonyl) 
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7.3 γ-lactones 
 
 
7.3.1 (3S,4S,5R)-(+)-5-[(S)-1,2-dihydroxy-ethyl]-3,4-dihydroxy-dihydro-furan-2-one 
(10)23c 
 
This reaction was carried out using a Büchi hydrogenation apparatus equipped with 1L 
vessel connected with a water thermostat, a plug valve for gas-discharging and 
introduction of H2, a manometer, a metal finger for the insertion of a contact thermometer 
and a security 6 Bar limit-pressure valve. 65.0g (369mmol) of L(+)-ascorbic acid (9) were 
dissolved in 500ml of distilled water and introduced into the 1L vessel. To this solution 
6.5g of Pd/C-10% were added and  the mixture was degassed under stirring for 5min by 
connecting the valve for gas-discharging with a membrane pump. After this period, the 
plug valve was closed thereby taking great care to avoid any entry of air and the flask was 
connected under vacuum with a hydrogen source via a rubber hose. The mixture was 
stirred under 5 Bar pressure of hydrogen for 24h at 50 °C. Then, the catalyst was separated 
by filtration and the water removed from the reaction mixture using a rotavapor at 45 °C. 
65.7g (369mmol; quantitative yield) of 10 were obtained as colorless crystals. 
Recrystallization from EtOH/H2O afforded 10 in very high purity. In order to collect more 
material this reaction was repeated twice. 
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m.p.: 180 – 181 °C (EtOH/H2O). 
 
 
[ ]20Dα  = +56.7 (c = 0,88, H2O). 
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1H NMR (d6-DMSO):  
 
δ 5.75 (d, 1H, J=7.5 Hz, C-2-OH), 5.3 (d, 1H, J=3.75 Hz, C-3-OH), 4.9 (d, 1H, J=5.2 Hz, 
C-5-OH), 4.6 (t, 1H, J=5.6 Hz, C-6-OH), 4.4 (dd, 1H, J=7.3 Hz, J=4.5 Hz, C-4), 4.2 (d, 
1H, J=8.1 Hz, C-2), 4.1 (d, 1H, J=3.3 Hz, C-3), 3.7 (m, 1H, C-5), 3.45 (m, 2H, C-6). 
 
 
13C NMR (d6-DMSO):  
 
δ 176.3 (C-1), 80.9 (C-2), 70 7 (C-4), 70.1 (C-5), 69.4 (C-3), 61.9 (C-6). 
 
 
IR (KBr, cm-1):  
 
3550 (OH), 3470 (OH), 2980 (-CH2-asym), 2890 (-CH2-sym), 1780 (C=O). 
 
 
MS m/z:  
 
160 (M+ - H2O), 147 (M+ - .CH2OH), 100 (C4H4O3+), 85, 73 (C2H2O3+), 61 (C2H5O2+), 57, 
43. 
 
 
Elemental Analysis: 
 
Anal. Calcd for C6H10O6: C, 40.45; H, 5.66. Found: C, 40.22 ; H, 6.17. 
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7.3.2 (3S,4S,5R)-(+)-5-{(S)-2,2-dimethyl-[1,3]-dioxolan-4-yl}-3,4-dihydroxy-dihydro-
furan-2-one23c (11) 
 
To a stirred solution of 126g of 10 (710mmol) in 1.3L of dry DMF, at 0 °C, under argon, 
p-TsOH (6.7g, 35mmol, 0.05eq) was added. To this solution 2-methoxy-propene (86.6ml, 
910mmol, 1.3eq) was slowly added from a dropping funnel and the resulting mixture was 
stirred for 24h at rt. The reaction progress was monitored via T.l.c. Then, 130g of 
Na2CO3·10H2O were added and the resulting suspension vigorously stirred for a further 2h. 
After filtration over Celite and removal of DMF by vacuum distillation (oil bath 70 °C, 
membrane pump), 118g (530mmol, 76% yield) of a yellow-brown solid was isolated which 
was reacted without further purification. For analyses a few grams of crude 11 were 
purified by column chromatography on silica gel using as eluent AcOEt. After removal of 
the solvent, a white solid was obtained. 
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m.p.: 119-120 °C. 
 
 
Rf: 0.26 AcOEt. 
 
 
[ ]20Dα  = +55.8 (c= 0.52, methanol). 
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1H NMR (d6-DMSO): 
 
δ 5,8 (d, 1H, J=6.0 Hz, C-3-OH), 5.4 (d, 1H, J=2.5 Hz, C-2-OH), 4.4 (s, 1H, C-4), 4.2 (m, 
1H, C-2), 4.0 (dd, 1H, J=8.8 Hz, J=6.2 Hz, C-3), 3.7 (dd, 1H, J=8.8 Hz, J=6.1 Hz, C-5), 
3.3 (s, 2H, C-6), 1.3 (s, 3H, C-8), 1.25 (s, 3H, C-8). 
 
 
13C NMR (d6-DMSO):  
 
δ 175,9 (C-1), 109,0 (C-7), 81,2 (C-4), 75,0 (C-5), 70,2 (C-2), 69,1 (C-3), 64,3 (C-6), 26,6 
(C-8), 25,3 (C-8). 
 
 
IR (KBr, cm-1):  
 
3520 (OH), 3460 (OH), 2990 (CH3), 2930 (-CH2-asym), 2870 (-CH2-sym), 1760 (C=O). 
 
 
MS m/z:  
 
218 (M+), 203 (M+ - .CH3), 187 (C8H11O5+), 175 (C6H8O6+), 160 (C6H8O5+), 125, 
115(C6H10O2+), 101 (C5H9O2+), 85 (C4H6O2+), 69, 60, 55, 43. 
 
 
Elemental Analysis:  
 
Anal. Calcd for C9H14O6: C, 49.54; H, 6.47. Found: C, 47.91; H, 7.01. 
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7.3.3 (Triphenyl-λ5-phosphanylidene)-acetic acid ethyl ester25 (13) 
 
A 2000ml three-necked flask, equipped with a mechanical stirrer and dropping funnel was 
charged with triphenylphosphine (153.5g, 590mmol) and 1L toluene. To this stirred 
solution bromoacetic acid ethyl ester (64.8ml, 590mmol, 1eq) was added dropwise at rt. 
After 12h the white solid was collected by suction and remaining traces of toluene were 
removed in vacuo. The solid was dissolved in 1.5L distilled water and a 2N aqueous 
solution of NaOH was added until a positive reaction with phenolphthalein was observed. 
Filtration by suction and removal of traces of water with the help of a rotavapor first (bath 
45 °C) followed by high vacuum afforded 184.4g (530mmol, 90% yield) of 13 as a white 
solid.  
 
Ph3P O
O
1
2
3
4
13  
 
m.p.: 127-129 °C. 
 
 
1H NMR (CDCl3): 
 
δ 7.9 – 7.3 (m, 15H, C-6 – C-8), 3.9 (q, 2H, J=6.6 Hz, C-2), 2.9 (br, 1H, C-4), 1.1 (br, 3H, 
C-1). 
 
 
13C NMR (CDCl3): 
 
δ 171.25 (C-3), 132.92 (d, JC-P=9.1 Hz, Car.), 131.83 (Car.), 131.80 (Car.), 128.59 (d, JC-
P=12.2 Hz, Car.), 57.77 (C-2), 30.03 (d, JC-P=125.1 Hz, C-4), 14.75 (C-1). 
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IR (KBr, cm-1): 
 
3440, 3060 (-CH-aromat), 2980 (=CH-), 2900 (-CH2-), 1610 (C=O) 
 
 
7.3.4 R-(-)-Z-3-(2,2-Dimethyl-[1,3]-dioxolan-4-yl)-acrylic acid ethyl ester23c (14) 
 
To a solution of 118g (530mmol) of 11 in 600ml of distilled water, NaIO4 (227.3g, 
1060mmol, 2eq) was added and the pH was maintained at pH≅5.5 by addition of 4N 
NaOH using an autotitrator. After stirring for 2h at rt, the mixture was saturated with NaCl, 
filtered by suction and the pH of the solution adjusted to 6.5 – 7.0. The resulting solution 
was added under vigorous stirring to (Triphenyl-λ5-phosphanylidene)-acetic acid ethyl 
ester 13 (201.2g, 577mmol, 1.1eq) dissolved in 400ml dichloromethane and the biphasic 
mixture was vigorously stirred over night. The organic layer was separated, the aqueous 
phase extracted twice with 150ml dichloromethane, and the collected organic fractions 
were washed with water, brine and dried over anhydrous Na2SO4. After removal of the 
solvent in vacuo, a pale yellow solid was obtained which contained the Z-ester Z-14, the E-
ester E-15 and the by-product triphenylposphine oxide. The latter was removed from the 
mixture exploiting its different solubility in respect to the products. Thus, to the crude solid 
product mixture 300ml n-hexane/AcOEt (4/1) were added after which the insoluble Ph3PO 
was removed by suction. Evaporation of the organic phase afforded a yellow oil containing 
14 and 15 in a Z/E mixture of 80/20 (1H-NMR analysis). 
The stereoisomeric mixture was purified by column chromatography using as eluent n-
hexane/AcOEt (4/1) leading to the isomers Z-14 and E-15 in 58% (61.5g) and 14% (14.8g) 
respectively as colorless oils. 
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O
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9
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Analytical data for Z-14: 
 
 
Rf: 0.48 (n-hexane/AcOEt 4/1). 
 
 
[ ]20Dα  = -124.8 (c= 1,05, CHCl3). 
 
 
1H NMR (CDCl3): 
 
δ 6.35 (dd, 1H, J=11.6 Hz, J=6.6Hz, C-5), 5.83 (dd, 1H, J=11.6 Hz, J=1,8 Hz, C-4), 5.49 
(dq, 1H, J=6.8 Hz, J=1.7 Hz, C-6), 4.37 (dd, 1H, J=8.3 Hz, J=6.9 Hz, C-7), 4.16 (q, 2H, 
J=7.1 Hz, C-2), 3.60 (dd, 1H, J=8,2 Hz, J=6.6 Hz, C-7), 1.44 (s, 3H, C-9), 1.38 (s, 3H, C-
9), 1.28 (t, 3H, J=7.1, C-1). 
 
 
13C NMR (CDCl3): 
 
δ 165,6 (C-3), 149,1 (C-5), 120,8 (C-4), 109,7 (C-8), 73,5 (C-6), 69,4 (C-7), 60,4 (C-2), 
26,5 (C-9), 25,4 (C-9), 14,1 (C-1). 
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IR (film, cm-1):  
 
2990(=CH-), 2940(-CH3), 2910(-CH2-asym), 2880(-CH2-sym), 1720(C=O), 1640(C=C). 
 
 
MS m/z:  
 
200 (M+), 185 (M+ - .CH3), 170 (M+ - 2.CH3), 155 (M+ - EtO.), 142 (C7H10O3+), 125, 112 
(C6H8O2+), 97, 84 (C4H4O2+), 72 (C4H8O+), 59, 52, 43. 
 
 
Elemental Analysis:  
 
Anal. Calcd for C10H16O4: C, 59.98; H, 8.05. Found: C, 57.61; H, 8.70. 
 
 
Analytical data for E-15: 
 
E-15
3
4
5 O
O
O
O
6
7
8
 
 
Rf: 0.38 (n-hexane/AcOEt 4/1). 
 
 
[ ]20Dα  = -41.1 (c= 0.9, CHCl3). 
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1H NMR (CDCl3): 
 
δ 6,86 (dd, 1H, J=15.7 Hz, J=5.6 Hz, C-5), 6.08 (dd, 1H, J=15.7 Hz, J=1,4 Hz, C-4), 4.65 
(dq, 1H, J=5,6 Hz, J=1.3 Hz, C-6), 4.20 (q, 2H, J=14.1 Hz, J=7.0 Hz, C-2), 4.17 (dd, 1H, 
J=8.3 Hz, J=6.4 Hz, C-7), 3.66 (dd, 1H, J=8.2 Hz, J=7.2 Hz, C-7), 1.44 (s, 3H, C-9), 1.40 
(s, 3H, C-9), 1.28 (t, 3H, J=7.1Hz, C-1). 
 
 
13C NMR (CDCl3): 
 
δ 165,9 (C-3), 144,6 (C-5), 122,4 (C-4), 110,1 (C-8), 74,9 (C-6), 68,8 (C-7), 60,5 (C-2), 
26,5 (C-9), 25,7 (C-5), 14,2 (C-1). 
 
 
IR (film, cm-1):  
 
2990 (=CH-), 2940 (-CH3), 2880 (-CH2-), 1720 (C=O), 1660 (C=C) 
 
 
MS m/z:  
 
200 (M+), 185 (M+ - .CH3), 170 (M+ - 2.CH3), 155 (M+ - EtO.), 142 (C7H10O3+), 125, 112 
(C6H8O2+), 97, 84 (C4H4O2+), 72 (C4H8O+), 59, 52, 43. 
 
 
Elemental Analysis:  
 
Anal. Calcd for C10H16O4: C, 59.98; H, 8.05. Found: C, 58,4; H, 8,8. 
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7.3.5 R-(+)-5-Hydroxymethyl-5H-furan-2-one (16) 
 
To a stirred solution of R-(-)-Z-3-(2,2-dimethyl-[1,3]dioxolan-4-yl)-acrylic acid ethyl ester 
(14, M.W. 200.23, 46.1 g, 230mmol) in 150ml of MeOH, 6ml of a 10% aqueous solution 
of H2SO4 was added at rt. After 4h the weakly basic ion exchange resin Amberlite IRA-93 
was added portionwise until the pH was adjusted to 6-6.5. The resin was filtered off and 
the organic phase was evaporated under reduced pressure. The resulting crude product was 
purified by chromatography on silica gel using AcOEt as eluent to afford 18.8g of 16 in 
72% yield as white crystals. 
 
16
O O
HO
1
23
4
5
 
 
m.p. 43-44 °C (from CHCl3/Et2O). 
 
 
Rf : 0.45 AcOEt. 
 
 
[ ]20Dα = +124.7 (c 1.08, CHCl3). 
 
 
1H NMR (CDCl3): 
 
δ 7.49 (dd, J=5.83 Hz, J=1.57 Hz, 1H, C-3), 6.19 (dd, J=5.76 Hz, J=2.03 Hz, 1H, C-2), 
5.15 (m, 1H, C-4), 3,98 (dd, J=12.19 Hz, J=3.37 Hz, 1H, C-5), 3.79 (dd, J=12.19 Hz, 
J=4.88 Hz, 1H, C-5’), 2.58 (br, 1OH). 
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13C NMR (CDCl3): 
 
δ 173.02 (C-1), 153.45 (C-3), 122.97 (C-2), 83.98 (C-4), 62.39 (C-5). 
 
 
IR (KBr, cm-1): 
 
3350 (OH), 3085 (=C-H), 2920 (-CH2-asym), 2860 (-CH2-sym), 1735 (C=O), 1595 (C=C). 
 
 
Elemental Analysis:  
 
Anal. Calcd for C5H6O3: C, 52.58; H, 5.25. Found: C, 52.30; H, 5.21 . 
 
 
7.3.6 2,2,2-Trichloro-acetimidic acid benzyl ester28 (17) 
 
500ml of a 50% aqueous solution of KOH were added at –15 °C to a stirred solution of 
PhCH2OH (50ml, 480mmol) in 500ml dichloromethane. To this biphasic mixture the phase 
transfer catalyst tetrabutylammonium hydrogensulfate (500mg) was added followed by the 
dropwise addition of trichloroacetonitrile (58ml, 580mmol; 1.2eq) via a dropping funnel. 
After stirring for 30min at –15 °C, the temperature was increased to rt and the mixture 
stirred for an additional 30min. The phases were separated, the aqueous layer was 
extracted with dichloromethane (2x100ml) and the collected organic phases reduced to 1/3 
of their volume. The pale yellow solution was filtered over Celite and the solvent was 
evaporated in vacuo to afford 101g (400mmol, 83% yield) of 17 as yellow oil. Without any 
further purification, this reagent was used for further transformations. 
 
17
1
2
3
Ph O CCl3
NH
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1H NMR (CDCl3): 
 
δ 8.4 (s, 1H, NH), 7.5 – 7.3 (m, 5H, Ph), 5.4 (s, 2H, C-3). 
 
 
13C NMR (CDCl3): 
 
δ 162.5 (C-2), 135.4 (Car), 128.5 (Car), 128.2 (Car), 127.9 (Car), 91.3 (C-1), 70.7 (C-3). 
 
 
IR (film, cm-1): 
 
3340 (NH), 3070 (-CH-aromat), 3030 (-CH-aromat), 2950 (-CH2-), 1660 (C=N). 
 
 
MS m/z:  
 
251 (M+), 186 (M+ - Ph.), 145 (C2OCl3+), 134 (PhCH2OCH=NH+), 125 (C2HNOCl2+), 107 
(PhCH2O+), 91 (tropyllium ion ), 79, 65, 51, 39. 
 
 
Elemental Analysis:  
 
Anal. Calcd for C9H8Cl3NO: C, 42.81; H, 3.19; N, 5.55. Found: C, 42.31; H, 3.51; N, 5.90. 
 
 
7.3.7 R-(+)-5-Benzyloxymethyl-5H-furan-2-one (1) from 16 
 
A solution of R-(+)-5-hydroxymethyl-5H-furan-2-one (16, M.W. 114.10, 4.0g, 35.05 
mmol) in a 300ml mixture of anhydrous dichloromethane/cyclohexane (2/1) was stirred 
under argon. The reaction mixture was cooled to 0 °C and trichloroacetamidic acid benzyl 
ester (17, M.W. 252.53, 7.2ml, 38.55mmol, 1.1eq) and trifluoromethanesulfonic acid 
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(M.W. 150.08, 305.6µl, 3.50mmol, 0.1eq) were added. After10 min at 0 °C the 
temperature was increased to rt and the mixture was stirred for an additional 2 hours. The 
solution was filtered to remove the solid trichloroacetamide and the solvents were removed 
under reduced pressure. The crude product was suspended in 60ml n-
hexane/dichloromethane (2/1) and filtered again to remove residual trichloroacetamide. 
Purification by column chromatography on silica gel using as eluent Et2O/n-hexane 
(2/1)→Et2O afforded 6.0g of 1 (84% yield), as colorless oil. 
 
O O
O
1
23
4
56
7
8
8
9
9
10
1  
 
Rf: 0.28 Et2O/hexane (2/1). 
 
 
[ ]20Dα  = +137.3 (c 1.31, CHCl3). 
 
 
ee ≥98% (conditions: see paragraph 7.3.18) 
 
 
1H NMR (CDCl3): 
 
δ 7.50 (dd, J=5.67 Hz, J= 1.39 Hz, 1H, C-3), 7.38-7.27 (m, 5H, Ph), 6.17 (dd, J=5.67 Hz, 
J=1.96 Hz, 1H, C-2), 5.17 (m, 1H, C-4), 4.58 (s, 2H, C-6), 3.74 (dd, J=10.35 Hz, J=5.19 
Hz, 1H, C-5), 3.69 (dd, J=10.50 Hz, J=5.05 Hz, 1H, C-5’). 
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13C NMR (CDCl3): 
 
δ 172.63 (C-1), 153.80 (C-3), 137.27 (C-7), 128.46 (Car.), 127.93 (Car.), 127.67 (Car.), 
122.55 (C-2), 82.13 (C-4), 73.74 (C-6), 69.47 (C-5). 
 
 
IR (film, cm-1): 
 
3070 (=C-H), 3045 (=C-Harom), 3015 (=C-Harom), 2890 (-CH2-asym), 2845 (-CH2-sym), 1750 
(C=O), 1590 (C=C). 
 
 
MS m/z: 
 
204 (M+), 161, 151 (C9H10O2+), 126, 108 (PhCH2O+), 98 [(M+1) -PhCH2O.]+, 91 
(tropyllium ion), 82 (C5H5O+), 77 (Ph+), 62, 49, 44 (100%), 36. 
 
 
Elemental Analysis:  
 
Anal. Calcd for C12H12O3: C, 70.51; H, 5.87. Found: C, 69.95 ; H, 5.76 . 
 
 
7.3.8 R-(+)-2-(3-Benzyloxy-2-hydroxy-propyl)-malonic acid diethyl ester (19) 
 
Method A: 
 
In a 250ml three-necked flask, equipped with two dropping funnels, diethyl malonate 
(2.7ml, 18.28mmol, 1.4eq) was dissolved in 50ml dry THF. To this solution, at –78 °C and 
under argon, 9.8ml of n-butyllithium (1.6M in n-hexane, 15.66mmol, 1.2eq) were added 
dropwise under stirring. After 15min one dropping funnel was charged with R-(-)-2-
benzyloxymethyl oxirane (18, 2ml, 13.05mmol), dissolved in 10ml dry THF and the other 
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with neat BF3-Et2O (1.9ml, 15.66mmol, 1.2eq). 18 and BF3-Et2O were added 
simultaneously and the mixture was stirred for 1.30h at –78 °C. After this time the 
temperature was increased to rt and 20ml of a saturated aqueous solution of NH4Cl were 
added to quench the base. The mixture was transferred to a separatory funnel and 30ml of 
AcOEt were added. The organic layer was separated, washed with brine and dried over 
anhydrous Na2SO4. Column chromatography on silica gel [n-hexane/AcOEt (3/1)] afforded 
3.4g of 19 (81% yield) as colorless oil. 19 is unstable, it cyclizes spontaneously with loss 
of ethanol. 
 
 
Method B: 
 
Sodium (360mg, 15.66mmol, 1.2eq) was added portionwise at 0 °C to 20ml of dry ethanol 
in a flask with an attached bubbler to allow escape of produced H2. When all the sodium 
was consumed, diethyl malonate (2.7ml, 18.28mmol, 1.4eq), dissolved in 10ml of dry 
ethanol was added via a syringe. After 10min at 0 °C, R-(-)-2-benzyloxymethyl-oxirane 
(18, 2ml, 13.05mmol) was added dropwise and the resulting mixture stirred for 2h at 0 °C. 
After this time, 10ml of a saturated aqueous solution of NH4Cl were added and the entire 
mixture transferred to a separatory funnel. 30ml of AcOEt were added, the organic layer 
was washed with brine and dried over anhydrous Na2SO4. After removal of the solvents, 
the crude product was purified by column chromatography on silica gel [n-hexane/AcOEt 
(3/1)] to afford 2.1g of 19 (50% yield) as colorless oil. 19 is unstable, it cyclizes 
spontaneously with loss of ethanol. 
 
19
O
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O
O
O
O
1
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Rf:: 0.23 n-hexane/AcOEt (3/1)  
                                                                                                               Experimental Section 
 
 103 
[ ]20Dα  = +2.1 (c 2.87, CHCl3)   
 
 
1H NMR (CDCl3): 
 
δ 7.40-7.25 (m, Ph), 4.56 (s, 2H, C-8), 4.20 (m, 4H, C-2), 3.86 (m, 1H, C-4), 3.67 (dd, 1H, 
J=8.64 Hz, J=5.59 Hz, C-6), 3.53 (dd, 1H, J=9.66 Hz, J=3.56 Hz, C-7), 3.38 (dd, 1H, 
J=9.66 Hz, J=7.12 Hz, C-7’), 2.06 (m, 2H, C-5), 1.27 (m, 6H, C-1). 
 
 
13C NMR (CDCl3): 
 
δ 169.72 (C-3), 169.44 (C-3), 137.82 (C-9), 128.44 (Car), 127.81 (Car), 127.71 (Car), 74.13 
(C-7), 73.41 (C-8), 68.31 (C-4), 61.44 (C-2), 48.67 (C-6), 32.23 (C-5), 14.03 (C-1), 13.99 
(C-1’). 
 
 
IR (film, cm-1): 
 
3512 (OH), 2982 (-CH2-asym), 2866 (-CH2-sym), 1731 (C=O).   
 
 
MS m/z:  
 
324 (M+), 278 (M+ - PhCH2OCH2.), 172, 157 (C8H13O3+), 129, 111, 91 (tropyllium ion).  
 
 
Elemental Analysis: 
  
Anal. Calcd for C17H24O6: C, 62.95; H, 7.46. Found: C, 62.23 ; H, 7.31. 
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7.3.9 R-(-)-5-Benzyloxymethyl-dihydro-furan-2-one (21) 
 
2.0g of 19 (6.16mmol) were dissolved in 20ml of DMSO. To this solution H2O (222µl, 
12.32mmol, 2eq) was added together with NaCl (720mg, 12.32mmol, 2eq) and the mixture 
was heated at 150 °C for 6h, allowed to cool to rt, diluted with 20ml Et2O and washed with 
brine. The organic phase was dried over anhydrous Na2SO4 and the resulting crude product 
purified by column chromatography on silica gel using as eluent n-hexane/AcOEt (2/1). 21 
was isolated as colorless oil in 36%yield (576mg). 
 
21
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O
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Rf:: 0.18 n-hexane/AcOEt (2/1)  
 
 
[ ]20Dα  = -22.0 (c 2.95, CHCl3)  
 
 
1H NMR (CDCl3): 
 
δ 7.37-7.27 (m, Ph), 4.67 (m, 1H, C-4), 4.57 (d, J=2.54 Hz, 2H, C-6), 3.68 (dd, J=10.68 
Hz, J=3.56 Hz, 1H, C-5), 3.59 (dd, J=10.68 Hz, J=4.07 Hz, 1H, C-5’), 2.61 (m, 1H, C-2), 
2.47 (m, 1H, C-2’), 2.28 (m, 1H, C-3), 2.12 (m, 1H, C-3’).  
 
 
13C NMR (CDCl3): 
 
δ 177.20 (C-1), 137.62 (C-7), 128.45 (Car), 127.75 (Car), 127.54 (Car), 78.90 (C-4), 73.51 
(C-6), 71.51 (C-5), 28.30 (C-2), 24.04 (C-3).  
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IR (film, cm-1): 
 
2939 (-CH2-asym), 2865 (-CH2-sym), 1770 (C=O). 
 
 
MS m/z:  
 
206 (M+), 107 (PhCH2O+), 100 (M+1-PhCH2O.), 91 (tropyllium ion), 85 (M+-
PhCH2OCH2.). 
 
 
Elemental Analysis:  
 
Anal. Calcd for C12H14O3: C, 69.89; H, 6.84. Found: C, 69.72 ; H, 6.80. 
 
 
7.3.10 (3R,S-5R)-Benzyloxymethyl-3-phenylselanyl-dihydro-furan-2-one (22) from 21 
 
To a stirred solution of HMDS (425µl, 2.03mmol, 1.4eq) in 3ml of dry THF, under argon, 
at –78 °C, n-butyllithium (1.6M in n-hexane, 1.1ml, 1.74mmol, 1.2eq) was added 
dropwise. After 5min, R-(-)-5-benzyloxymethyl-dihydro-furan-2-one (21, 300mg, 
1.45mmol), dissolved in 2ml of dry THF was added. The reaction was stirred for 30min 
and then PhSeBr (378mg, 1.60mmol, 1.1eq), dissolved in 3ml of dry THF was added via a 
syringe and after 2min 5ml aqueous 1N HCl was added in one portion. The mixture was 
diluted with AcOEt (20ml) and the separated organic layer washed with brine and then 
dried over anhydrous Na2SO4. Column chromatography using as eluent n-hexane/AcOEt 
(2/1) afforded 277mg of the diastereoisomeric mixture 22 (52%). No effort was made to 
separate the diastereoisomers. 
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Rf : 0.29 and 0.38 (n-hexane/AcOEt: 2/1) 
 
 
7.3.11 R-(+)-5-Benzyloxymethyl-5H-furan-2-one (1) from 22 
 
Method A: 
 
The diastereoisomeric mixture 22 (277mg, 0.76mmol) was dissolved in 10ml of 
H2O/MeOH: 1/1 (v/v) and NaIO4 (487g, 2.28mmol, 3eq) was added at rt. After 1h the 
reaction mixture was diluted with AcOEt (10ml) and successively washed with H2O (5ml), 
an aqueous solution of Na2S2O3 (5ml). The organic phase was washed with brine and then 
dried over anhydrous Na2SO4. Purification by column chromatography on silica gel using 
as eluent Et2O/n-hexane (2/1)→Et2O afforded 1 in 85% yield (132mg) as colorless oil. 
 
 
Method B: 
 
500 mg of the diastereoisomeric mixture 22 (1.38mmol) were placed in a 25ml round 
bottom flask equipped with a magnetic stirrer and containing 5ml of THF. This solution 
was cooled to 0 °C and 3 drops of acetic acid were added via a Pasteur pipette. Then, 1.5ml 
of a 30% aqueous solution of H2O2 were added and the resulting mixture stirred at 0 °C for 
30min. After this period the entire solution was transferred to a separatory funnel 
containing 10ml of dichloromethane. The separated organic phase was washed 
successively with a saturated aqueous solution of NaHCO3, brine, and then dried over 
anhydrous Na2SO4. Purification by column chromatography on silica gel using as eluent 
Et2O/n-hexane (2/1)→Et2O afforded 1 in 65% yield (183mg) as colorless oil. 
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[ ]20Dα = +136 (c 1.30, CHCl3). 
 
 
ee ≥97% (conditions: see paragraph 7.3.18) 
 
 
All spectroscopic data were consistent with those reported above (paragraph 7.3.7). 
 
 
7.3.12 Phenylselanyl acetic acid33 (23) 
 
To a stirred solution of diphenyldiselenide (26, 3.1g, 10.0mmol) in 60ml of dry EtOH, 
under argon, 850mg (22.4mmol, 2.2eq) of NaBH4 were added portionwise and the mixture 
was stirred until a clear solution was obtained. Then, chloroacetic acid (25, 1.9g, 
20.0mmol, 2eq), dissolved in 7ml of dry EtOH was added and the reaction mixture stirred 
for 7h at rt. After that, 10ml of a saturated water solution of NaHCO3 were added, the 
solution was diluted with 30ml water and extracted with 2x50ml Et2O/n-hexane (2/1). The 
aqueous phase was acidified to pH=1 and extracted with 2x50ml Et2O/n-hexane (2/1). 
Removal of the solvents afforded 23 in 70% yield (3.0g) as yellow powder. 
 
23
Se
O
OH
 
m.p. 35-36 °C  
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1H NMR (CDCl3): 
 
δ 10.31 (br, 1OH), 7.63-7.60 (m, 2H, C-4), 7.31-7.27 (m, 3H, C-5 – C-6), 3.53 (s, 2H, C-
2). 
 
 
13C NMR (CDCl3): 
 
δ 177.26 (C-1), 133.43 (Car.), 129.26 (Car.), 128.93 (Car.), 128.05 (Car.), 27.24 (C-2). 
 
 
IR (film, cm-1): 
 
3000 (OH), 1700 (C=O), 1580  
 
 
MS m/z:  
 
216 (M+), 171 (PhSeCH2+), 156 (PhSe+). 
 
 
Elemental Analysis:  
 
Anal. Calcd for C8H8O2Se: C, 44.67; H, 3.75. Found: C, 44.21 ; H, 3.56. 
 
 
7.3.13 (3R,S-5R)-Benzyloxymethyl-3-(phenylselanyl)-dihydro-furan-2-one (22) from 23 
 
To a stirred solution of diisopropylamine (2.0ml, 14.36mmol, 2.2eq) in 15ml of dry THF, 
at -78 °C under argon, n-butyllithium (1.6 M in n-hexane, 9.0ml, 14.36mmol, 2.2eq) was 
added dropwise and the mixture stirred for 15min. Then, 6.52mmol (1eq) of 
PhSeCH2CO2H in 5ml of dry THF was added dropwise and, after stirring for 1h at -78 °C, 
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R-(-)-2-benzyloxymethyl oxirane (18, 1ml, 6.52mmol), dissolved in 10ml of dry THF was 
added. The mixture was stirred for 3h at rt. After this period at 0 °C 5ml of AcOH were 
added and the resulting solution was refluxed under argon over night. The mixture was 
diluted with 20ml of Et2O, washed with a saturated aqueous solution of NaHCO3 (3x10ml), 
brine and dried over anhydrous Na2SO4. The solvents were removed under reduced 
pressure and the crude product containing the mixture of diastereoisomers 22 purified by 
column chromatography on silica gel using as eluent n-hexane/AcOEt: 2/1 leading to 1.7g 
of the diastereoisomeric mixture 22 (72% yield). No effort was made to separate the 
diastereoisomers. 
 
22
O O
O
SePh
1
23
4
56
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Rf : 0.29 and 0.38 (n-hexane/AcOEt: 2/1) 
 
 
7.3.14 R-(+)-5-Benzyloxymethyl-5H-furan-2-one (1) from 22 
 
This transformation has been carried out under the same conditions already described 
above (paragraph 6.3.11) to obtain 1 also in this case with high enantiomeric purity. 
 
[ ]20Dα = +136.2 (c 1.37, CHCl3). 
 
 
ee ≥97% (conditions: see paragraph 7.3.18) 
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7.3.15 Phenylsulfanyl acetic acid35 (27) 
 
To a stirred solution of thiophenol (31, 5g, 44.1mmol) in a mixture of 20 ml THF and 30ml 
water at 0 °C, tetrabutylammonium bromide (100mg) was added. Then, NaOH (3.3g, 
80.3mmol) was added portionwise, followed by a solution of bromoacetic acid (30, 6.4g, 
45.1mmol) in 50ml of THF. The mixture was stirred for 30min at rt, acidified with 
concentrated HCl and diluted with 20ml of diethyl ether. The aqueous phase was extracted 
with diethyl ether (3x50ml) and the combined organic layers dried over anhydrous 
Na2SO4. Removal of the solvent yielded 27 as pale yellow solid in 95% yield (7.1g) and 
high chemical purity (NMR analyses). 
 
27
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O
OH1
23
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m.p. 61-62 °C 
 
 
1H NMR (CDCl3): 
 
δ 10.25 (br, 1OH), 7.64-7.61 (m, 2H, C-4), 7.33-7.26 (m, 3H, C-5 – C-6), 3.53 (s, 2H, C-
2). 
 
 
13C NMR (CDCl3): 
 
δ 177.34 (C-1), 133.45 (Car.), 129.28 (Car.), 129.13(Car.), 127.82 (Car.), 27.22 (C-2). 
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IR (film, cm-1): 
 
3000 (OH), 1710 (C=O), 1600, 1200.  
 
 
MS m/z:  
 
168 (M+), 123 (PhSCH2+), 109 (PhS+).  
 
 
Elemental Analysis:  
 
Anal. Calcd for C8H8O2S: C, 57.12; H, 4.79; S, 19.06. Found: C, 56.89; H, 4.72; S, 18.95. 
 
 
7.3.16 (3R,S-5R)-Benzyloxymethyl-3-(phenylsulfanyl)-dihydro-furan-2-one (28) 
 
To a stirred solution of diisopropylamine (2.0ml, 14.36mmol, 2.2eq) in 15ml of dry THF, 
at -78 °C under argon, n-butyllithium (1.6 M in n-hexane, 9.0ml, 14.36mmol, 2.2eq) was 
added dropwise and the mixture stirred for 15min. Then, 6.52mmol (1eq) of PhSCH2CO2H 
in 5ml of dry THF was added dropwise and after stirring for 1h at -78 °C, R-(-)-2-
benzyloxymethyl oxirane (18, 1ml, 6.52mmol) dissolved in 10ml of dry THF was added. 
The mixture was stirred for 3h at rt. Then at 0 °C 5ml of AcOH were added and the 
resulting solution was refluxed under argon over night. The mixture was diluted with 20ml 
of Et2O, washed with a saturated aqueous solution of NaHCO3 (3x10ml), brine and dried 
over anhydrous Na2SO4. The solvents were removed under reduced pressure and the crude 
product containing the mixture of diastereoisomers 28 purified by column chromatography 
on silica gel using as eluent n-hexane/AcOEt: 2/1. Obtained were 1.4g of the 
diastereoisomeric mixture 28 (70% yield). No effort was made to separate the 
diastereoisomers. 
 
                                                                                                               Experimental Section 
 
 112 
28
O O
O
SPh
1
23
4
56
7
8
8
9
9
10
 
 
Rf : 0.29 and 0.38 (n-hexane/AcOEt: 2/1) 
 
 
7.3.17 R-(+)-5-Benzyloxymethyl-5H-furan-2-one (1) from 28 
 
28 (1.4g, 4.56mmol) was dissolved in 50ml of H2O/MeOH: 1/1 (v/v) and NaIO4 (2.9g, 
13.68mmol, 3eq) was added in one portion at rt. After stirring over night, the reaction 
mixture was diluted with AcOEt (50ml), washed successively with H2O (20ml), an 
aqueous solution of Na2S2O3 (20ml), brine and then dried over anhydrous Na2SO4. After 
removal of the solvents under vacuum, the crude product was dissolved in toluene (10ml) 
and refluxed for 30min. The solution was allowed to cool at rt and the toluene evaporated 
under reduced pressure. The crude product was purified by column chromatography on 
silica gel using as eluent Et2O/n-hexane: 2/1. 1 was isolated in 50% yield (465mg) as 
colorless oil. 
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[ ]20Dα = +134.1 (c 1.28, CHCl3).  
 
 
ee ≥95% (conditions: see paragraph 7.3.18) 
 
 
All spectroscopic data were consistent with those reported above (paragraph 7.3.7). 
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7.3.18 R-(+)-5-(tert-Butyl-diphenyl-silanyloxymethyl)-5H-furan-2-one (32) from 16 
 
Method A: 
 
To a stirred solution of R-(+)-5-hydroxymethyl-5H-furan-2-one (16, 100mg, 0.87mmol) in 
10ml of dry dichloromethane, at 0 °C, under argon, Et3N (146µl, 1.05mmol, 1.2eq) was 
added via a syringe followed by addition of DMAP (10.7mg, 0.08mmol, 0.1eq). The 
mixture was allowed to warm to rt and was then stirred for 4h. After that the solvent was 
evaporated and, without any additional work-up, the crude product was purified by column 
chromatography on silica gel using as eluent n-hexane/AcOEt (4/1). 32 was obtained in 
79% yield (242mg) as white solid. Under these conditions, complete racemization of 32 
was observed (see discussion section). 
 
 
Method B: 
 
To a stirred solution of R-(+)-5-hydroxymethyl-5H-furan-2-one (16, 50mg, 0.44mmol) in 
2ml of dry DMF, under argon, at room temperature were added NH4NO3 (105.2mg, 
1.31mmol, 3eq) and tert-butyl-diphenylsilylchloride (145.7µl, 0.57mmol, 1.3eq). After 
stirring for 24h, water (10ml) was added and the mixture was extracted with Et2O 
(3x10ml). The organic layer was dried over anhydrous Na2SO4 and the solvent evaporated 
under reduced pressure. The crude product was purified by chromatography on silica gel 
using as eluent n-hexane/AcOEt (4/1) to afford the title compound 32 in 91% yield 
(140mg) as white crystals. Under these conditions 32 was isolated without any 
racemization. 
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m.p. 79-80 °C (from pentane/Et2O). 
 
 
Rf : 0.37 n-hexane/AcOEt (4/1). 
 
 
[ ]20Dα = +76.4 (c 1.15, CHCl3); ee ≥98% (HPLC analysis, column LiChoCART 250-4 (S,S)-
Whelk-5µm, eluent n-hexane/isopropanol (97/3 v/v), flow rate 1 ml/min, detector UV 254 
nm, see Figure 2.2, chapter 2). 
 
 
1H NMR (CDCl3): 
 
δ 7.62-7.36 (complex, 11H, 2Ph + C-3), 6.15 (dd, J=5.77 Hz, J=1.76 Hz, 1H, C-2), 5.04 
(m, 1H, C-4), 3,93 (dd, J=10.68 Hz, J=4.57 Hz, 1H, C-5), 3.88 (dd, J=11.18 Hz, J=5.08 
Hz, 1H, C-5’), 1,02 (s, 9H, C-6). 
 
 
13C NMR (CDCl3): 
 
δ 172.82 (C-1), 153.94 (C-3), 135.58 (Car.), 132.79 (Car.), 130.00 (Car.), 127.86 (Car.), 
122.71 (C-2), 83.19 (C-4), 63.43 (C-5), 26.70 (C-6), 19.21 (C-11). 
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IR (KBr, cm-1): 
 
3090 (=C-H), 3050 (=C-Harom), 2880 (-CH2-), 1740 (C=O), 1595 (C=C). 
 
 
MS m/z: 
 
295 (M+ - t-Bu), 199 (100%, Ph2SiO+), 181, 135, 77 (Ph+), 55. 
 
 
Elemental Analysis:  
 
Anal. Calcd for C21H24O3Si: C, 71.48; H, 6.80. Found: C, 70.89 ; H, 6.45. 
 
 
7.3.19 R-(+)-5-(tert-Butyl-diphenyl-silanyloxymethyl)-5H-furan-2-one (32) from 1 
 
To a solution of 1 (80mg, 0.39mmol) in 10ml of AcOEt, 10mg of 10% Pd/C were added 
and the suspension was degassed for 5 min under stirring by applying vacuum using an 
aspirator. Then, the flask was connected with a source of H2 via a rubber hose and stirred 
for 1h at rt. The catalyst was removed by filtration and the solvent evaporated under 
reduced pressure. Quantitative deprotection was observed via NMR. The crude product 
was dissolved in 2ml of dry DMF and under argon at rt NH4NO3 (94mg, 1.17mmol, 3eq) 
and tert-butyl-diphenylsilylchloride (130µl, 0.51mmol, 1.3eq) were added. After 24h, 
water (10ml) was added and the mixture was extracted with Et2O (2x10ml). The organic 
layer was dried over anhydrous Na2SO4 and the solvent evaporated under reduced 
pressure. The crude product was purified by column chromatography on silica gel using as 
eluent n-hexane/AcOEt (4/1) to afford 32 in 90% yield (124mg) as white crystals. 
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m.p. 79-80 °C. 
 
 
[ ]20Dα = +76.2 (c 1.18, CHCl3) from R-(-)-2-benzyloxymethyl oxirane (18) using the 
Krapcho method (paragraphs 7.3.8 – 7.3.11); ee ≥97% (HPLC analysis, column 
LiChoCART 250-4 (S,S)-Whelk-5µm, eluent n-hexane/isopropanol (97/3 v/v), flow rate 1 
ml/min, detector UV 254 nm, see Figure 2.2, chapter 2). 
 
 
[ ]20Dα = +76.4 (c 1.30, CHCl3) from R-(-)-2-benzyloxymethyl oxirane (18) using 
PhSeCH2CO2H (paragraphs 7.3.12 – 7.3.14); ee ≥97% (HPLC analysis, column 
LiChoCART 250-4 (S,S)-Whelk-5µm, eluent n-hexane/isopropanol (97/3 v/v), flow rate 1 
ml/min, detector UV 254 nm, see Figure 2.2, chapter 2). 
 
 
[ ]20Dα = +75.1 (c 1.42, CHCl3) from R-(-)-2-benzyloxymethyl oxirane (18) using 
PhSCH2CO2H (paragraphs 7.3.15 – 7.3.17); ee ≥95% (HPLC analysis, column 
LiChoCART 250-4 (S,S)-Whelk-5µm, eluent n-hexane/isopropanol (97/3 v/v), flow rate 1 
ml/min, detector UV 254 nm, see Figure 2.2, chapter 2). 
 
 
All spectroscopic data were consistent with those reported above (paragraph 7.3.18). 
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7.4 2-Deoxy-L-ribose 
 
7.4.1 2,2’-Bis-benzyloxymethyl-3’,4’-dihydro-2H,2’H-[2,3’]bifuranyl-5,5’-dione (51) 
 
To a stirred solution of R-(+)-5-benzyloxymethyl-5H-furan-2-one (1) (50mg, 0.22mmol) in 
1ml of DMSO and 0.2ml of HMPT, cesium acetate (43.6mg, 0.22mmol, 1eq) was added 
under an argon atmosphere and the mixture stirred at rt for 1h. Then 10ml of AcOEt were 
added and the solution was washed consecutively with 10% aqueous HCl (2x5ml), water 
and brine. The organic layer was dried over anhydrous Na2SO4 and the resulting crude 
product purified by column chromatography on silica gel using as eluent Et2O/n-hexane 
(4/1) to afford 51 in 27% yield.  
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Rf : 0.20 Et2O/n-hexane (4/1). 
 
 
[ ]20Dα = +9.7 (c 0.87, CHCl3). 
 
 
1H NMR (CDCl3): 
 
δ 7.39-7.17 (m, 11H, 2Ph + C-13), 6.17 (d, J=6.10 Hz, 1H, C-12), 4.58 (d, J=11.68 Hz, 
1H, C-6), 4.51 (s, 2H, C-16), 4.48 (d, J=12.20 Hz, 1H, C-6’), 4.39 (m, 1H, C-4), 3.69 (d, 
J=10.17 Hz, 1H, C-15), 3.67 (dd, J=11.18 Hz, J=3.05 Hz, 1H, C-5), 3.47 (dd, J=10.68 Hz, 
                                                                                                               Experimental Section 
 
 118 
J=3.05 Hz, 1H, C-5’), 3.47 (d, J=9.66 Hz, 1H, C-15’), 3.12 (m, 1H, C-3), 2.70 (dd, 
J=18.31 Hz, J=10.17 Hz, 1H, C-2), 2.50 (dd, J=17.80 Hz, J=5.59 Hz, 1H, C-2’).      
 
 
13C NMR (CDCl3): 
 
δ 174.80 (C-1), 170.71 (C-11), 155.57 (C-13), 137.28, 136.57 (C-7 + C-17), 128.62 (Car), 
128.54 (Car), 128.29 (Car), 128.03 (Car), 127.90 (Car), 127.72 (Car), 123.59 (C-12), 88.40 
(C-14), 78.19 (C-4), 73.98 (C-6), 73.62 (C-16), 72.05 (C-15), 70.45 (C-5), 40.17 (C-3), 
30.01 (C-2).  
 
 
IR (film, cm-1): 
 
3030 (=C-Harom), 2865 (-CH2-sym), 1758 (C=O). 
 
 
MS m/z: 
 
408 (M+), 317 (M+ - PhCH2.), 211 (C10H10O5+), 181 (C9H8O4+), 91 (tropyllium ion), 43. 
 
 
Elemental Analysis: 
  
Anal. Calcd for C24H24O6: C, 70.57; H, 5.92. Found: C, 69.92 ; H, 6.07. 
 
 
7.4.2 Dimethylphenylsilyl lithium 
 
A three-neck flask equipped with an argon inlet and a bubbler was charged with lithium 
powder (Aldrich 37,239-0, 897mg, 129.27mmol, 3eq) and under argon at 0 °C a solution 
of phenyldimethylchlorosilane (7.1ml, 43.09mmol) in 40ml of dry THF was added 
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dropwise. After completion of  the addition, the flask was immersed into a sonicator for 
15min and the purple solution was stirred overnight at –5 °C. This mixture was used 
directly and was always prepared freshly prior to the application. In our experience this 
reagent must always be transferred via cannula for best results. 
 
 
7.4.3 Dimethylphenylsilyl lithium – Determination of concentration 
 
0.50ml of the solution obtained above (paragraph 6.4.2, ≅ 0.50mmol) were poured into 
50ml of distilled water. To this solution a catalytic amount of phenolphthalein was added 
and the violet solution was titrated with a standard solution of 0.1N HCl in water until 
decolorization was observed (equivalent point). 55ml of 0.1N HCl solution (0.55mmol 
HCl) were consumed corresponding to 0.55mmol of OH- equivalents produced by 
quenching the original solution with water and therefore the conversion could be 
considered quantitative corresponding to a 1.1 M solution of dimethylphenylsilyl lithium in 
THF. 
 
 
7.4.4 (4R,5S)-(-)-5-Benzyloxymethyl-4-(dimethyl-phenyl-silanyl)-dihydro-furan-2-one 
(54) 
 
A suspension of CuCN (dried over night at 120 °C under high vacuum, 1.9g, 21.54mmol, 
1.1eq) in 100ml of dry THF was stirred under argon at –45 °C. To this suspension 
Ph(Me)2SiLi (see above, 43.09mmol, 2.2eq) was added via cannula and the mixture was 
vigorously stirred for 30min. Then, at –45 °C, R-(+)-5-benzyloxymethyl-5H-furan-2-one 
(1, 4.0g, 19.58mmol) in 15ml of dry THF was slowly added via a syringe. The reaction 
mixture was stirred for 1h and quenched at –45 °C with 10ml of a saturated aqueous 
solution of NH4Cl. The mixture was filtered by suction using an aspirator, AcOEt (20ml) 
was added and the entire mixture transferred to a separatory funnel. The organic layer was 
separated, successively washed with water and brine, and then dried over anhydrous 
Na2SO4. Chromatographic separation was carried out on silica gel using as eluent n-
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hexane/AcOEt (3/1). 54 was isolated in 90% yield (6.0g) as a colorless oil. The 13C-NMR 
analysis showed the formation of a single diastereoisomer. 
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Rf : 0.44 n-hexane/AcOEt (3/1). 
 
 
[ ]20Dα  = -22.5 (c 1.08, CHCl3). 
 
 
1H NMR (CDCl3): 
 
δ 7.48-7.27 (m, 10H, 2Ph), 4.51 (m, 1H, C-4), 4.49 (s, 2H, C-6), 3.57 (dd, J=11.18 Hz, 
J=2.49 Hz, 1H, C-5), 3.36 (dd, J=11.19 Hz, J=4.68 Hz, 1H, C-5’), 2.64 (dd, J=17.70 Hz, 
J=9.96 Hz, 1H, C-2), 2.38 (dd, J=17.74 Hz, J=11.06 Hz, 1H, C-2’),  1.96 (q, J =9.66 Hz, 
1H, C-3), 0.37 (s, 3H, C-11), 0.35 (s, 3H, C-11). 
 
 
13C NMR (CDCl3): 
 
δ 176.87 (C-1), 137.68 (C-7), 135.26 (C-12), 133.70 (C-13), 129.88 (Car.), 128.21 (Car.), 
127.75 (Car.), 127.67 (Car.), 82.05 (C-4), 73.45 (C-6), 71.38 (C-5), 31.33 (C-2), 24.07 (C-
3), -4.53 (C-11), -5.15 (C-11). 
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IR (film, cm-1): 
 
3045 (=C-Harom), 3010 (=C-Harom), 2930 (-CH3asym), 2890 (-CH2-), 2840 (-CH2-), 1760 
(C=O), 1580 (C=Carom). 
 
 
MS m/z: 
 
340 (M+), 325 (M+ - .CH3), 280, 271, 262 [(M-1) - Ph.]+, 241, 219 (M+ - PhCH2OCH2.), 
191 (C11H14OSi+), 165, 156 (M+ - Ph. – PhCH2O.), 136 (PhMe2SiH+), 117, 105, 91 (100%, 
tropyllium ion), 84 (M+ - PhMe2Si. – PhCH2OCH2.), 75, 65, 57, 43. 
 
 
Elemental Analysis:  
 
Anal. Calcd for C20H24O3Si: C, 70.48; H, 7.04. Found: C, 69.78; H, 6.97. 
 
 
7.4.5 (4R,5S)-(-)-5-Benzyloxymethyl-4-hydroxy-dihydro-furan-2-one (48) from 54 
 
Method A: 
 
To a stirred solution of 54 (5.0g, 14.68mmol) in 15ml of AcOOH (39% in AcOH, 6eq), at 
0 °C, under argon, Br2 (1M in AcOH, 7.3ml, 0.5eq) was added dropwise and the mixture 
was stirred for 5h at rt. The solution was then diluted with Et2O (100ml) and under stirring 
at 0 °C 20ml of an aqueous solution of Na2S2O3 were carefully added. The organic layer 
was separated, treated under stirring with 20ml of a saturated aqueous solution of NaHCO3 
followed by addition of NaHCO3 powder until no further gas evolution was observed. The 
organic phase was washed again successively with 20ml of a saturated aqueous solution of 
NaHCO3, brine and then dried over anhydrous Na2SO4. Chromatographic purification was 
achieved on silica gel using as eluent n-hexane/AcOEt (1/1) to afford 48 in 65% yield 
(2.1g) as a colorless oil. 
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Method B: 
 
To a stirred solution of 54 (642mg, 1.88mmol) in 4ml of AcOH were added successively 
KBr (269mg, 2.26mmol, 1.2eq) and AcONa (580mg, 7.07mmol, 3.7eq). The mixture was 
cooled to 0 °C and 2.4ml of a 39% solution of AcO2H in AcOH (14.14mmol, 7.5eq) was 
slowly added. After stirring for 30min, more AcONa (1.7g, 21.21mmol, 11.3eq) and 
AcO2H (39% in AcOH, 7.2ml, 22.5eq) were added and the mixture stirred for 5h at rt. 
Work up and purification as described for method A afforded 250mg of 48 (60% yield) as 
a colorless oil. 
 
 
Method C: 
 
To a stirred solution of 54 (220mg, 0.64mmol) in 1ml of AcOH, a 39% solution of AcO2H 
in AcOH (2.8ml, 16.79mmol, 26eq) was added followed by Hg(OAc)2 (308mg, 0.96mmol, 
1.5eq). This mixture was stirred under an argon atmosphere for 3h at rt, diluted with Et2O 
(10ml) and washed consecutively with a saturated aqueous solution of Na2S2O3 (2x5ml), 
H2O, a saturated aqueous solution of NaHCO3 and finally brine. The organic layer was 
dried over anhydrous Na2SO4 and the crude product purified by column chromatography 
on silica gel using as eluent n-hexane/AcOEt (1/1) to afford 48 in 44% yield (62mg) as 
colorless oil. 
 
 
Method D: 
 
54 (500mg, 1.46mmol) was dissolved in 8ml of a mixture 1:1 (v/v) of AcOH and 
CF3CO2H. Then 752mg of Hg(O2CCF3)2 (1.76mmol, 1.2eq) were added, the resulting 
mixture cooled to 0 °C and a 39% solution of AcO2H in AcOH (0.7ml, 4.40mmol, 3eq) 
was slowly added. After stirring for 3.5h at rt, the mixture was diluted with 
dichloromethane (10ml), poured into 10ml of a 1:1 (v/v) mixture of a saturated aqueous 
solution of NaHCO3 and NaCl and treated with powdered NaHCO3 until pH=5 was 
reached. Then, the mixture was extracted with dichloromethane (3x20ml) and the collected 
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organic phases dried over anhydrous Na2SO4. The crude product was purified by column 
chromatography on silica gel using as eluent n-hexane/AcOEt (1/1) to afford 48 in 38% 
yield (124mg) as a colorless oil. 
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Rf : 0.26 hexane/AcOEt (1/1). 
 
 
[ ]20Dα = -5.0 (c 1.38, CHCl3). 
 
 
1H NMR (CDCl3): 
 
δ 7.38-7.27 (m, 5H, Ph), 4.60-4.47 (complex, 4H, C-6, C-4, C-3), 3.70 (dd, J=10.70 Hz, 
J=3.21 Hz, 1H, C-5), 3.66 (dd, J=10.73 Hz, J=3.59 Hz, 1H, C-5’), 2.93 (dd, J=18.05 Hz, 
J=6.8 Hz, 1H, C-2), 2.45 (dd, J=17.96 Hz, J=2.65 Hz,1H, C-2’), 2.09 (br, 1 OH). 
 
 
13C NMR (CDCl3): 
 
δ 175.89 (C-1), 137.28 (C-7), 128.53 (C-9), 127.98 (C-8), 127.65 (C-10), 86.26 (C-4), 
73.75 (C-6), 69.71 (C-5), 69.41 (C-3), 38.37 (C-2). 
 
 
 
 
 
                                                                                                               Experimental Section 
 
 124 
IR (film, cm1): 
 
3440 (OH), 3060 (=C-Harom), 3030 (=C-Harom) , 2920 (-CH2-asym), 2860 (-CH2-sym), 1770 
(C=O). 
 
 
MS m/z: 
 
222 (M+), 176, 159, 133, 116 (M+ - PhCH2O.), 105, 98 (C5H6O2+), 91 (100%, tropyllium 
ion), 83 (C4H4O2+), 77 (Ph+), 70, 65, 57, 51, 43. 
 
 
Elemental Analysis:  
 
Anal. Calcd for C12H14O4: C, 64.79; H, 6.30. Found: C, 64.21; H, 6.12. 
 
 
7.4.6 (2R,S-4R,5S)-(-)-5-Benzyloxymethyl-tetrahydro-furan-2,4-diol (47) 
 
Method A: 
 
To a stirred solution of 2-methyl-2-butene (19ml, 182.23mmol, 22.5eq) in 20ml of dry 
THF, at 0 °C, under argon, a 1 M solution of BH3-THF (45.3ml, 5.6eq) was added and the 
mixture was stirred for 20min. Then, (4R,5S)-(-)-5-benzyloxymethyl-4-hydroxy-dihydro-
furan-2-one (48, 8.09mmol, 1.8g) in 10ml of dry THF was added dropwise. After stirring 
for 24 hours, water (20ml) was added and the reaction mixture was refluxed for 30min. 
After this time at 0 °C 20ml of a 30% aqueous solution of H2O2 was added dropwise and 
the pH was adjusted to pH=8 with 2N NaOH. The mixture was stirred for an additional 
10min, AcOEt (30ml) was added and the organic layer was separated. The aqueous phase 
was extracted twice with AcOEt and the collected organic layers were washed with brine 
and dried over anhydrous Na2SO4. The solvents were removed under vacuum (bath 
temperature max 30 °C). Chromatographic purification was carried out on silica gel using 
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as eluent AcOEt/n-hexane (3/1) to afford 47 in 60% yield (1.1g) as a colorless oil. 47 
constitutes an anomeric mixture (α/β ≅ 70/30 in CDCl3).  
 
 
Method B: 
 
(4R,5S)-(-)-5-benzyloxymethyl-4-hydroxy-dihydro-furan-2-one (48, 3.06mmol, 684mg) 
was dissolved in 10ml of dry THF and the resulting solution was stirred at –78 °C under 
argon. Then, a 1 M solution of DIBAL in toluene (9.2ml, 9.22mmol, 3eq) was added 
dropwise and the mixture stirred at –78 °C for 4h. The monitoring of the reaction progress 
(T.l.c.) showed only partial conversion together with unreacted starting material (main 
spot). The reaction was quenched with a saturated aqueous solution of NH4Cl followed by 
extraction with AcOEt (3x10ml). The separated organic phases were collected and dried 
over anhydrous Na2SO4. After removal of the solvents, the crude product was purified by 
column chromatography on silica gel using as eluent AcOEt/n-hexane (3/1) to afford 47 in 
only 10% yield (68mg) as colorless oil. Again as anomeric mixture (α/β ≅ 70/30 in 
CDCl3). 
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Rf :0.26 AcOEt/hexane (3/1). 
 
 
[ ]20Dα = -32.3 (c 1.22, CHCl3, 2h). 
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1H NMR (CDCl3): 
 
β anomer: δ 7.37-7.27 (m, 5H, Ph), 5.54 (d, J=4.78 Hz, 1H, C-1), 4.57 (d, J=6.10 Hz, 2H, 
C-6), 4.44 (m, 1H, C-3), 4.05 (q, J=4.06, 1H, C-4), 3.61 (d, J=4.22, 2H, C-5), 3.45 (br, 2 
OH), 2.13 (d, J=3.05 Hz, 1H, C-2), 2.11 (d, J=5.08 Hz, 1H, C-2’). 
 
 
13C NMR (CDCl3): 
 
β anomer: δ 137.21 (C-7), 128.51 (C-9), 127.98 (C-8), 127.85 (C-10), 99.03 (C-1), 84.95 
(C-4), 73.66 (C-6), 73.10 (C-3), 71.26 (C-5), 43.61 (C-2). 
 
 
1H NMR (CDCl3): 
 
α anomer: δ 7.37-7.27 (m, 5H, Ph), 5.54 (d, J=4.78 Hz, 1H, C-1), 4.52 (s, 2H, C-6), 4.35 
(dt, J=4.48 Hz, J=1.50 Hz, 1H, C-4), 4.23 (d, J=5.98 Hz, 1H, C-3), 3.50 (dd, J=10.18 Hz, 
J=4.73 Hz, 1H, C-5), 3.45 (br, 2 OH), 3.41 (dd, J=10.17 Hz, J=5.09 Hz, 1H, C-5’), 2.13 (d, 
J=13.40 Hz, 1H, C-2), 1.98 (d, J=13.73 Hz, 1H, C-2’). 
 
 
13C NMR (CDCl3): 
 
α anomer: δ 137.78 (C-7), 128.37 (C-9), 127.71 (C-8), 127.61 (C-10), 99.24 (C-1), 85.86 
(C-4), 73.44 (C-6), 73.33 (C-3), 70.49 (C-5), 41.30 (C-2). 
 
 
IR (film, cm-1): 
 
3350 (OH), 3000 (=C-Harom), 2900 (-CH2-asym), 2840 (-CH2-sym). 
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MS m/z: 
 
206 (M+ - H2O), 115 (M+ - H2O - tropyllium ion), 107 (PhCH2O+), 91 (tropyllium ion), 71, 
59, 45 (100%). 
 
 
Elemental Analysis:  
 
Anal. Calcd for C12H16O4: C, 64.21; H, 7.13. Found: C, 64.05; H, 7.08. 
 
 
7.4.7 2-Deoxy-L-ribose (37 + 38) 
 
A (10% v/v) solution of formic acid in methanol was degassed under vacuum for 5 min. 
20ml of this solution were added carefully under argon to 1g of 10%Pd/C in a Schlenk 
flask equipped with a magnetic stirrer. To this suspension α,β-(4R,5S)-(-)-5-
benzyloxymethyl-tetrahydro-furan-2,4-diol (47, 0.89mmol, 200mg), dissolved in 10ml of 
this solution, was added dropwise under stirring. After 1 hour the catalyst was filtered off, 
washed with 5ml of distilled water and the solvents were removed under vacuum 
(membrane pump, bath temperature max 30 °C). The crude product was purified by 
column chromatography using as eluent AcOEt/MeOH (9/1). The mixture of 37 + 38 was 
isolated as a syrup in 80% yield (95mg) which crystallized slowly from AcOEt/MeOH 4/1. 
After 24h in D2O at rt the product mixture was analyzed by NMR. It consisted of the α,β-
pyranose 37 and the α,β-furanose 38 in a ratio of 72:28. The anomeric ratios for 37 and 38 
were nearly 1:1 in both cases. 
 
O OH
HO
HO
O
OH
OH
HO
2-deoxy-L-ribose 3837  
 
m.p. 89-90 °C (from AcOEt/MeOH 4/1). 
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Rf : 0.25 AcOEt/MeOH (9/1). 
 
 
[ ]20Dα = +52.0 (c 1.0, H2O, 24h; Lit.94 +52 (c 0.5, H2O); Lit. for 2-deoxy-D-ribose, -51 (c 
1.3, H2O)95, -52 (c 1.05, H2O)96. 
 
 
The spectroscopic data were consistent with those of commercially available, natural 2-
deoxy-D-ribose.  
 
 
7.4.8. 3-Phenyl-2-(phenylsulfonyl)-oxaziridine (58)55 
 
To a stirred solution of N-benzylidene-benzenesulfonamide (60, 1g, 4.10mmol) in 40ml 
toluene, at rt and under mechanical stirring, a solution of K2CO3 (4.7g, 34.36mmol, 8eq) in 
25ml water was added and the resulting biphasic mixture was vigorously stirred. After this 
period, Oxone® [2KHSO5, KHSO4, K2SO4, 3g, 4.87mmol (9.74 referred to KHSO5, 
2.3eq)] dissolved in 25ml water was added dropwise via a dropping funnel over a period of 
30min. The separated aqueous phase was extracted with 2x20ml toluene, the collected 
organic phases washed with a freshly prepared 10% aqueous solution of NaHSO3, and then 
dried over anhydrous Na2SO4. The filtered solution was evaporated (bath temperature <40 
°C) and the crude product was allowed to solidify over night in the freezer. The crude 
product was then triturated with pentane and after removal of traces of solvents 58 was 
obtained in 89% yield as a white solid. At –20 °C 58 is stable for several months.  
 
58
N
O
S
O
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m.p. 93 - 94 °C (from pentane). 
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1H NMR (CDCl3): 
 
δ 5.50 (s, 1H, C-1), 8.08-7.41 (m, 10H, 2Ph). 
 
 
13C NMR (CDCl3): 
 
δ 135.00 (Car.), 133.49 (Car.), 131.39 (Car.), 131.31 (Car.), 129.34 (Car.), 129.32 (Car.), 128.71 
(Car.), 128.19 (Car.), 76.27 (C-1). 
 
 
7.4.9 Oxodiperoxymolybdenum(pyridine)(hexamethylphosphoric-triamide) (MoOPH) 
(59)56 
 
MoO3 (30g, 0.2mol) was suspended in 150ml of a 30% aqueous solution of H2O2 and the 
mixture vigorously stirred. The mixture was immersed into a preheated oil bath (40 °C) 
until the internal temperature reached 35 °C. Then the bath was removed and the 
temperature maintained between 35 and 40 °C by cooling with a water bath if necessary. 
After the initial exothermic period, the mixture was stirred for 3.5h at 40 °C. After cooling 
to 20 °C, the reaction mixture was filtered to remove all solids, and the resulting yellow 
solution was cooled to 10 °C. HMPT (37.3g) was added under stirring and the crystalline 
precipitate was collected by suction. The solid was dried in a desiccator containing P2O5 
for 24h under vacuum. 
18g (51.9mmol) of the anhydrous complex (MoO5-HMPA) were dissolved in 40ml dry 
THF and at 20 °C (water bath) dry pyridine (4.11g, 51,9mmol, 1eq) was added dropwise 
under stirring. The yellow, crystalline precipitate was collected and washed successively 
with a small amount of THF (10ml) and dry diethyl ether (100ml). The product was dried 
under vacuum and stored at –20 °C in a dark glass flask. 
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7.4.10 (3S,4R,5S)-(-)-5-Benzyloxymethyl-4-(dimethyl-phenyl-silanyl)-3-hydroxy-
dihydro-furan-2-one (61) 
 
200mg (0.58mmol) of (4R,5S)-(-)-5-benzyloxymethyl-4-(dimethyl-phenyl-silanyl)-
dihydro-furan-2-one (54) were dissolved in 15ml of dry THF and the resulting solution 
stirred under argon at –78 °C. Then, KHMDS (0.5M in toluene; 2.4ml, 1.23mmol, 2.1eq) 
was added dropwise and after 10min solid MoOPH (59, 255mg, 0.58mmol, 1eq) was 
added in one portion. The mixture was stirred for 1h at –60 °C, poured at this temperature 
into 20ml of a 5% aqueous solution of NaHSO3, and was then extracted with 50 ml Et2O. 
The organic phase was washed with brine and dried over anhydrous Na2SO4. The crude 
product was purified by column chromatography on silica gel using as eluent n-
hexane/AcOEt (3/1) to afford 61 in 52% yield (220mg) as colorless oil. 
 
61
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Rf : 0.28 n-hexane/AcOEt (3/1). 
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[ ]20Dα = -10.2 (c 1.48, CHCl3). 
 
 
1H NMR (CDCl3): 
 
δ 7.51-7.27 (m, 10H, 2Ph), 4.46 (s, 2H, C-6), 4.39 (m, 1H, C-4), 4.28 (m, 1H, C-2), 3.55 
(dd, J=11.69 Hz, J=2.03 Hz, 1H, C-5), 3.41 (br, OH), 3.29 (dd, J=11.69 Hz, J=5.08 Hz, 
1H, C-5), 1.92 (t, J=10.17 Hz, 1H, C-3), 0.44 (s, 3H, C-11), 0.40 (s, 3H, C-11). 
 
 
13C NMR (CDCl3): 
 
δ 177.28 (C.1), 137.22 (C-7), 134.97 (C-12), 133.78 (C-13), 129.94 (Car.), 128.44 (Car.), 
128.22 (Car.), 127.87 (Car.), 127.77 (Car.), 79.24 (C-4), 73.41 (C-6), 70.59 (C-5), 70.50 (C-
2), 32.94 (C-3), -3.82 (C-11), -5.28 (C-11).  
 
 
IR (film, cm-1): 
 
3431 (OH), 3068 (=C-Harom), 2955 (-CH2-asym), 2901 (-CH2-sym), 1774 (C=O). 
 
 
MS m/z: 
 
356 (M+), 341 (M+ - CH3.), 232 (C13H16O2Si+), 217 (C12H14O2Si+), 135 (PhMe2Si+), 113 
(C5H6O3+), 92, 75 (C2H2O3+), 43. 
 
 
Elemental Analysis:  
 
Anal. Calcd for C20H24O4Si: C, 67.38; H, 6.79. Found: C, 68.89 ; H, 6.47. 
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7.4.11 R-(+)-5-Benzyloxymethyl-5H-furan-2-one (1) from 61 via Tf2O 
 
To a stirred solution of 61 (100mg, 0.28mmol) in 4ml of anhydrous dichloromethane, at 0 
°C under argon, pyridine (45µl, 0.56mmol, 2eq) was added. Then, Tf2O (95µl, 0.56mmol, 
2eq) was added dropwise and the resulting mixture stirred for 3h at rt. Then, the mixture 
was transferred to a separatory funnel and the organic layer washed consecutively with a 
1% HCl aqueous solution, water and brine. The organic phase was dried over anhydrous 
Na2SO4 and after removal of the solvent, the crude product was purified by column 
chromatography on silica gel using as eluent Et2O/n-hexane (2/1)→Et2O. 1 was isolated in 
65% yield (37mg) as colorless oil. 
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All spectroscopic data were identical with those already reported above (paragraph 7.3.7). 
 
 
7.4.12 R-(+)-5-Benzyloxymethyl-5H-furan-2-one (1) from 61 via DCC/CuCl 
 
In a 10ml round bottomed flask equipped with magnetic stirrer and condenser, 61 (200mg, 
0.56mml) was dissolved in 3ml of 1,4-dioxane. Then, DCC (139mg, 0.67mmol, 1.2eq) and 
CuCl (catalytic ammounts, a few mg’s) were successively added and the resulting mixture 
was stirred for 3 days at 50 °C. After this time the solvent was removed and the crude 
product redissolved in 5ml of dry toluene. To this solution at rt solid ClCH2CO2H (64mg, 
0.67mmol, 1.2eq) was added in one portion. The mixture was refluxed for 24h, allowed to 
cool at rt, and after removal of the solvent the crude product was purified by column 
chromatography on silica gel using as eluent Et2O/n-hexane (2/1)→Et2O. 1 was isolated in 
40% yield (55mg) as a colorless oil.  
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All spectroscopic data were identical with those already reported above (paragraph 7.3.7). 
 
 
7.4.13 (3S,4S,5S)-(-)-5-Benzyloxymethyl-3,4-dihydroxy-dihydro-furan-2-one (65) 
 
Method A: 
 
To a vigorously stirred solution of R-(+)-5-benzyloxymethyl-5H-furan-2-one (1, 500mg, 
2.45mmol) and dicyclohexano-18-crown-6 (91.2mg, 0.24mmol, 0.1eq) in 15ml of dry 
dichloromethane, under argon, at –42 °C (CH3CN/CO2 bath) KMnO4 (465mg, 2.94mmol, 
1.2eq) was added in several portions over 30min. The mixture was stirred for 2h at that 
temperature and then transferred to a separatory funnel. 2g of solid Na2SO3 were added, 
followed by the dropwise addition of 1M H2SO4 under shaking until complete 
decolorization was observed. The mixture was filtered by suction to remove excess solids 
and the aqueous phase was extracted with dichloromethane (2x20ml). The collected 
organic layers were dried over anhydrous Na2SO4 and the solvent evaporated under 
reduced pressure. The crude product was purified by column chromatography over silica 
gel using as eluent AcOEt/n-hexane (2/1). The diol 65 (291mg) was obtained in 60% yield 
by taking into account the recovered starting material 1 (85mg). Recrystallization from 
AcOEt/n-hexane gave 65 in form of white needles. 
 
 
Method B: 
 
R-(+)-5-benzyloxymethyl-5H-furan-2-one (1, 500mg, 2.45mmol) was dissolved in 10ml 
acetone/H2O 9:1 (v/v) to which at -5 °C, KMnO4 (465mg, 2.94mmol, 1.2eq) was added in 
several portions, thereby maintaining the temperature below 0 °C. The mixture was stirred 
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for 2h at that temperature, and if required additional KMnO4 was added to the mixture until 
complete disappearance of the starting material (T.l.c.). The solution was then heated to 50 
°C for 10min, filtered by suction and transferred to a separatory funnel. 2g of solid Na2SO3 
were added followed by the dropwise addition of 1M H2SO4 under shaking until complete 
decolorization was observed. The mixture was diluted with AcOEt and extracted with 
water and brine. The organic phase was dried over anhydrous Na2SO4 and the solvent 
evaporated under reduced pressure. The crude product was purified by column 
chromatography over silica gel using as eluent AcOEt/n-hexane (2/1). The diol 65 was 
obtained in only 27% yield (158mg) and no starting material could be recovered.  
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m.p. 106-107 °C (from AcOEt/n-hexane). 
 
 
Rf : 0.25 AcOEt/n-hexane (2/1)  
 
 
[ ]20Dα = -22.7 (c 0.91, acetone). 
 
 
1H NMR (acetone-d6):  
 
δ 7.36-7.23 (m, 5H, Ph), 4.62 (br, 2OH), 4.59 (d, J=5.59 Hz, 1H, C-2), 4.52 (s, 2H, C-6), 
4.46 (t, J=3.05 Hz, 1H, C-4), 4.36 (d, J=5.59 Hz, 1H, C-3), 3.75 (dd, J=11.08 Hz, J=3.05 
Hz, 1H, C-5), 3.71 (dd, J=10.92 Hz, J=3.12 Hz, 1H, C-5’). 
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13C NMR (acetone-d6):  
 
δ 177.02 (C-1), 139.57 (C-7), 129.85 (Car), 129.14 (Car), 129.05 (Car), 84.99 (C-4), 74.65 
(C-6), 71.64 (C-2), 70.93 (C-5), 70.44 (C-3).   
 
 
IR (KBr, cm-1): 
 
3474 (OH), 3298 (OH), 2923 (-CH2-asym), 2864 (-CH2-sym), 1756 (C=O). 
 
 
MS m/z: 
 
238 (M+), 107 (PhCH2O+), 91 (tropyllium ion). 
 
 
Elemental Analysis:  
 
Anal. Calcd for C12H14O5: C, 60.50; H, 5.92. Found: C, 60.14; H, 5.45. 
 
 
7.4.14 (3S,4S,5S)-(+)-5-Benzyloxymethyl-4-hydroxy-3-(4-methylbenzenesulfonate)-
dihydro-furan-2-one (78) 
 
Method A: 
 
280mg of (3S,4S,5S)-(-)-5-benzyloxymethyl-3,4-dihydroxy-dihydro-furan-2-one (65, 
1.17mmol) were dissolved in 10ml of dry dichloromethane. To this stirred solution, at 0 °C 
was added Et3N (248µl, 1.76mmol, 1.5eq) followed by the addition of solid p-TsCl 
(224mg, 1.17mmol, 1eq) in one portion. The mixture was allowed to stand in a freezer at –
20 °C without stirring for 18h and was then diluted with dichloromethane (10ml). The 
organic layer was consecutively washed with aqueous 1N HCl and brine and then dried 
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over anhydrous Na2SO4. The crude product was purified by column chromatography on 
silica gel using as eluent AcOEt/n-hexane (1/1) and 78 was isolated as pale yellow oil in 
82% yield (363mg). 
 
 
Method B: 
 
100mg of (3S,4S,5S)-(-)-5-benzyloxymethyl-3,4-dihydroxy-dihydro-furan-2-one (65, 
0.42mmol) were dissolved in 1ml of pyridine. Then, p-TsCl (80mg, 0.42mmol, 1eq), 
dissolved in 1ml acetone was added slowly and dropwise within 5min via a syringe and the 
resulting mixture stirred over night at 0 °C. Then, the mixture was transferred to a 
separatory funnel, diluted with 10ml AcOEt, and extracted with a 5% aqueous solution of 
HCl (2x5ml). The organic layer was washed with brine and dried over anhydrous Na2SO4. 
The solvents were removed under reduced pressure and the crude product was purified by 
column chromatography on silica gel using as eluent AcOEt/n-hexane (1/1). 78 was 
isolated as pale yellow oil in 50% yield (82mg). 
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Rf : 0.38 AcOEt/n-hexane (1/1) 
 
 
[ ]20Dα = +37.2 (c 1.0, CHCl3). 
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1H NMR (CDCl3):  
 
δ 7.80 (d, J=8.14 Hz, 2H, C-12), 7.40-7.22 (m, 7H, C-8–C10, C-13), 5.34 (d, J=5.09 Hz, 
1H, C-2), 4.62 (d, J=5.09 Hz, 1H, C-3), 4.59 (m, C-4), 4.53 (d, J=11.69 Hz, 1H, C-6), 4.48 
(d, J=11.69 Hz, 1H, C-6’), 3.73 (t, J=2.03 Hz, 2H, C-5), 2.56 (br, 1OH), 2.45 (s, 3H, C-
15).  
 
 
13C NMR (CDCl3):  
 
δ 169.27 (C-1), 145.88 (C-14), 136.79 (C-7), 131.56 (Car), 130.01 (Car), 128.62 (Car), 
128.28 (Car), 127.97 (Car), 127.70 (Car), 83.61 (C-4), 74.30 (C-2), 73.85 (C-6), 70.15 (C-3), 
68.86 (C-5), 21.70 (C-15). 
 
 
IR (film, cm-1): 
 
3508 (OH), 2924 (-CH2-asym), 2870 (-CH2-sym), 1797 (C=O), 1370 (-SO3-). 
 
 
MS m/z: 
 
392 (M+), 237 (M+ - CH3PhSO2.), 220 (C12H12O4+), 155 (CH3PhSO2+), 107 (PhCH2O+), 91 
(tropyllium ion). 
 
 
Elemental Analysis:  
 
Anal. Calcd for C19H20O7S: C, 58.15; H, 5.14; S, 8.17. Found: C, 58.01; H, 5.07; S, 8.05. 
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7.4.15 (4R,5S)-(-)-5-Benzyloxymethyl-4-hydroxy-dihydro-furan-2-one (48) from 78 
 
To a stirred solution of (3S,4S,5S)-(+)-5-Benzyloxymethyl-4-hydroxy-3-(4-methylbenzene 
sulfonate)-dihydro-furan-2-one (78, 300mg, 0.79mmol) in 5ml of THF at 0 °C, hydrazine 
(80% aq. solution, 370µl, 3.96mmol, 5eq) was added and the mixture stirred for 30min at 
rt. Then at 0°C, Br2 (304µl, 5.92mmol, 7.5eq) was added dropwise until no more N2 
evolution was observed. The organic solvent was removed under vacuum and the crude 
aqueous solution diluted with 10ml of water. The pH was adjusted to pH ≅7 and the 
aqueous phase was extracted with dichloromethane (3x10ml). After removal of the solvent, 
chromatographic purification on silica gel using as eluent n-hexane/AcOEt (1/1) yielded 
132mg of 48 (75%) as a colorless oil. Rf: 0.26 hexane/AcOEt (1/1). [ ]20Dα = -5.0 (c 1.44, 
CHCl3).  
 
48
O O
O
HO
1
3
4
56
7
8
8
9
9
10 2
 
 
All spectroscopic data were consistent with those already reported above (paragraph 7.4.5). 
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7.5 2-Deoxy-L-nucleosides 
 
7.5.1 α,β-(-)-Di-O-Acetyl-5-O-benzyl-2-deoxy-ribofuranose (79) 
 
To a stirred solution of α,β-(4R,5S)-(-)-5-benzyloxymethyl-tetrahydro-furan-2,4-diol (47, 
735mg, 3.27mmol) in 10ml of dry THF, under argon, at 0 °C pyridine (1.6ml, 19.66mmol, 
6eq) and Ac2O (8.1ml, 85.21mmol, 26eq) were added and the reaction mixture was stirred 
for 18h at rt. Then, the mixture was poured unto ice/H2O (50ml) and stirred for 30min. The 
solution was then extracted with dichloromethane (2x100ml) and the organic layer dried 
over Na2SO4. The crude product was purified by column chromatography on silica gel 
using as eluent n-hexane/AcOEt (2/1). 79 was isolated as colorless oil in 95% yield 
(950mg) as anomeric mixture (α/β ≅ 1/1, 1H-NMR). 
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Rf : 0.28 n-hexane/AcOEt (2/1) 
 
 
[ ]20Dα = -20.8 (c 1.38, CHCl3). 
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1H NMR (CDCl3): 
 
δ 7.37-7.25 (m, 10H, 2Ph), 6.38 (m, 2H, 2C-1), 5.32 (m, 1H, C-3), 5.23 (m, 1H, C-3), 4.57 
(s, 2H, C-6), 4.54 (d, J=4.57 Hz, 2H, C-6), 4.37 (m, 1H, C-4), 4.28 (m, 1H, C-4), 3.68 (dd, 
J=10.68 Hz, J=3.56 Hz, 1H, C-5), 3.62 (m, 3H, C-5), 2.49 (m, 2H, C-2), 2.27 (m, 2H, C-
2), 2.07 + 2.07 + 2.06 + 2.05 (4s, 12H, 2C-12 + 2C-14). 
 
 
13C NMR (CDCl3): 
 
δ 170.73 + 170.44 + 170.26 + 169.99 (2C-11 + 2C-13), 137.93 + 137.83 (2C-7), 128.33 
(Car), 128.28 (Car), 127.62 (Car), 127.57 (Car), 127.47 (Car), 127.46 (Car), 98.69 (C-1), 98.30 
(C-1), 85.03 (C-4), 83.85 (C-4), 74.35 (C-3), 74.28 (C-3), 73.56 (C-6), 73.32 (C-6), 70.48 
(C-5), 69.90 (C-5), 38.52 (C-2), 38.34 (C-2), 21.18 + 21.08 + 20.95 + 20.85 (2C-12 + 2C-
14) 
 
 
IR (film, cm-1):  
 
2936 (-CH2-asym), 2856 (-CH2-sym),, 1739 (C=O), 1232. 
 
 
MS m/z: 
 
248 (M+ - CH3CO2.), 91 (tropyllium ion). 
 
 
Elemental Analysis:  
 
Anal. Calcd for C16H20O6: C, 62.33; H, 6.54. Found: C, 62.21; H, 6.40. 
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7.5.2 α,β-(+)-3’-Acetyl-5’-benzyl-L-thymidine (80) 
 
Thymine (410mg, 3.24mmol, 2eq) was suspended in 20ml hexamethyldisilazane (HMDS) 
together with a catalytic amount of (NH4)2SO4 and heated at 150 °C until a clear solution 
was formed (3-5 hours). Then, the solvent was removed via short path distillation at 30 °C 
under high vacuum. The crude product containing the thus silylated thymine was dissolved 
in 5 ml of dry CH3CN. To this solution 79 (400mg, 1.29mmol), dissolved in 10ml of dry 
CH3CN was added. The mixture was cooled to –30 °C and under argon TMS-triflate 
(256µl, 1.42mmol, 1.1eq) was added dropwise. The temperature was allowed to reach 0 °C 
and the mixture was stirred for a further 30min. T.l.c analysis showed complete 
conversion. Dichloromethane was then added (25ml) and the entire mixture poured unto 
ice/water (50ml) and stirred for a few minutes. Then, 70ml of a saturated solution of 
NaHCO3 were added and the separated aqueous layer extracted with dichloromethane 
(2x100ml). The collected organic layers were washed with brine and dried over anhydrous 
Na2SO4. Purification was accomplished by column chromatography on silica gel using as 
eluent AcOEt/n-hexane (2/1) to afford 80 as amorphous solid in 73% yield (355mg) as a 
1:2 mixture of the α and β anomers (1H-NMR analysis). 
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Rf : 0.26 AcOEt/n-hexane (2/1) 
 
 
[ ]20Dα = +13.7 (c 0.93, CHCl3). 
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1H NMR (CDCl3): 
 
 β-anomer: δ 9.03 (br, 1NH), 7.55 (s, 1H, C-13), 7.40-7.28 (m, 5H, Ph), 6.44 (dd, J=9.15 
Hz, J=5.59 Hz, 1H, C-1), 5.37 (d, J=5.08 Hz, 1H, C-3), 4.58 (m, 2H, C-6), 4.18 (m, 1H, C-
4), 3.81 (m, 1H, C-5), 3.62 (m, 1H, C-5’), 2.38 (dd, J=14.24 Hz, J=5.59 Hz, 1H, C-2), 2.26 
(m, 1H, C-2’), 2.10 (s, 3H, C-12), 1.62 (s, 3H, C-17). 
 
 
1H NMR (CDCl3): 
 
α-anomer: δ 8.94 (br, 1NH), 7.40-7.28 (m, 6H, Ph + C-13), 6.32 (dd, J=7.12 Hz, J=2.03 
Hz, 1H, C-1), 5.29 (d, J=6.10 Hz, 1H, C-3), 4.58 (m, 3H, C-6 + C-4), 3.81 (m, 1H, C-5), 
3.62 (m, 1H, C-5’), 2.87 (m, 1H, C-2), 2.15 (m, 1H, C-2’), 2.03 (s, 3H, C-12), 1.94 (s, 3H, 
C-17). 
 
 
13C NMR (CDCl3): 
 
δ 170.54 + 169.90 (2C-11), 163.86 + 163.60 (2C-15), 150.49 + 150.30 (2C-16), 137.43 + 
137.28 (2C-7), 135.55 + 135.42 (2C-13), 128.62 + 128.50 + 128.09 + 127.87 + 127.57 + 
127.45 (4C-8 + 4C-9 + 2C-10), 111.35 + 110.06 (2C-14), 86.89 (α-anomer, C-1), 86.02 
(α-anomer, C-4), 84.69 (β-anomer, C-1), 84.00 (β-anomer, C-4), 75.69 (β-anomer, C-3), 
75.19 (α-anomer, C-3), 73.75 + 73.70 (2C-6), 70.52 + 70.48 (2C-5), 38.92 (α-anomer, C-
2), 37.73 (β-anomer, C-2), 20.94 + 20.89 (2C-12), 12.59 +12.09 (2C-17). 
 
 
IR (film, cm-1): 
 
3160 (C=C), 3040, 1690 (COO + CO-NH-CO), 1460 . 
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MS m/z: 
 
374 (M+), 249 (M+ -thymine), 189 (C12H14O2+), 159 (C7H10O4+), 121, 91 (tropyllium ion) 
 
 
Elemental Analysis:  
 
Anal. Calcd for C19H22N2O6: C, 60.95; H, 5.92; N, 7.48. Found: C, 60.11; H, 5.23; N, 7.08. 
 
 
7.5.3 α,β-(+)-5’-Benzyl-L-thymidine (81) 
 
To a stirred solution of 80 (240mg, 0.64mmol) in 3ml of MeOH, 1ml of n-butylamine was 
added and the mixture stirred for 3h at rt. A clear solution was obtained. Then, the solvent 
and excess n-BuNH2 were removed under vacuum and the crude product purified by 
column chromatography on silica gel using as eluent AcOEt. 81 was isolated in 90% yield 
(212mg) as colorless oil as anomeric mixture (α/β ≅ 1/2, 1H-NMR). 
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Rf : 0.30 AcOEt 
 
 
[ ]20Dα = +4.46 (c 0.94, CHCl3). 
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1H NMR (CDCl3): 
 
δ 9.14 (NH), 9.00 (NH), 7.56 (d, J=1.01 Hz, 1H, C-11), 7.50 (d, J=1.01 Hz, 1H, C-11), 
7.39-7.26 (m, 10H, 2Ph), 6.40 (dd, J=7.62 Hz, J=6.10 Hz, 1H, C-1), 6.12 (dd, J=7.62 Hz, 
J=2.54 Hz, 1H, C-1), 4.59 (s, 2H; C-6), 4.55 (d, J=4.00 Hz, 2H, C-6), 4.46 (m, 1H, C-4), 
4.43 (m, 1H, C-4), 4.12 (m, 2H, 2C-3), 3.79 (dd, J=10.17 Hz, J=2.54 Hz, 1H, C-5), 3.68 
(dd, J=10.68 Hz, J=3.05 Hz, 1H, C-5), 3.56 (m, 2H, C-5), 3.23 (m, 1H, C-2), 2.73 (m, 1H, 
C-2), 2.35 (m, 1H, C-2), 2.20 (m, 1H, C-2), 1.89 (s, 3H, C-15), 1.64 (s, 3H, C-15). 
 
 
13C NMR (CDCl3): 
 
δ 164.49 + 164.10 (2C-13), 150.68 (2C-14), 137.63 (C-7), 137.49 (C-11), 137.46 (C-11), 
136.00 (C-7), 128.93 (Car), 128.51 (Car), 128.40 (Car), 128.13 (Car), 127.91 (Car), 127.74 
(Car), 127.55 (Car), 127.43 (Car), 110.89 + 109.77 (2C-12), 87.93 (C-1 +C-4), 86.03 (C-4), 
84.97 (C-1), 73.54 (C-6), 73.49 (C-6), 72.36 (C-3), 72.23 (C-3), 70.59 (C-5), 70.26 C-5), 
40.76 (C-2), 39.53 (C-2), (C-15), 12.06 (C-15). 
 
 
IR (film, cm-1): 
 
3361 (OH), 3195 (C=C), 2929 (-CH2-asym), 2863 (-CH2-sym), 1693 (CO-NH-CO), 1472. 
 
 
MS m/z: 
 
332 (M+), 207 (M+ - thymine), 99, 91 (tropyllium ion). 
 
 
Elemental Analysis: 
 
Anal. Calcd for C17H20N2O5: C, 61.44; H, 6.07; N, 8.43. Found: C, 61.35; H, 6.01; N, 8.21. 
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7.5.4 α,β-(-)-L-Thymidine (82) 
 
In a 50ml Schlenk flask equipped with amagnetic stirrer, 10ml of MeOH were degassed for 
a few minutes by connecting the flask to an aspirator. Then, 10% Pd/C (20mg) was 
carefully added and the solution degassed again for a few minutes. After this, the plug 
valve was closed thereby taking care to avoid any entry of air and the flask was then 
connected under vacuum with a hydrogen source via a rubber hose. The suspension was 
vigorously stirred for 15min and after this period 81 (186mg, 0.55mmol), dissolved in 2ml 
degassed MeOH was added and the resulting mixture stirred for 1h at rt. Removal of the 
catalyst by filtration and evaporation of the solvent afforded a crude product which was 
purified by column chromatography on silica gel using as eluent AcOEt/MeOH 9/1. The 
anomeric mixture of 82 was obtained in 76% yield (102mg) as white solid as anomeric 
mixture (α/β ≅ 1/2, 1H-NMR). The anomeric ratio was also confirmed via HPLC using as 
reference natural β-D-thymidine (column LiChroCART 250-4, LiChroSPHER 100, RP-8 
(5µm), UV 262, eluent: methanol - phosphate buffer pH 4.4 – water (0.1:5:94.9), flow rate 
1ml/min). 
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m.p. 162 - 163 °C (from AcOEt/MeOH 9/1). 
 
 
Rf : 0.35 AcOEt/MeOH 9/1. 
 
 
[ ]20Dα = -19.2 (c 1.0, MeOH). 
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1H NMR (CDCl3):  
 
β-anomer: δ 7.70 (s, 1H, C-6), 6.13 (m, 1H, C-1), 4.42 (m, 1H, C-3), 4.35 (m, 1H, C-4), 
3.67 (dd, J=17.80 Hz, J=5.59 Hz, 1H, C-5), 3.58 (dd, J=12.20 Hz, J=5.08 Hz, 1H, C-5’), 
2.68 (m, 1H, C-2), 2.12 (m, 1H, C-2’), 1.86 (s, 3H, C-10). 
 
 
13C NMR (CDCl3)  
 
β-anomer: δ 168.93 (C-8), 153.85 (C-9), 140.28 (C-6), 112.85 (C-7), 90.77 (C-4), 89.14 
(C-1), 72.91 (C-3), 63.75 (C-5), 41.71 (C-2), 13.81 (C-10). 
 
 
1H NMR (CDCl3):  
 
α-anomer: δ 7.59 (s, 1H, C-6), 6.23 (t, J=6.74 Hz, 1H, C-1), 4.42 (m, 1H, C-3), 3.97 (m, 
1H, C-4), 3.80 (dd, J=12.20 Hz, J=3.56 Hz, 1H, C-5), 3.71 (dd, J=12.71 Hz, J=5.08 Hz, 
1H, C-5’), 2.32 (m, 2H, C-2), 1.84 (s, 3H, C-10). 
 
 
13C NMR (CDCl3): 
 
α-anomer: δ 168.68 (C-8), 153.90 (C-9), 139.72 (C-6), 113.65 (C-7), 88.75 (C-4), 87.31 
(C-1), 72.70 (C-3), 63.44 (C-5), 40.77 (C-2), 13.75 (C-10). 
 
 
IR (Kbr, cm-1): 
 
3311 (OH), 3156 (C=C), 3025 (CO-NH), 2975 (-CH2-asym), 2836 (-CH2-sym), 1700 (C=O), 
1658 (C=O),  
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MS m/z  
 
242 (M+), 126 (thymine), 117 (M+ - thymine). 
 
 
Elemental Analysis:  
 
Anal. Calcd for C10H14N2O5: C, 49.58; H, 5.83; N, 11.56. Found: C, 49.41; H, 5.60; N, 
11.44. 
 
 
7.5.5 α,β-(-)-3’-Acetyl-5’-benzyl-2’-deoxy-L-adenosine (83) 
 
Adenine (201mg, 1.49mmol, 1eq) was suspended in 5ml hexamethyldisilazane (HMDS) 
together with a few mg’s of (NH4)2SO4 and heated at 150 °C until formation of a clear 
solution (3-5 hours). Then, the solvent was removed via short path distillation at 30 °C 
under high vacuum. The crude product containing the silylated adenine was dissolved in 
14ml of toluene/CH3CN (1/1 v/v) and to this solution α,β-(-)-Di-O-Acetyl-5-O-benzyl-2-
deoxy-ribofuranose (79, 460mg, 1.49mmol) was added together with KI (247mg, 
1.49mmol, 1eq) and dibenzo-18-crown-6 (107mg, 0.29mmol, 0.2eq). The resulting mixture 
was refluxed for 4h, allowed to cool at rt and then transferred to a separatory funnel. The 
organic phase was washed successively with H2O and brine and then dried over anhydrous 
Na2SO4. Evaporation of the solvents under reduced pressure afforded a crude product 
which was purified by column chromatography on silica gel using as eluent AcOEt/MeOH 
(9/1 v/v). 83 was isolated in 56% yield (320mg) as a pale yellow solid as anomeric mixture 
(α/β ≅ 2/1, 1H-NMR). 
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m.p.: 56 – 57 °C (form AcOEt/MeOH). 
 
 
Rf : 0.46 AcOEt/MeOH 9/1. 
 
 
[ ]20Dα = -9.2 (c 0.6, MeOH). 
 
 
1H NMR (CDCl3): 
 
α anomer: δ 8.34 (s, 1H, C-16), 8.09 (s, 1H, C-13), 7.36-7.27 (m, 5H, Ph), 6.55 (dd, 
J=7.62 Hz, J=2.03 Hz, 1H, C-1), 6.34 (s, NH2), 5.39 (m, 1H, C-3), 4.56 (m, 3H, 2C-6 + C-
4), 3.70 (dd, J=10.68 Hz, J=3.56 Hz, 1H, C-5), 3.65 (dd, J=10.68 Hz, J=3.56 Hz, 1H, C-
5’), 2.97 (m, 1H, C-2), 2.61 (d, J=14.75 Hz, 1H, C-2’), 1.95 (s, 3H, C-12)  
 
 
13C NMR (CDCl3): 
 
α anomer: δ 170.11 (C-11), 155.62 (C-15), 152.91 (C-16), 149.38 (C-17), 138.37 (C-13), 
137.51 (C-7), 128.38 (Car), 127.74 (Car), 127.47 (Car), 119.71 (C-14), 85.63 (C-4), 85.38 
(C-1), 75.22 (C-3), 73.64 (C-6), 70.32 (C-5), 38.65 (C-2), 20.79 (C-12). 
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1H NMR (CDCl3): 
 
β anomer: δ 8.31 (s, 1H, C-16), 8.09 (s, 1H, C-13), 7.36-7.27 (m, 5H, Ph), 6.52 (dd, 
J=8.64 Hz, J=6.10 Hz, 1H, C-1), 6.39 (s, NH2), 5.45 (m, 1H, C-3), 4.56 (m, 2H, 2C-6), 
4.28 (m, C-4), 3.75 (d, J=3.05 Hz, 2H, C-5), 2.75 (m, 1H, C-2), 2.55 (ddd, J=14.24 Hz, 
J=6.10 Hz, J=1.52 Hz 1H, C-2’), 2.09 (s, 3H, C-12). 
 
 
13C NMR (CDCl3): 
 
β anomer: δ 170.33 (C-11), 155.67 (C-15), 152.96 (C-16), 149.64 (C-17), 138.43 (C-13), 
137.26 (C-7), 128.47 (Car), 127.92 (Car), 127.70 (Car), 119.52 (C-14), 84.17 (C-4), 83.96 
(C-1), 75.72 (C-3), 73.69 (C-6), 70.26 (C-5), 38.54 (C-2), 20.87 (C-12). 
 
 
IR (Kbr, cm-1): 
 
3323 + 3172 (d, N-Hstr), 1740 (C=O), 1647 + 1597 (d, N-Hdef.). 
 
 
MS m/z 
 
383 (M+), 292 (M+ - PhCH2.), 277 (C11H11N5O4+), 218 (C10H11N5O+), 164, 135 (adenine). 
 
 
7.5.6 α,β-(-)-5’-Benzyl-2-deoxy-L-adenosine (84) 
 
To a stirred solution of α,β-(-)-3’-Acetyl-5’-benzyl-2’-deoxy-L-adenosine (83, 238mg, 
0.62mmol) in 3ml of MeOH, 1ml of n-butylamine was added and the mixture stirred for 1h 
at rt. Then, the solvent and excess n-BuNH2 were removed under vacuum and the crude 
product purified by column chromatography on silica gel using as eluent AcOEt/MeOH 
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9/1. 84 was isolated in 88% yield (185mg) as a white solid as anomeric mixture (α/β ≅ 2/1, 
1H-NMR). 
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m.p.: 59 – 60 °C (from AcOEt/MeOH) 
 
 
Rf : 0.33 (AcOEt/MeOH 9/1). 
 
 
[ ]20Dα = -8.3 (c 0.7, MeOH). 
 
 
1H NMR (CDCl3): 
 
α anomer: δ 8.36 (s, 1H, C-14), 8.17 (s, 1H, C-11), 7.35-7.21 (Ph, 5H), 6.39 (dd, J=7.62 
Hz, J=2.03 Hz, 1H, C-1), 4.53 (d, J=1.01 Hz, 2H, C-6), 4.43 (m, 1H, C-3), 4.39 (m, 1H, C-
4), 3.58 (d, J=4.06 Hz, 2H, C-5), 2.89 (m, 1H, C-2), 2.38 (m, 1H, C-2). 
 
 
13C NMR (CDCl3): 
 
α anomer: δ 157.39 (C-13), 153.49 (C-11), 149.80 (C-15), 141.93 (C-14), 139.48 (C-7), 
129.42 (Car), 128.81 (Car), 128.82 (Car), 120.46 (C-12), 89.37 (C-4), 86.78 (C-1), 74.58 (C-
6), 74.50 (C-3), 71.90 (C-5), 41.62 (C-2). 
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1H NMR (CDCl3): 
 
β anomer: δ 8,23 (s, 1H, C-14), 8.15 (s, 1H, C-11), 7.35-7.21 (Ph, 5H), 6.43 (t, J=6.61 Hz, 
1H, C-1), 4.57 (m, 1H, C-3), 4.52 (s, 2H, C-6), 4.11 (m, 1H, C-3), 3.73 (dd, J=10.68 Hz, 
J=3.56 Hz, 1H, C-5), 3.66 (dd, J=10.68 Hz, J=4.06 Hz, 1H, C-5’), 2.71 (m, 1H, C-2), 2.44 
(m, 1H, C-2’). 
 
 
13C NMR (CDCl3): 
 
β anomer: δ 157.25 (C-13), 153.80 (C-11), 150.31 (C-15), 140.76 (C-14), 139.30 (C-7), 
129.45 (Car), 128.91 (Car), 128.75 (Car), 120.26 (C-12), 87.87 (C-4), 85.76 (C-1), 74.50 (C-
6), 72.92 (C-3), 71.32 (C-5), 41.59 (C-2). 
 
 
IR (Kbr, cm-1): 
 
3323 + 3170 (d, N-Hstr), 3300 (OH), 1650 + 1600(d, N-Hdef.). 
 
 
MS m/z  
 
341 (M+), 250 (M+ - Bn.),135 (adenine), 108 (BnO+) 91 (tropyllium ion). 
 
 
7.5.7 α,β-(-)-2-Deoxy-L-adenosine (85) 
 
84 (63mg, 0.18mmol) was dissolved in 4ml EtOH and 2ml cyclohexene. To this solution 
50mg of Pd(OH)2/C were added and the resulting suspension stirred for 2h at reflux. Then 
the cooled mixture was filtered to remove the catalyst and the solvents were evaporated 
under reduced pressure. The crude product was purified by column chromatography on 
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silica gel using as eluent MeOH/AcOEt 2/1. 85 was isolated in 65% yield (30mg) as a 
white solid. Anomeric mixture (α/β ≅ 2/1, 1H-NMR) 
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m.p.: 158 – 160 °C (from AcOEt/MeOH). 
 
 
Rf : 0.46 (MeOH/AcOEt 2/1). 
 
 
[ ]20Dα = -27 (c 1, MeOH). 
 
 
1H NMR (CDCl3): 
 
α anomer: δ 8.38 (s, 1H, C-9), 8.18 (s, 1H, C-6), 6.40 (m, 1H, C-1), 4.43 (m, 1H, C-3), 
4.28 (m, 1H, C-4), 3.64 (dd, J=11.69 Hz, J=4.06 Hz, 1H, C-5), 3.59 (dd, J=12.20 Hz, 
J=4.57 Hz, 1H, C-5’), 2.86 (m, 1H, C-2), 2.43 (m, 1H, C-2’). 
 
 
13C NMR (CDCl3): 
 
α anomer: δ 157.52 (C-8), 153.49 (C-6), 149.91 (C-10), 141.86 (C-9), 120.45 (C-7), 90.83 
(C-4), 86.65 (C-1), 72.95 (C-3), 63.46 (C-5), 41.63 (C-2). 
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1H NMR (CDCl3): 
 
β anomer: δ 8.28 (s, 1H, C-9), 8.15 (s, 1H, C-6), 6.40 (m, 1H, C-1), 4.55 (m, 1H, C-3), 
4.04 (m, 1H, C-4), 3.82 (dd, J=12.20 Hz, J=3.05 Hz, 1H, C-5), 3.71 (dd, J=12.20 Hz, 
J=3.56 Hz, 1H, C-5’), 2.78 (m, 1H, C-2), 2.37 (m, 1H, C-2’). 
 
 
13C NMR (CDCl3): 
 
β anomer: δ 157.49 (C-8), 153.49 (C-6), 149.96 (C-10), 141.50 (C-9), 120.86 (C-7), 89.88 
(C-4), 87.09 (C-1), 73.01 (C-3), 63.62 (C-5), 41.54 (C-2). 
 
 
IR (Kbr, cm-1):  
 
3320 + 3180 (d, N-Hstr), 3200 (OH), 1640 + 1605(d, N-Hdef.). 
 
 
MS m/z: 
 
251 (M+), 162 (C7H7N5), 100 (C5H8O2). 
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7.6 δ-lactones 
 
7.6.1 R-(-)-5-Hydroxy-hex-2-ynoic acid tert-butyl ester (88) 
 
To a stirred solution of tert-butyl propiolate (23.5ml, 0.17mol, 1.2eq) in 1L of dry THF, 
under argon, at –78 °C, n-butyllithium (15% in n-hexane, 104.4ml, 0.17mol, 1.2eq) was 
added dropwise. After stirring for 30 min. R-(+)-2-methyl-oxirane (10ml, 0.14mol) in 30ml 
of dry THF and BF3-Et2O (17.9ml, 0.14mol, 1eq) were added and the reaction mixture was 
stirred for 2.5 hours. Subsequently the temperature was increased to –10 °C and the 
reaction was quenched with 50ml of a saturated aqueous solution of NH4Cl. Water and 
AcOEt were added to favor phase separation and the separated aqueous phase was 
extracted twice with AcOEt. The collected organic layers were washed with brine and then 
dried over anhydrous Na2SO4. After filtration and removal of the solvents under reduced 
pressure on a rotavapor, the crude product mixture containing also the impurities derived 
from the hydrolysis of BF3-Et2O (boronates) was either directly purified by column 
chromatography on silica gel using as eluent n-hexane/AcOEt (3/1) or stored in the freezer 
over night. (88 had been observed to be instable in the crude mixture at rt). After 
chromatography 88 was isolated in 87% yield (22.8g) as a pale yellow oil. 
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Rf : 0.23 (n-hexane/AcOEt 3/1).  
 
 
[ ]20Dα = -11.9 (c 1.7, CHCl3);  
 
 
 
                                                                                                               Experimental Section 
 
 155 
1H NMR (CDCl3): 
 
δ 4.02 (m, 1H, C-2), 2.48 (br, 1OH), 2.42 (d, J=5.95, 2H, C-3), 1.44 (s, 9H, C-8), 1.24 (d, 
J=6.21, 3H, C-1). 
 
 
13C NMR (CDCl3): 
 
δ 152.74 (C-6), 83.41 (C-4), 83.23 (C-5), 76.23 (C-2), 65.78 (C-7), 29.02 (C-3), 27.91 (C-
8), 22.48 (C-1).  
 
 
IR (film, cm-1): 
 
3390 (OH), 2945 (-CH3), 2900 (-CH2-asym), 2215 (-C≡C-), 1690 (C=O). 
 
 
MS m/z:  
 
140 (C8H11O2+), 128 (M+ - t-Bu.), 111 (M+ - t-BuO.), 101 (t-BuOC=O+), 84 (C5H7O+), 67 
(C4H2O+), 56, 41.  
 
 
Elemental Analysis:  
 
Anal. Calcd for C10H16O3: C, 65.13; H, 8.68. Found: C, 64.32; H, 8.71. 
 
 
7.6.2 R-(-)-5-Hydroxy-hexanoic acid tert-butyl ester (89) 
 
2 g of 5% Pd/C were placed in a 500ml Schlenk round bottom flask equipped with 
magnetic stirrer and a septum to which 200ml of AcOEt (HPLC grade) were added. The 
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resulting suspension was degassed under stirring for 5min by applying vacuum using an 
aspirator. After this, the plug valve was closed thereby taken great care to avoid any entry 
of air and the flask under vacuum was connected under vacuum with a hydrogen source via 
a rubber hose. The resulting suspension was vigorously stirred for 30min to allow 
absorption of H2 onto the metal surface. After this time the solution was cooled to –20 °C 
and 88 (20.1 g, 0.11mol) dissolved in 20ml of AcOEt was added. The mixture was stirred 
for 6 hours at –20 °C while the reaction progress was monitored via GC analysis of drawn 
samples. The samples were drawn as follows: with a syringe connected to a long needle a 
few drops of the suspension were taken from the flask, filtered in a micro chromatography 
column consisting of a Pasteur pipette filled with about 3cm silica gel in order to remove 
the catalyst. To elute the products HPLC grade AcOEt was used and the resulting eluate 
injected into the gas chromatograph. When the starting material was completely consumed 
(6h), the suspension was filtered using a double filter in order to avoid the presence of any 
traces of catalyst and the organic solvent removed under reduced pressure. Without further 
purification 89 was isolated in quantitative yield (20.5 g) and 97% purity (GC analysis) as 
a colorless oil. 
 
89
OH O
O1
2
3
4
5
6 7 8
8
8
 
Rf : 0.20 (n-hexane/AcOEt 3/1).  
 
 
[ ]20Dα = -6.3 (c 1.8, CHCl3);  
 
 
1H NMR (CDCl3): 
 
δ 3.76 (m, 1H, C-2), 2.21 (t, J=7.54, 2H, C-5), 1.63 (m, 2H, C-3 + 1OH), 1.42 (m, 2H, C-
4), 1.41 (s, 9H, C-8), 1.16 (d, J=6.14, 3H, C-1);  
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13C NMR (CDCl3): 
 
δ 173.14 (C-6), 80.16 (C-2), 67.49 (C-7), 38.60 (C-3), 35.30 (C-5), 28.08 (C-8), 23.42 (C-
1), 21.11 (C-4);  
 
 
IR (film, cm-1): 
 
3420 (OH), 2960 (-CH3), 2920 (-CH2-asym), 1715 (C=O).  
 
 
MS m/z: 
 
115 (M+ - t-BuO.), 97 (C6H10O+), 88, 73 (t-BuO+), 69, 57 (t-Bu+), 45, 41;  
 
 
Elemental Analysis: 
 
Anal. Calcd for C10H20O3: C, 63.74; H, 10.62. Found: C, 62.97; H, 10.34. 
 
 
7.6.3 R-(+)-6-Methyl-tetrahydro-pyran-2-one (87) from 89 
 
Method A: 
 
To a stirred solution of 89 (19.6 g, 0.104mol) in 500ml of anhydrous dichloromethane, 
under argon atmosphere, at rt, 0.7ml of trifluoroacetic acid were added dropwise and the 
resulting mixture stirred for a period of 24h. The course of the reaction was monitored via 
GC by taking aliquots from the solution with a capillary and diluting the probe with HPLC 
grade AcOEt. The resulting solution could be directly injected in the gas chromatograph 
for analysis. After completion of the reaction the entire solution was transferred to a 
separatory funnel and the organic phase was extracted twice with a saturated aqueous 
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solution of Na2CO3 (2x100ml). Particularly attention must be addressed to this operation. 
Vigorous shaking during the extractions is essential in order to completely remove all TFA 
into the aqueous phase (see chapter 5 for discussion). The separated organic layer was then 
washed with brine and dried over anhydrous Na2SO4. The solvent was evaporated under 
reduced pressure and the resulting crude product purified by column chromatography on 
silica gel  using as eluent Et2O/n-hexane 2/1. After removal of the solvents again under 
removed pressure, a short path distillation (Kugelrohr, 70 °C, 10-3 mbar) afforded 4.1g of 
87 (35% yield) as white crystals.  
 
 
Method B: 
 
30ml of toluene and 30ml of water were placed into a separatory funnel and shaken well. 
The water saturated organic phase was then separated and transferred into a 100ml Schlenk 
flask containing 89 (2.9g, 15.55mmol). To this stirred solution solid p-toluenesulfonic acid 
(296mg, 1.55mmol, 0.1eq) was added and the resulting mixture refluxed for 1.30h. After 
this period, the solution was allowed to cool to rt and the solvent was removed under 
reduced pressure. Without any additional work-up, the crude product (containing also p-
TsOH) was purified by column chromatography on silica gel using as eluent Et2O/n-
hexane 2/1. After removal of the solvents, a short path distillation (Kugelrohr, 70 °C, 10-3 
mbar) afforded 1.2g of 87 (70% yield) as white crystals.  
 
87
O O1
2
3
4
5
6
 
 
m.p. 31 °C.  
 
 
Rf : 0.32 (n-hexane/AcOEt 2/1)  
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[ ]20Dα = +36 (c 0.7, CHCl3);  
 
 
1H NMR (CDCl3): 
 
δ 4.39 (m, 1H, C-5), 2.44 (m, 2H, C-2), 1.84 (m, 3H, 2H(C-3) + 1H(C-4)), 1.47 (m, 1H, C-
4), 1.32 (d, J=6.10, 3H, C-6);  
 
 
13C NMR (CDCl3): 
 
δ 171.67 (C-1), 76.76 (C-5), 29.47 (C-2), 29.09 (C-4), 21.56 (C-3), 18.40 (C-6).  
 
 
IR (film, cm-1): 
 
2945 (-CH3), 1720 (C=O). 
 
 
MS m/z: 
 
114 (M+), 99 (M+ - .CH3), 70 (C4H6O+), 55, 42 (C3H6+), 39. 
 
 
Elemental Analysis:  
 
Anal. Calcd for C6H10O2: C, 63.14; H, 8.83. Found: C, 62.52; H, 8.57. 
 
 
 
 
 
                                                                                                               Experimental Section 
 
 160 
7.6.4 (6R,12R,18R)-(-)-6,12,18-Trimethyl-1,7,3-trioxa-cyclooctadecane-2,8,14-trione 
(90)  
 
Trifluoroacetic acid (0.043mmol, 3.3µl, 0.01eq) was added to 500mg of neat 87 and the 
mixture was homogenized by gently heating the mixture to 40 °C until complete melting 
was observed and then stored at 20 °C. NMR spectra (1H and 13C) were taken every 7 days 
in order to establish the rate of formation of trimer 90. After 5 weeks an equilibrium was 
reached between the monomer 87 and the trimer 90. This mixture was dissolved in 10ml of 
dichloromethane and the resulting solution washed twice with 5ml of a saturated aqueous 
solution of Na2CO3. The separated organic phase was dried over anhydrous Na2SO4 and 
the solvent evaporated under vacuum. 87 could be removed from the mixture by short path 
distillation (Kugelrohr, 100 °C, 10-3mBar) to afford pure 90 in 50% (250mg) yield as 
highly viscous colorless oil. 
 
90
O
O
O
O
O
O 1
2 3
4
5
12 4
4
5
5
6
6
6
1
2
3
3
 
 
[ ]20Dα = -8 (c 0.6, CHCl3);  
 
 
1H NMR (CDCl3): 
 
δ 4.90 (m, 3H), 2.29 (m, 6H), 1.61 (m, 12H), 1.21 (d, J=6.10, 9H);  
 
 
 
                                                                                                               Experimental Section 
 
 161 
13C NMR (CDCl3):  
 
δ 172.84 (C-1), 70.37 (C-5), 35.23 (C-2), 34.18 (C-4), 20.81 (C-3), 19.87 (C-6).  
 
 
IR (film, cm-1): 
 
2921 (-CH3), 1701 (C=O).  
 
 
Elemental Analysis:  
 
Anal. Calcd for C18H30O6: C, 63.14; H, 8.83. Found: C, 62.62; H, 8.59. 
 
 
7.6.5 R-(+)-6-Methyl-tetrahydro-pyran-2-one (87) from 90 
 
The trimer 90 (5.0 g, 14.60mmol) was dissolved in THF (200ml) and at 0 °C 2N NaOH 
(50ml) was slowly added. After stirring at rt for 30 min, the pH was adjusted to pH=1-2 
with concentrated aqueous HCl. The solvents were removed under reduced pressure and 
the crude product containing NaCl was dried over night in a vacuum-desiccator containing 
P2O5. The so obtained δ-hydroxy acid 91 was suspended in anhydrous dichloromethane 
(100ml) and trifluoroacetic acid (500µl) was then added under argon. The mixture was 
stirred over night at rt, the organic layer was washed with a saturated aqueous solution of 
Na2CO3, water, brine and dried over anhydrous Na2SO4. The solvent was removed under 
reduced pressure and the crude product purified by column chromatography on silica gel 
using as eluent Et2O/n-hexane 2/1. The collected fractions were evaporated and after short 
path distillation on a Kugelrohr (10-3mBar, 70 °C), 87 was obtained in 35% overall yield 
(1.7g).  
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7.6.6 Determination of molecular weight of 90 by freezing point depression 
 
1.27 g of 1,4-dioxane was placed into a test tube (13cm x 1.3cm) containing a small 
magnetic stirrer. The test tube was closed with a septum which was previously pierced in 
order to allow the insertion of a metal contact thermometer with electronic display (0.1 °C 
scale). This apparatus was immersed into a cooling bath maintained at 0 °C and the 
solution was stirred. Every 15 seconds the temperature was recorded until it became 
constant for ca. 30 seconds. This value (10.6 °C) was taken as freezing point of pure 1,4-
dioxane (a supercooling effect was observed). Then 90 (91 mg) was added carefully to the 
test tube thereby avoiding any loss of solvent until a homogeneous solution was obtained 
and the experiment was repeated as above recording the data. The thus obtained freezing 
point of the solution was +9.7 °C. 
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Applying the formula for the calculation of the molecular weight via the freezing point 
depression of a substance we found:  
 
(Kf) (g solute)
MW =
∆Tf  (Kg solvent) - 0.9 x (1.27 x 10-3) 
= 367.16    (theor. 342.43)- 4.63 x 0.091 =
 
 
supercool ing
effect
freezing poin t
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Kf  is the cryoscopic constant (-4.63 for 1,4-dioxane) and ∆Tf = Tf solution - Tf solvent is the 
difference of the freezing points between pure 1,4-dioxane and the above described 
solution of 90 in the same solvent. The error thus was 7.2%. 
   
Bibliography 
                                                                                                                             Bibliography 
 165 
Bibliography 
 
                                                 
1  a) R.L. Letsinger, W.B. Lunsford, J. Am. Chem. Soc. 1976, 98, 3655; b) S.L. 
Beaucage, M.H. Caruthers, Tetrahedron Lett. 1981, 22, 1859; c) K.K. Ogilvie, N. 
Usman, J. Nicoghosian, R.J. Cedergren, Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 5764. 
2  a) A.M. Belikova, V.F. Zarytova, N.I. Grineva, Tetrahedron Lett. 1967, 37, 3557; b) 
P.S. Miller, S. Chandrasegaran, D.L. Dow, S.M. Pulford, L.S. Kan, Biochemistry 
1982, 21, 5468; c) B.M. Paterson, B.E. Roberts, E.L. Kuff, Proc. Natl. Acad. Sci. 
U.S.A. 1977, 74, 4370; d) P.C. Zamecnik, M.L. Stephenson, Proc. Natl. Acad. Sci. 
U.S.A. 1978, 75, 280. 
3  C. Helene, J.J. Toulme, Biochim. Biophys. Acta 1990, 1049, 99. 
4  A. Bielinska, R.A. Shivdasani, L. Zhang, G.J. Nabel, Science 1990, 250, 997. 
5  B. Belleau, D. Dixit, N. Nguyen-Bu, J.L. Kraus, International Conference on AIDS, 
Montreal-Canada, 1989. 
6  a) J.A.V. Coates, N. Cammack, H.J. Jenkinson, Antimicrob. Agents Chemother. 
1992, 36, 202; b) R.F. Schinazi, C.K.Chu, A. Peck, Antimicrob. Agents Chemother. 
1992, 36, 672. 
7  S. Hellman, E.E. Vokes, Scientific American 1996, 84. 
8  M.J.C. Ellis, K. Sikora, Molecular Biology in Medicine 1997, 149. 
9  R.W. Ruddon, Cancer Biology 3rd edition, Oxford University Press, New York, 1995. 
10  W.P. Gati, L. Dagnino, A.R.P. Patterson, Biochem. J. 1989, 263, 957. 
11  T. Casillas, E.G. Delicado, F.G. Carmona, M.T.M. Portugal, Biochemistry 1993, 32, 
14203. 
12  A. Verri, A. Montecucco, G. Gosselin, V. Boudou, J.L. Imbach, S. Spadari, F. 
Focher, Biochem. J. 1999, 337, 585. 
13  K.L. Grove, Y.C. Cheng, Cancer Res. 1996, 56, 4187. 
14  a) S.A. Rabbani, P. Harakidas, T. Bowlin, G. Attardo, Cancer Res. 1998, 58, 3461; b) 
L.L. Sui, G. Attardo, E. Izbicka, R. Lawrence, C. Cerna, L. Gomez, K. Davidsin, C. 
Finake, C. Marsolais, E.K. Rowinsky, D.D. Von Hoff, Ann. Oncol. 1998, 9, 885. 
15  D.S. Shewach, D.C. Liotta, R.F. Schinazi, Biochem Pharmacol. 1993, 45, 1540. 
                                                                                                                             Bibliography 
 166 
                                                                                                                                                    
16  H. Pelicano, C. Pierra, S. Eriksson, G. Gosselin, J.L. Imbach, G. Maury, J. Med. 
Chem. 1997, 40, 3969. 
17  J. Balzarini, L. Naesens, E. De Clercq, Current Opinion in Microbiology 1998, 1, 
535. 
18  R.F. Schinazi, G. Gosselin, A. Faraj, B.E. Korba, D.C. Lotta, C.K. Chu, C. Mathè, 
J.L. Imbach, J.P. Sommadossi, Antimicrobial Agents and Chemotherapy 1994, 38, 
2172. 
19  M. Danis, M. Gentilini, Rev. Prat. 1998, 48, 254. 
20  a) Personal information, Prof. Dr. A.M. Gero, University of New South Wales, 
Sydney-Australia. b) J.M. Upston, A.M. Gero, Biochim. Biophys. Acta 1995, 123, 
249. 
21  H. Vorbrüggen, C. Ruh-Pohlenz, Organic Reactions 2000, 55, 1. 
22  a) A. Star, I. Goldberg, N.G. Lemcoff, B. Fuchs, Eur. J. Org. Chem. 1999, 9, 2033; 
b) Z.Y. Yao, Y.L. Wu, J. Org. Chem. 1995, 60, 1170; c) S. Takano, M. Akiyama, T. 
Sugihara, K. Ogasawara, Heterocycles 1992, 33, 831; d) J.P. Vigneron, R. Meric, M. 
Larcheveque, A. Debal, G. Kunesch, Tetrahedron Lett.  1982, 23, 5051. 
23  a) S. Takano, H. Numata, K. Ogasawara, Heterocycles 1980, 19, 327; b) M.E. Jung, 
T.J. Shaw, J. Am. Chem. Soc. 1980, 102, 6304; c) C. Hubschwerlen, Synthesis 1986, 
962; d) A.J. Mancuso, S.L. Huang, D. Swern J. Org. Chem. 1978, 43, 2480. 
24  E. Baer, M.O. Fisher, J. Am. Chem. Soc. 1939, 61, 761. 
25  M. Hanak, C.J. Collins, H. Stutz, B.M. Benjamin, J. Am. Chem. Soc. 1981, 103, 
2356. 
26  B. Häfele, V. Jäger, Liebigs Ann. Chem. 1987, 85. 
27  P. Camps, J. Cardellach, J. Font, R.M. Ortuno, O. Ponsati, Tetrahedron 1982, 38, 
2395. 
28  V. J. Patil, Tetrahedron Letters 1996, 37, 1481. 
29  A.H. Dekmezian, M.K. Kaloustian, Synth. Commun. 1979, 9, 431. 
30  K. Tomioka, T. Ishiguru, Y. Iitaka, K. Koga, Tetrahedron 1984, 40, 1303. 
31  K. Tomioka, T. Ishiguru, K. Koga, Tetrahedron Lett. 1980, 21, 2973. 
32  a) S. Hanessian, S. Sahoo, P. Saumya, M. Botta, Tetrahedron Lett. 1987, 28, 1147; b) 
S. Hanessian, P.J. Hodges, P.J. Murray, S.P. Sahoo, J. Chem. Soc., Chem. Commun. 
1986, 754; c) M. Figueredo, J. Font, A. Virgili, Tetrahedron 1987, 43, 1881; d) K. 
                                                                                                                             Bibliography 
 167 
                                                                                                                                                    
Tomioka, F. Sato, K. Koga, Heterocycles 1982, 17, 311; e) S. Hanessian, N.G. 
Cooke, B. De Hoff, Y. Sakito, J. Am. Chem. Soc. 1990, 112, 5276. 
33  H.J. Reich, F. Chow, S.K. Shah, J. Am. Chem. Soc. 1979, 101, 6638. 
34  a) S. Hanessian, P.J. Murray, S.P. Sahoo, Tetrahedron Lett. 1985, 26, 5623; b) S. 
Hanessian, P.J. Murray, Can J. Chem. 1986, 64, 2231; c) J. Nokami, T. Ono, Y. 
Kajitani, and S. Wakabayashi, Chem. Lett. 1984, 707; d) K. Akiba, Y. Takasu, M. 
Wada, Tetrahedron Lett. 1985, 20, 2463. 
35  D.G. Lee, T. Chen, J. Org. Chem. 1991, 56, 5346. 
36  R.M. Ortuno, M. Ballesteros, J. Corbera, F. Sanchez-Ferrando, J. Font, Tetrahedron 
1988, 44, 1711. 
37  S. Hardinger, N. Wijaya, Tetrahedron Lett. 1993, 34, 3821. 
38  a) Y. Kita, O. Tamura, F. Itoh, H. Yasuda, H. Kishino, Y.Y. Ke, Y. Tamura, J. Org. 
Chem. 1988, 53, 554; b) C. Vargeese, E. Abushanab, J. Org. Chem. 1990, 55, 4400; 
c) A.P. Kozikowski, A.K. Ghosh, J. Org. Chem. 1984, 49, 2762; d) M.E. Jung, Y. 
Xu, Tetrahedron Lett. 1997, 38, 4199. 
39  M.E. Jung, C.J. Nichols, Tetrahedron Lett. 1998, 39, 4615. 
40  M.E. Jung, C.J. Nichols, O. Kretschik, Y. Xu, Nucleosides Nucleotides, 1999, 18, 
541. 
41  B. Giese, S. Gilges, K.S. Gröninger, C. Lamberth, T. Witzel, Liebigs Ann. Chem. 
1988, 615. 
42  M.E. Jung, Y. Xu, Org. Lett. 1999, 1, 1517. 
43  R.G. Pearson, J. Am. Chem. Soc. 1963, 85, 3533. 
44  a) F.A. Kang, Z.Q. Yu, H.Y. Yin, C.L. Yin, Tetrahedron: Asymmetry 1997, 8, 3591; 
b) F.A Kang, C.L. Yin, Tetrahedron 1998, 54, 13155. 
45  a) M. Yoshida, R. Imai, Y. Komatsu, Y. Morinaga, N. Kamigata, M. Iyoda, J. Chem. 
Soc. Perkin Trans 1 1993, 4, 501; b) R. Alguacil, F. Farina, M.V. Martin, 
Tetrahedron 1996, 52, 3457; c) R.M. Ortuno, J. Cardellach, J. Font, J. Hetreocyclic 
Chem. 1987, 24, 79. 
46  W.D. Emmons, A.S. Pagano, J. Am. Chem. Soc. 1955, 77, 89. 
47  A.A. Jakubowski, F.S. Guziec, M. Sugiura, C.C. Tam, M. Tishler, J. Org. Chem. 
1982, 47, 1221. 
48  R. Curci, M. Fiorentino, L. Troisi, J. Org. Chem. 1980, 45, 4758. 
                                                                                                                             Bibliography 
 168 
                                                                                                                                                    
49  a) I. Fleming, N.L Reddy,. K. Takaky, A.C. Ware, J. Chem. Soc., Chem. Commun. 
1987, 1472; b) R.A.N.C. Crump, I. Fleming, C.J. Urch, J. Chem. Soc. Perkin Trans. 1 
1994, 701; c) I. Fleming, T.W. Newton, J. Chem. Soc. Perkin Trans. 1 1984, 1805; d) 
I. Fleming, T.W. Newton, F.J. Roessier, J. Chem. Soc. Perkin Trans. 1 1981, 2527; e) 
I. Fleming, D.C. Parker, H.E. Plaut, P.E.J. Sanderson, J. Chem. Soc. Perkin Trans. 1 
1995, 317. 
50  a) I. Fleming, R. Henning, H. Plaut, J. Chem. Soc., Chem. Commun. 1984, 29; b) I. 
Fleming, E. J. Sanderson, Tetrahedron Lett. 1987, 28, 4229; c) H.C. Kolb, S.V. Ley, 
A.M.Z. Slawin, D. J. Williams, J. Chem. Soc. Perkin Trans. 1 1992, 2735. 
51  a) F. Winterfeldt, Synthesis 1975, 617; b) N.M. Yoon, Y.G. Gyoung, J. Org. Chem. 
1985, 50, 2443; c) C. Dehoux, E. Fontaine, J.M. Escudier, M. Baltas, L. Gorrichon, J. 
Org. Chem. 1998, 63, 2601. 
52  a) T.A. Giudici, A.L. Fluharty, J. Org. Chem. 1967, 32, 2043; b) P. Kohn R.H. 
Samaritano, L.M. Lerner, J. Am. Chem. Soc. 1965, 87, 5475; c) H.C. Brown, D.B. 
Bigley, S.K. Arora, N.M. Yoon, J. Am. Chem. Soc. 1970, 92, 7161. 
53  a) Personal information, Prof. Dr. J. Buddrus, Inst. Spektrochem. & Angew. 
Spektroskopie, Dortmund, Germany; b) H. Bauer, A. Brinkmeier, J. Buddrus, M. 
Jablonowski, Liebigs Ann. Chem. 1986, 10, 1804. 
54  V.S. Rao, A.S. Perlin, Carbohydr. Res. 1980, 83, 175. 
55  a) F.A. Davis, A.C. Sheppard, Tetrahedron 1989, 45, 5703; b) F.A. Davis, L.C. 
Vishwakarma, J.M. Billmers, J. Org. Chem. 1984, 49, 3243; c) F.A. Davis, O.D. 
Stringer, J. Org. Chem. 1982, 47, 1774. 
56  a) M. Mimoun, L. Seere de Roch, L. Sajus, Bull. Soc. Chim. Fr. 1969, 1481; b) E. 
Vedejs, D.A. Engler, J.E. Telschow, J. Org. Chem. 1978, 43, 188; c) S. Hanessian, 
P.J. Murray, Tetrahedron 1987, 43, 5055. 
57  O. Mitsunobu, Synthesis 1981, 1. 
58  R.M. Moriarty, H. Zhuang, R. Penmasta, K. Liu, A.K. Awasthi, S.M. Tuladhar, 
M.S.C. Rao, V.K. Singh, Tetrahedron Lett. 1993, 34, 8029. 
59  G. Casy, G. Gorins, R. McCague, H.F. Olivo, S. Roberts, J. Chem. Soc. Chem. 
Commun.  1994, 1085. 
60  a) P.F. Hudrlik, D.J. Peterson, J. Am. Chem. Soc. 1975, 97, 1464; b) D.J. Peterson, J. 
Org. Chem. 1968, 33, 780. 
                                                                                                                             Bibliography 
 169 
                                                                                                                                                    
61  a) J.B. Lambert, E.C. Chelius, J. Am. Chem. Soc. 1990, 112, 8120; b) J.B. Lambert, 
Tetrahedron 1990, 46, 2677. 
62  J. Kaulen, Angew. Chem. 1987, 99, 800. 
63  T. Mukaiyama, F. Tabusa, K. Suzuki, Chem. Lett. 1983, 173. 
64  B. Sundermann, H.D. Scharf, Tetrahedron: Asymmetry 1996, 7, 1995. 
65  S. Hanessian, C. Girare, J.L. Chiara, Tetrahedron Lett. 1992, 33, 573. 
66  R.P. Elliot, G.W.J. Fleet, Y.S. Gyoung, N.G. Ramsden, C. Smith, Tetrahedron Lett. 
1990, 31, 3785. 
67  I. Kalwinsh, K.H. Metten, R. Breuckner, Heterocycles 1995, 40, 939. 
68  a) M.D. Smith, D.D. Long, D.G. Marquess, T.D.W. Claridge, G.W.J. Fleet, J. Chem. 
Soc. Chem. Commun. 1998, 18, 2039; b) S.J. Mantel, P.S. Ford, D.J. Watkin, G.W.J. 
Fleet, D. Brown, Tetrahedron 1993, 49, 3343. 
69  H. Paulsen, D. Stoye, Chem. Ber. 1966, 99, 908. 
70  a) K. Dax, A.P. Rauter, A.E. Steutz, H. Weidmann, Liebigs Ann. Chem. 1981, 10, 
1768; b) B.M. Malle, I. Lundt, R.H. Furneaux, J. Carbohydr. Chem. 2000, 19, 573. 
71  G.M. Blackburn, M.J. Gait, Nucleic acids in Chemistry and Biology, Oxford 
University Press, New York, 1996. 
72  E. Fischer, B. Helferich, Chem. Ber. 1914, 47, 210. 
73  a) W.W. Zorbach, Synthesis 1970, 329; b) L. Goodman, Basic Principles in Nucleic 
Acid Chemistry, Ts’o, P.O.P. Ed., Academic: New York, 1974. 
74  a) G.E. Hilbert, T.B. Johnson, J. Am. Chem. Soc. 1930, 52, 2001; b) G.E. Hilbert, 
T.B. Johnson, J. Am. Chem. Soc. 1930, 52, 4489; c) G.E. Hilbert, E.F. Jansen, J. Am. 
Chem. Soc. 1936, 58, 60. 
75  S. Czernecki, J.M. Valery, Synthesis 1991, 239. 
76  a) H. Vorbrüggen, G. Höfle, Chem. Ber. 1981, 114, 1256; b) H. Vorbrüggen, K. 
Krolikiewicz, B. Bennua, Chem. Ber. 1981, 114, 1234. 
77  a) A. Van Schepdael, F. Heerinckx, A. Van Aerschot, P. Herdewijn, E. Roets, J. 
Hoogmartens, Nucleosides, Nucleotides 1994, 13, 1113. b) K.L. Dueholm, E.B. 
Pedersen, Synthesis 1991, 1. 
78  A. Faraj, A.G. Loi, L. Cui, M.Y. Xie, M. Bryant, E.G. Bridges, A. Joudawis, C. 
Pierra, D. Dukhan, G. Gosselin, J.L. Imbach, R.F. Schinazi, B. Pai, B. Korba, P. 
Marion, J.P. Sommadossi, Antivir. Res. 2000, 4, 88. 
                                                                                                                             Bibliography 
 170 
                                                                                                                                                    
79  M.V. Baud, C. Chavis, M. Lucas, J.L. Imbach, Tetrahedron Lett. 1990, 31, 4437. 
80  M. Hoffer, Chem. Ber. 1960, 93, 2777. 
81  a) Z. Kazimierczuk, H.B. Cottam, G.R. Revankar, R.K. Robins, J. Am. Chem. Soc. 
1984, 106, 6379; b) Z. Kazimierczuk, J.A. Vilpo, F. Seela, Nucleosides Nucleotides 
1995, 14, 1403. 
82  M.P. Kotick, C. Szantay, T.J. Bardos, J. Org. Chem. 1969, 34, 3806. 
83  M. Prystas, F. Sorm, Collect. Czech. Chem. Commun. 1964, 29, 121. 
84  a) J.J. Fox, N.C. Yung, I. Wempen, M. Hoffer, J. Am. Chem. Soc. 1961, 83, 4066; b) 
H.J. Minnemeyer, P.B. Clarke, H. Tieckelmann, J.F. Holland, J. Med. Chem. 1964, 7, 
567; c) T.J. Bardos, M.P. Kotick, C. Szantay, Tetrahedron Lett. 1966, 1759; d) H. 
Aoyama, Bull. Chem. Soc. Jpn. 1987, 60, 2073. 
85  Z. Wang, D.R. Prudhomme, J.R. Buck, M. Park, C.J. Rizzo, J. Org. Chem. 2000, 65, 
5969. 
86  a) D.H.R. Barton, S.W. McCombie, J. Chem. Soc. Perkin Trans 1 1975, 1574; b) B. 
Quiclet-Sire, S.Z. Zard, Tetrahedron Lett. 1998, 39, 9435; c) K.S. Ramasamy, R.C. 
Tam, J. Bard, D.R. Averett, J. Med. Chem. 2000, 43, 1019. 
87  a) A.R. Maguire, W. Meng, S.M. Roberts, A.J. Willets, J. Chem. Soc. Perkin Trans 1 
1993, 15, 1795; b) P. Herdewijn, Tetrahedron 1989, 45, 6563. 
88  a) M.T. Davies-Coleman, D.E.A. Rivett, Fortschr. Chem. Org. Naturst. 1989, 55, 1; 
b) W. Albrecht, M. Schwarz, J. Heidlas, R. Tressl, J. Org. Chem. 1992, 57, 1954; c) 
J.M. Brand, Fortschr. Chem. Org. Naturst. 1979, 37, 1. 
89  a) B. Haase, M.P. Schneider, Tetrahedron: Asymmetry 1993, 4, 1017. b) Dissertation 
B. Haase, Bergische Universität, GH-Wuppertal, 1997. 
90  CI and electrospray MS analyses of 87 were carried out by the Bayer AG, Wuppertal, 
Germany. 
91  L. Mandolini, J. Am. Chem. Soc. 1978, 100, 550. 
92  J. Dale, J.E. Schwartz, Acta Chem. Scand. 1986, B 40, 559. 
93  D.D. Perrin, W.L.F. Armarego, D.R. Perrin, Purification of Laboratory Chemicals 
2nd Edition, Pergamon Press, 1980. 
94  R.A. Gakhokidze, N.N. Sidamonidze, J. Org. Chem. USSR 1987, 1017. 
95  T. Harada, T. Mukaiyama, Chem. Lett. 1981, 1109.  
96  F. Gasparini, P. Vogel, J. Org. Chem. 1990, 55, 2451. 
                                                                                                                             Bibliography 
 171 
                                                                                                                                                    
 
 
